<?xml version="1.0"?>


<!DOCTYPE rdf:RDF [
    <!ENTITY foaf "http://xmlns.com/foaf/0.1/" >
    <!ENTITY obo "http://purl.obolibrary.org/obo/" >
    <!ENTITY dc "http://purl.org/dc/elements/1.1/" >
    <!ENTITY xsd "http://www.w3.org/2001/XMLSchema#" >
    <!ENTITY ND "http://purl.obolibrary.org/obo/ND#" >
    <!ENTITY ND2 "http://purl.obolibrary.org/obo/ND/" >
    <!ENTITY snap "http://www.ifomis.org/bfo/1.1/snap#" >
    <!ENTITY ro "http://www.obofoundry.org/ro/ro.owl#" >
    <!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#" >
    <!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#" >
    <!ENTITY oboInOwl "http://www.geneontology.org/formats/oboInOwl#" >
]>


<rdf:RDF xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.w3.org/2002/07/owl"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:ro="http://www.obofoundry.org/ro/ro.owl#"
     xmlns:foaf="http://xmlns.com/foaf/0.1/"
     xmlns:ND2="&obo;ND/"
     xmlns:snap="http://www.ifomis.org/bfo/1.1/snap#"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
     xmlns:ND="&obo;ND#">
    <Ontology rdf:about="&obo;ND">
        <dc:contributor>Kinga Szigeti</dc:contributor>
        <dc:contributor>Alexander P. Cox</dc:contributor>
        <dc:contributor>Marcus Ng</dc:contributor>
        <dc:contributor>Patrick Ray</dc:contributor>
        <dc:contributor>Alexander D. Diehl</dc:contributor>
        <dc:contributor>Alan Ruttenberg</dc:contributor>
        <dc:contributor>Mark Jensen</dc:contributor>
        <dc:contributor>Naveed Chaudhry</dc:contributor>
        <dc:contributor>Bill Duncan</dc:contributor>
        <rdfs:comment xml:lang="en">More information can be found at http://code.google.com/p/neurological-disease-ontology/

There is a google group for discussing the ND project found at https://groups.google.com/forum/?hl=en&amp;fromgroups#!forum/nd-ontology

If you are interested in participating in the development of ND, please send an email to addiehl_at_buffalo.edu.</rdfs:comment>
        <dc:description xml:lang="en">The Neurological Disease Ontology (ND) provides a set of logically connected classes that represent the range of neurological diseases and their associated signs and symptoms, assessments, diagnoses, and interventions encountered in the course of clinical practice. ND is built as an extension of the Ontology for General Medical Sciences (OGMS). Classes in ND utilize both textual and axiomatized definitions that describe and formalize the relations between classes within the ontology itself as well as to classes in external ontologies.</dc:description>
        <imports rdf:resource="http://ogms.googlecode.com/svn/trunk/src/ontology/ogms.owl"/>
        <imports rdf:resource="&obo;ND/external/FMA_import.owl"/>
        <imports rdf:resource="&obo;ND/external/OBI_import.owl"/>
        <imports rdf:resource="&obo;ND/external/PR_import.owl"/>
    </Ontology>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000111 -->

    <rdf:Description rdf:about="&obo;IAO_0000111">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000115 -->

    <rdf:Description rdf:about="&obo;IAO_0000115">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000116 -->

    <rdf:Description rdf:about="&obo;IAO_0000116">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000117 -->

    <rdf:Description rdf:about="&obo;IAO_0000117">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000118 -->

    <rdf:Description rdf:about="&obo;IAO_0000118">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000119 -->

    <rdf:Description rdf:about="&obo;IAO_0000119">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000232 -->

    <rdf:Description rdf:about="&obo;IAO_0000232">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000412 -->

    <rdf:Description rdf:about="&obo;IAO_0000412">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/communityPrefLabel -->

    <AnnotationProperty rdf:about="&obo;communityPrefLabel"/>
    


    <!-- http://purl.obolibrary.org/obo/synonym -->

    <AnnotationProperty rdf:about="&obo;synonym"/>
    


    <!-- http://purl.org/dc/elements/1.1/contributor -->

    <rdf:Description rdf:about="&dc;contributor">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/elements/1.1/description -->

    <rdf:Description rdf:about="&dc;description">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/elements/1.1/license -->

    <AnnotationProperty rdf:about="&dc;license"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasDbXref -->

    <AnnotationProperty rdf:about="&oboInOwl;hasDbXref"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasSynonym -->

    <AnnotationProperty rdf:about="&oboInOwl;hasSynonym"/>
    


    <!-- http://xmlns.com/foaf/0.1/mbox -->

    <AnnotationProperty rdf:about="&foaf;mbox"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/BFO_0000050 -->

    <ObjectProperty rdf:about="&obo;BFO_0000050">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000052 -->

    <rdf:Description rdf:about="&obo;BFO_0000052">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000054 -->

    <rdf:Description rdf:about="&obo;BFO_0000054">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000055 -->

    <rdf:Description rdf:about="&obo;BFO_0000055">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000056 -->

    <rdf:Description rdf:about="&obo;BFO_0000056">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000057 -->

    <rdf:Description rdf:about="&obo;BFO_0000057">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000066 -->

    <rdf:Description rdf:about="&obo;BFO_0000066">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000082 -->

    <rdf:Description rdf:about="&obo;BFO_0000082">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000087 -->

    <rdf:Description rdf:about="&obo;BFO_0000087">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000110 -->

    <rdf:Description rdf:about="&obo;BFO_0000110">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000113 -->

    <rdf:Description rdf:about="&obo;BFO_0000113">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000117 -->

    <rdf:Description rdf:about="&obo;BFO_0000117">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000118 -->

    <rdf:Description rdf:about="&obo;BFO_0000118">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000127 -->

    <rdf:Description rdf:about="&obo;BFO_0000127">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000132 -->

    <rdf:Description rdf:about="&obo;BFO_0000132">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000133 -->

    <rdf:Description rdf:about="&obo;BFO_0000133">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000158 -->

    <rdf:Description rdf:about="&obo;BFO_0000158">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000167 -->

    <rdf:Description rdf:about="&obo;BFO_0000167">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000171 -->

    <rdf:Description rdf:about="&obo;BFO_0000171">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000186 -->

    <rdf:Description rdf:about="&obo;BFO_0000186">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/ND_0004000 -->

    <ObjectProperty rdf:about="&obo;ND_0004000">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdfs:label>results in</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>This is a shortcut relation.  More specifically:
(&apos;disease d&apos; results in &apos;syndrome s&apos;)
is a shortcut for:
((&apos;disease d&apos; realized in &apos;disease course c&apos;) and (&apos;disease course c&apos; produces &apos;syndrome s&apos;).  

Alternatively, if syndromes are process profiles, then:
(&apos;disease d&apos; results in &apos;syndrome s&apos;)
is a shortcut for:
((&apos;disease d&apos; realized in &apos;disease course c&apos;) and (&apos;disease course c&apos; has profile &apos;syndrome s&apos;))</obo:IAO_0000115>
        <obo:IAO_0000118>results_in</obo:IAO_0000118>
        <inverseOf rdf:resource="&obo;ND_0004001"/>
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND_0004001 -->

    <ObjectProperty rdf:about="&obo;ND_0004001">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdfs:label>results from</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>This is a shortcut relation.  More specifically:
(&apos;syndrome s&apos; results from &apos;disease d&apos;)
is a shortcut for:
((&apos;syndrome s&apos; produced by &apos;disease course c&apos;) and (&apos;disease course c&apos; realizes &apos;disease d&apos;)).

Alternatively, if syndromes are process profiles, then:
(&apos;syndrome s&apos; results from &apos;disease d&apos;)
is a shortcut for:
((&apos;syndrome s&apos; process profile of &apos;disease course c&apos;) and (&apos;disease course c&apos; realizes &apos;disease d&apos;)).</obo:IAO_0000115>
        <obo:IAO_0000118>results_from</obo:IAO_0000118>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000299 -->

    <rdf:Description rdf:about="&obo;OBI_0000299">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/ND#ND_diagnostic_criterion -->

    <ObjectProperty rdf:about="&obo;ND#ND_diagnostic_criterion">
        <rdfs:label>has diagnostic criterion</rdfs:label>
        <obo:IAO_0000115>A has diagnostic criterion B = B is either a necessary, sufficient, or partially sufficient condition for diagnosing a patient with A* according to the diagnostic guideline A.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:domain rdf:resource="&obo;ND_0001100"/>
        <rdfs:range rdf:resource="&obo;OGMS_0000014"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#ND_major_diagnostic_criterion -->

    <ObjectProperty rdf:about="&obo;ND#ND_major_diagnostic_criterion">
        <rdfs:label>has major diagnostic criterion</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A has major diagnostic criterion B = B is a necessary or sufficient condition for diagnosing a patient with A* according to the diagnostic guideline A.</obo:IAO_0000115>
        <obo:IAO_0000118>has primary diagnostic criterion</obo:IAO_0000118>
        <rdfs:domain rdf:resource="&obo;ND_0001100"/>
        <rdfs:range rdf:resource="&obo;OGMS_0000014"/>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#ND_diagnostic_criterion"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#ND_minor_diagnostic_criterion -->

    <ObjectProperty rdf:about="&obo;ND#ND_minor_diagnostic_criterion">
        <rdfs:label>has minor diagnostic criterion</rdfs:label>
        <obo:IAO_0000115>A has minor diagnostic criterion B = B is a non-necessary but partially sufficient condition for diagnosing a patient with A* according to the diagnostic guideline A.</obo:IAO_0000115>
        <obo:IAO_0000118>has secondary diagnostic criterion</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>has supporting diagnostic criterion</obo:IAO_0000118>
        <rdfs:domain rdf:resource="&obo;ND_0001100"/>
        <rdfs:range rdf:resource="&obo;OGMS_0000014"/>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#ND_diagnostic_criterion"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#ND_satisfies -->

    <ObjectProperty rdf:about="&obo;ND#ND_satisfies">
        <rdfs:label>satisfies</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A satisfies B = A is a clinical finding that matches diagnostic criterion A* which is part of diagnostic guideline B</obo:IAO_0000115>
        <rdfs:range rdf:resource="&obo;ND_0001100"/>
        <rdfs:domain rdf:resource="&obo;OGMS_0000014"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#definitely_indicates -->

    <ObjectProperty rdf:about="&obo;ND#definitely_indicates">
        <rdfs:label>indicates definite presence of</rdfs:label>
        <obo:IAO_0000115>A indicates definite presence of B = A is a diagnosis of a patient that hypothesizes with a very high degree of certainty that the disease, disorder, syndrome, or nothing abnormal of type B inheres in the patient.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#indicates"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#indicates -->

    <ObjectProperty rdf:about="&obo;ND#indicates">
        <rdfs:label>indicates presence of</rdfs:label>
        <obo:IAO_0000115>A indicates presence of B = A is a diagnosis of a patient that hypothesizes that the disease, disorder, syndrome, or nothing abnormal of type B inheres in the patient.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:domain rdf:resource="&obo;OGMS_0000073"/>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#is_about"/>
        <rdfs:range>
            <Class>
                <unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;OGMS_0000031"/>
                    <rdf:Description rdf:about="&obo;OGMS_0000045"/>
                    <rdf:Description rdf:about="&obo;OGMS_0000086"/>
                    <rdf:Description rdf:about="&obo;ND#normal"/>
                </unionOf>
            </Class>
        </rdfs:range>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#is_about -->

    <ObjectProperty rdf:about="&obo;ND#is_about">
        <rdfs:label>is about</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#lacks -->

    <ObjectProperty rdf:about="&obo;ND#lacks">
        <rdfs:label>lacks clinical finding</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A lacks clinical finding B = B is a clinical finding, A is a diagnostic guideline, and the presence of B must be ruled out in order to conclude a diagnostic process with a diagnosis of A*, where A* is the diagnosis associated with A.</obo:IAO_0000115>
        <rdfs:domain rdf:resource="&obo;ND_0001100"/>
        <rdfs:range rdf:resource="&obo;OGMS_0000014"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#possibly_indicates -->

    <ObjectProperty rdf:about="&obo;ND#possibly_indicates">
        <rdfs:label>indicates possible presence of</rdfs:label>
        <obo:IAO_0000115>A indicates possible presence of B = A is a diagnosis of a patient that hypothesizes with a moderate degree of certainty that the disease, disorder, syndrome, or nothing abnormal of type B inheres in the patient.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#indicates"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#probably_indicates -->

    <ObjectProperty rdf:about="&obo;ND#probably_indicates">
        <rdfs:label>indicates probable presence of</rdfs:label>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A indicates probable presence of B = A is a diagnosis of a patient that hypothesizes with a moderately high degree of certainty that the disease, disorder, syndrome, or nothing abnormal of type B inheres in the patient.</obo:IAO_0000115>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#indicates"/>
    </ObjectProperty>
    


    <!-- http://purl.obolibrary.org/obo/ND#warrants -->

    <ObjectProperty rdf:about="&obo;ND#warrants">
        <rdfs:label>warrants</rdfs:label>
        <obo:IAO_0000115>A warrants B = A is a diagnostic guideline that has had its diagnostic criteria satisfied such that the physician is justified in concluding the diagnostic process for the patient with the diagnosis B.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:domain rdf:resource="&obo;ND_0001100"/>
        <rdfs:range rdf:resource="&obo;OGMS_0000073"/>
        <rdfs:subPropertyOf rdf:resource="&obo;ND#is_about"/>
    </ObjectProperty>
    


    <!-- http://www.obofoundry.org/ro/ro.owl#has_part -->

    <ObjectProperty rdf:about="&ro;has_part"/>
    


    <!-- http://www.obofoundry.org/ro/ro.owl#has_participant -->

    <ObjectProperty rdf:about="&ro;has_participant"/>
    


    <!-- http://www.obofoundry.org/ro/ro.owl#located_in -->

    <ObjectProperty rdf:about="&ro;located_in"/>
    


    <!-- http://www.obofoundry.org/ro/ro.owl#part_of -->

    <ObjectProperty rdf:about="&ro;part_of"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/BFO_0000019 -->

    <rdf:Description rdf:about="&obo;BFO_0000019">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000028 -->

    <rdf:Description rdf:about="&obo;BFO_0000028">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000040 -->

    <rdf:Description rdf:about="&obo;BFO_0000040">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/BFO_0000141 -->

    <rdf:Description rdf:about="&obo;BFO_0000141">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/CHEBI_33708 -->

    <Class rdf:about="&obo;CHEBI_33708">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/FMA_242199 -->

    <rdf:Description rdf:about="&obo;FMA_242199">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_242789 -->

    <rdf:Description rdf:about="&obo;FMA_242789">
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000028"/>
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_256237 -->

    <rdf:Description rdf:about="&obo;FMA_256237">
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_50801 -->

    <rdf:Description rdf:about="&obo;FMA_50801">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_61824 -->

    <rdf:Description rdf:about="&obo;FMA_61824">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_62907 -->

    <rdf:Description rdf:about="&obo;FMA_62907">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_67112 -->

    <rdf:Description rdf:about="&obo;FMA_67112">
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000141"/>
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/FMA_67165 -->

    <rdf:Description rdf:about="&obo;FMA_67165">
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000005 -->

    <rdf:Description rdf:about="&obo;IAO_0000005">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000007 -->

    <rdf:Description rdf:about="&obo;IAO_0000007">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000033 -->

    <rdf:Description rdf:about="&obo;IAO_0000033">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
        <obo:IAO_0000412 rdf:resource="&obo;iao.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/NCBITaxon_10239 -->

    <rdf:Description rdf:about="&obo;NCBITaxon_10239">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/NCBITaxon_2 -->

    <rdf:Description rdf:about="&obo;NCBITaxon_2">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/NCBITaxon_9606 -->

    <rdf:Description rdf:about="&obo;NCBITaxon_9606">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000001 -->

    <Class rdf:about="&obo;ND_0000001">
        <rdfs:label>neurological disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;OGMS_0000031"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005501"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000082"/>
                                        <someValuesFrom rdf:resource="&obo;OGMS_0000087"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000031"/>
        <obo:IAO_0000115>A disease which has material basis in a neurological disorder and, when realized, the resultant pathological processes affect functioning of the nervous system.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.nlm.nih.gov/medlineplus/neurologicdiseases.html</obo:IAO_0000119>
        <obo:IAO_0000118>nervous system disease</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000111>neurological disease</obo:IAO_0000111>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12681</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000116>Neurological diseases affect the functioning of the nervous system and are caused by structural, biochemical, or electrical abnormalities in the brain, spinal cord, peripheral nerves, plexus or glia.

There are varying etiologies and material bases for neurological diseases, resulting in various patholgies, all somewhat loosely associated by &quot;affecting&quot; the nervous system.</obo:IAO_0000116>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000002 -->

    <Class rdf:about="&obo;ND_0000002">
        <rdfs:label>central nervous system disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000001"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005501"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000171"/>
                                        <someValuesFrom rdf:resource="&obo;ND_0002023"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000232>This is a defined class that is included for the purpose of capturing a representation of all diseases that affect the central nervous system.</obo:IAO_0000232>
        <obo:IAO_0000115>Central nervous system disease is a neurological disease that affects the central nervous system.</obo:IAO_0000115>
        <obo:IAO_0000115>Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <rdfs:comment>A neurological disease realized by processes which are manifested in the central nervous system of an organism OR for whichthe disorder is located in/part of CNS.

One problem: does this mean ALL processes, how is relavence decided?</rdfs:comment>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?field=uid&amp;term=D002493</oboInOwl:hasDbXref>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000003 -->

    <Class rdf:about="&obo;ND_0000003">
        <rdfs:label>peripheral nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000115>Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
Donat Sule</obo:IAO_0000115>
        <obo:IAO_0000115>A peripheral nervous system disease is a neurological disease that affects the peripheral nervous system.</obo:IAO_0000115>
        <obo:IAO_0000232>This is a defined class that is included for the purpose of capturing a representation of all diseases that affect the peripheral nervous system.</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi</oboInOwl:hasDbXref>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000004 -->

    <Class rdf:about="&obo;ND_0000004">
        <rdfs:label>typical Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000152"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003002"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006007"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000152"/>
        <obo:IAO_0000115>Alzheimers disease is a neurological disease where episodic memory loss occurs with at least one other cognitive deficit [visual spatial, attention, orientation, executive function, functional] that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrillary tangles in the medial temporal lobes.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000006 -->

    <Class rdf:about="&obo;ND_0000006">
        <rdfs:label>disease resulting in dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000001"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?field=uid&amp;term=D003704</oboInOwl:hasDbXref>
        <rdfs:comment>Check Kinga&apos;s slides for all 6 domains of cognitive function!

*** UPDATE ***

There were 8 domains listed in the slides: 

Memory
Language
Perceptual skills
Attention
Constructive abilities
Orientation
Problem solving
Functional abilities

*** CHANGE COGNITIVE DEFICITS IN ALL INSTANCES OF DEMENTIA TO WHATEVER LIST IS USED IN THIS DEFINITION ***
Update: I think that all affected definitions have been changed, but this should be rechecked. (Alex Cox)</rdfs:comment>
        <obo:IAO_0000118>dementia disease</obo:IAO_0000118>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/dementias/dementia.htm </obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>a descriptive term for a collection of symptoms that can be caused by a number of disorders that affect the brain. People with dementia have significantly impaired intellectual functioning that interferes with normal activities and relationships. They also lose their ability to solve problems and maintain emotional control, and they may experience personality changes and behavioral problems, such as agitation, delusions, and hallucinations. While memory loss is a common symptom of dementia, memory loss by itself does not mean that a person has dementia.</obo:IAO_0000115>
        <obo:IAO_0000232>Should the logical definition for this class be simply:
disease and (&apos;results in&apos; some dementia)
instead?

Alexander P. Cox</obo:IAO_0000232>
        <obo:IAO_0000116>This is a defined class that is included for the purpose of representing all diseases that result in dementia (the syndrome).</obo:IAO_0000116>
        <obo:IAO_0000116>Neither of these defintion are correct. This is a simple &quot;syntactic&quot; class, and as such needs only a straightforward defintion. The explanatory exposition belongs with the description of the syndrome. 

Eg- A neurological disease which results in [produces] dementia syndrome.

-MJ</obo:IAO_0000116>
        <obo:IAO_0000115>Dementia is a neurological disease where at least two cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia.</obo:IAO_0000115>
        <obo:IAO_0000115>An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.</obo:IAO_0000115>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000007 -->

    <Class rdf:about="&obo;ND_0000007">
        <rdfs:label>autonomic nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <oboInOwl:hasDbXref>birnlex_12579</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12579</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.</obo:IAO_0000115>
        <obo:IAO_0000115>An autonomic nervous system disease is a neurological disease that affects the autonomic nervous system.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000008 -->

    <Class rdf:about="&obo;ND_0000008">
        <rdfs:label>enteric nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <obo:IAO_0000115>A disease of the enteric nervous system (which directly controls the gastrointestinal system).

</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>This term is not included in the NIF-Dysfunction ontology, but is a plausible sister class of both &apos;sympathetic nervous system disease&apos; and &apos;parasympathetic nervous system disease&apos;.</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000009 -->

    <Class rdf:about="&obo;ND_0000009">
        <rdfs:label>infectious disease resulting in dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000180"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000006"/>
        <rdfs:comment>A number of infectious agents can cause dementia in the elderly: fungi, parasites and viruses. Dementia can also occur with illnesses such as AIDS and Lyme disease.</rdfs:comment>
        <obo:IAO_0000118>infectious dementia</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurology.osu.edu/cognitive/dementia.html</obo:IAO_0000119>
        <obo:IAO_0000115>Infectious dementia is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by an infectious agent.</obo:IAO_0000115>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000010 -->

    <Class rdf:about="&obo;ND_0000010">
        <rdfs:label>HIV related dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000180"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005038"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000180"/>
        <obo:IAO_0000115>HIV related dementia is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by an HIV infection.</obo:IAO_0000115>
        <rdfs:comment>change label to &apos;HIV related dementia&apos;</rdfs:comment>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Neurological_Complications_of_AIDS</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>HIV-related dementia</obo:IAO_0000118>
        <obo:IAO_0000115>AIDS is primarily an immune system disorder caused by the human immunodeficiency virus (HIV), but it can also affect the nervous system. HIV does not appear to directly invade nerve cells but it jeopardizes their health and function, causing symptoms such as confusion, forgetfulness, behavioral changes, severe headaches, progressive weakness, loss of sensation in the arms and legs, stroke, cognitive motor impairment, or damage to the peripheral nerves. Other complications that can occur as a result of HIV infection or the drugs used to treat it include pain, seizures, shingles, spinal cord problems, lack of coordination, difficult or painful swallowing, anxiety disorder, depression, fever, vision loss, gait disorders, destruction of brain tissue, and coma. Other AIDS-related nervous system disorders may be caused by certain cancers or by illnesses that would not otherwise affect people with healthy immune systems. Among the most common neurological complications are: AIDS dementia complex, causing symptoms such as encephalitis (inflammation of the brain), behavioral changes, and a gradual decline in cognitive function; central nervous system lymphomas, cancerous tumors that either begin in the brain or result from a cancer that has spread from another site in the body; cryptococcal meningitis; cytomegalovirus infections; herpes virus infections; neuropathy; neurosyphilis; progressive multifocal leukoencephalopathy (PML); and psychological and neuropsychiatric disorders.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000011 -->

    <Class rdf:about="&obo;ND_0000011">
        <rdfs:label>dementia associated with Huntingtons disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000114"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000114"/>
        <rdfs:comment>*** DOUBLE-CHECK THIS LABEL ***</rdfs:comment>
        <obo:IAO_0000119>http://www.emedicinehealth.com/huntington_disease_dementia/article_em.htm</obo:IAO_0000119>
        <obo:IAO_0000115>Dementia associated with Huntingtons disease is Huntingtons disease that results in dementia.</obo:IAO_0000115>
        <obo:IAO_0000115>Huntington disease (HD) is a devastating disorder that destroys nerve cells (neurons) in parts of the brain. It also lowers levels of chemicals called neurotransmitters that carry signals in the brain. Loss of these cells and neurotransmitters causes uncontrolled movements, loss of mental abilities, and changes in personality, emotional state, or behavior. Mental, emotional, or behavioral decline severe enough to interfere with the ability to carry out everyday activities is known as dementia. </obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000012 -->

    <Class rdf:about="&obo;ND_0000012">
        <rdfs:label>sympathetic nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <rdfs:comment>There was neither a definition for &apos;sympathetic nervous system disease&apos; provided by the NIF-Dysfunction ontology nor available on wikipedia.  For this reason, a basic Aristotelian definition has been provided for this term.</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12589</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A disease of the sympathetic nervous system (which is responsible for accelerating the heart rate, constricting blood vessels and raising blood pressure).

Symptoms of SNS Disorders

    Blood pressure problems like high blood pressure
    Erectile dysfunction in men
    Heart diseases
    Trouble with breathing and swallowing
    Headache
    Memory loss
    Tremors, seizures
    Loss of muscle strength
    Slurred speech

Causes of SNS Disorders

Nervous system disorder is also known as &apos;dysautonomia&apos;. If you know the anatomy of the central nervous system, then you will be able to understand the causes of sympathetic nervous system disorders easily.

    Diseases: Many diseases lead to gradual degeneration of nerves, affecting their transmission system. Diabetes and Parkinson&apos;s disease can cause SNS disorders.
    Autoimmune Disorders: Autoimmune disorders, wherein immune system considers an organ as a foreign body and attacks it, can lead to SNS disorders.
    Excessive Alcohol Intake: Alcohol abuse is one of the main reasons of SNS disorders.
    Brain Injury: Any type of traumatic brain injury can result in SNS dysfunction.
    Brain Infection: When an infection affects brain and spinal cord directly, it can result in SNS disorders.
    Structural Defects: Structural defects, birth defects can cause SNS disorders.
    Immune System Problems: Severe immune system problems can cause SNS disorders.
    Brain Tumors: Brain tumors, benign or malignant, can result in SNS disorders.
    Interrupted Blood Supply to Brain: A stroke, wherein an interrupted blood supply to brain is noticed, can lead   to SNS dysfunction.

Sympathetic nervous system dysfunction can lead to a condition called &apos;fibromyalgia&apos;. Patients of fibromyalgia experience pain in muscles and surrounding structures without any obvious tissue damage. Percentage of women (between the ages of 35 and 60 years) or children suffering from fibromyalgia is quite high. SNS dysfunction can result in Reflex Sympathetic Dystrophy Syndrome or Complex Regional Pain Syndrome (CRPS) which is described as a chronic, painful condition. The person suffers from moderate to severe pain that is disproportionate to the event (sprain of fracture) which can induce the pain. Often, an arm or a leg is affected by CRPS. A damaged nerve that controls blood vessels and sweat glands can lead to disrupted blood flow, loss of sensation and abnormal skin temperature at the affected area. The person may complain about intense or burning pain at the site and the condition may worsen over time. This can restrict the movement of the limb and the person may suffer from anxiety and depression. Early detection of the problem helps lower the symptoms. Doctors usually recommend physical therapy and occupational therapy. Pain killers, steroids, medicines to maintain the blood pressure and/or bone loss medications are prescribed by doctors.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.buzzle.com/articles/sympathetic-nervous-system-disorders.html</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000013 -->

    <Class rdf:about="&obo;ND_0000013">
        <rdfs:label>parasympathetic nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://medical-wiki.com/articles/parasympathetic-nervous-system-disorders/</obo:IAO_0000119>
        <rdfs:comment>There was neither a definition for &apos;parasympathetic nervous system disease&apos; provided by the NIF-Dysfunction ontology nor available on wikipedia.  For this reason, a basic Aristotelian definition has been provided for this term.</rdfs:comment>
        <obo:IAO_0000115>A disease of the parasympathetic nervous system (which is part of the nervous system which serves the purpose to slow down the heart rate, increase the activity of the intestine and gland, and to relax down the sphincter muscles).

Any problems occurring in the parasympathetic nervous system are termed as parasympathetic nervous system disorders. There are certain symptoms that you should look out for to ensure that your parasympathetic nervous system and sympathetic nervous system, both are working fine.  For main a major symptom of parasympathetic nervous system disorder is problems with erectile dysfunctions. Men might find it a problem to either initiate an erection or maintain it. Other common symptoms of parasympathetic nervous system disorder include feeling dizzy and light – headed when one stands up. This happens when a person’s blood pressure decreases excessively. Other symptoms of parasympathetic nervous system disorder include the dryness of the mouth and eyes. One might not feel the heat and stop sweating at all. In other cases, if you are suffering from parasympathetic nervous system disorders you might feel like vomiting after having a meal.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12580</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000014 -->

    <Class rdf:about="&obo;ND_0000014">
        <rdfs:label>Horner syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Horner_syndrome</obo:IAO_0000119>
        <obo:IAO_0000115>Horner&apos;s syndrome (also Horner syndrome, Bernard-Horner syndrome, Claude Bernard-Horner syndrome or as oculosympathetic palsy) is the combination of drooping of the eyelid (ptosis) and constriction of the pupil (miosis), sometimes accompanied by decreased sweating of the face on the same side; redness of the conjunctiva of the eye is often also present. It indicates a problem with the sympathetic nervous system, a part of the autonomic nervous system. Medical imaging and response to particular eye drops may be required to identify the location of the problem and the underlying cause.

Signs that are found in all patients on the affected side of the face include partial ptosis (drooping of the upper eyelid from loss of sympathetic innervation to the superior tarsal muscle, also known as Müller&apos;s muscle[1]); upside-down ptosis (slight elevation of the lower lid); anhidrosis (decreased sweating on the affected side of the face); miosis (small pupils); enophthalmos (the impression that the eye is sunk in); loss of ciliospinal reflex; and bloodshot conjunctiva, depending on the site of lesion. Sometimes there is flushing on the affected side of the face due to dilation of blood vessels under the skin. The pupil&apos;s light reflex is maintained as this is controlled via the parasympathetic nervous system.

Horner syndrome is acquired as a result of disease but may also be congenital (inborn) or iatrogenic (caused by medical treatment). Although most causes are relatively benign, Horner syndrome may reflect serious disease in the neck or chest (such as a Pancoast tumor (tumor in the apex of the lung) or thyrocervical venous dilatation).</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12586</oboInOwl:hasDbXref>
        <rdfs:comment>horner syndrome does not appear to qualify as a disease</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000015 -->

    <Class rdf:about="&obo;ND_0000015">
        <rdfs:label>Adie syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12581</oboInOwl:hasDbXref>
        <obo:IAO_0000116>syndrome, disorder, or disease?</obo:IAO_0000116>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/holmes_adie/holmes_adie.htm</obo:IAO_0000119>
        <obo:IAO_0000118>Adie&apos;s pupil</obo:IAO_0000118>
        <obo:IAO_0000115>Adie syndrome, sometimes known as Holmes-Adie&apos;s syndrome or Adie&apos;s Tonic Pupil, is a neurological disorder characterized by a tonically dilated pupil. It is named after the British neurologist William John Adie. It is caused by damage to the postganglionic fibers of the parasympathetic innervation of the eye, usually by a viral or bacterial infection which causes inflammation, and affects the pupil of the eye and the autonomic nervous system.

Adie syndrome presents with three hallmark symptoms, namely at least one abnormally dilated pupil (mydriasis) which does not constrict in response to light, loss of deep tendon reflexes and diaphoresis (excessive sweating). Other signs may include hyperopia due to accommodative paresis, photophobia and difficulty reading.

Holmes-Adie syndrome is thought to be the result of a viral or bacterial infection that causes inflammation and damage to neurons in the ciliary ganglion, an area of the brain that controls eye movements, and the spinal ganglion, an area of the brain involved in the response of the autonomic nervous system.</obo:IAO_0000115>
        <obo:IAO_0000118>Holmes-Adie syndrome</obo:IAO_0000118>
        <obo:IAO_0000115>a neurological disorder affecting the pupil of the eye and the autonomic nervous system.  It is characterized by one eye with a pupil that is larger than normal and constricts slowly in bright light  (tonic pupil), along with the absence of deep tendon reflexes, usually in the Achilles tendon.</obo:IAO_0000115>
        <obo:IAO_0000118>HAS</obo:IAO_0000118>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Holmes-Adie_syndrome</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>Adie&apos;s syndrome</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000016 -->

    <Class rdf:about="&obo;ND_0000016">
        <rdfs:label>Frey syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12587</oboInOwl:hasDbXref>
        <rdfs:comment>syndrome, disorder, or disease?</rdfs:comment>
        <obo:IAO_0000115>Frey&apos;s syndrome (also known as Baillarger’s syndrome, Dupuy’s syndrome, Auriculotemporal syndrome or Frey-Baillarger syndrome) is a food related syndrome which can be congenital or acquired specially after parotid surgery and can persist for life.

The symptoms of Frey&apos;s syndrome are redness and sweating on the cheek area adjacent to the ear. They can appear when the affected person eats, sees, dreams, thinks about or talks about certain kinds of food which produce strong salivation. Observing sweating in the region after eating a lemon wedge may be diagnostic.

Frey&apos;s syndrome often results as a side effect of parotid gland surgery. The Auriculotemporal branch of the Trigeminal nerve carries sympathetic fibers to the sweat glands of the scalp and parasympathetic fibers to the parotid gland. As a result of severance and inappropriate regeneration, the fibers may switch courses, resulting in &quot;Gustatory Sweating&quot; or sweating in the anticipation of eating, instead of the normal salivatory response. It is often seen with patients who have undergone endoscopic thoracic sympathectomy, a surgical procedure wherein part of the sympathetic trunk is cut or clamped to treat sweating of the hands or blushing. The subsequent regeneration or nerve sprouting leads to abnormal sweating and salivating. It can also include discharge from the nose when smelling certain food.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Frey%27s_syndrome</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000017 -->

    <Class rdf:about="&obo;ND_0000017">
        <rdfs:label>familial dysautonomia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <rdfs:comment>There is conflict between labeling familial dysautonomia as a disease or as a disorder.</rdfs:comment>
        <obo:IAO_0000115>Familial dysautonomia (FD, sometimes called Riley–Day syndrome[1]) is a disorder of the autonomic nervous system which affects the development and survival of sensory, sympathetic and some parasympathetic neurons in the autonomic and sensory nervous system resulting in variable symptoms including: insensitivity to pain, inability to produce tears, poor growth, and labile blood pressure (episodic hypertension and postural hypotension). People with FD have frequent vomiting crises, pneumonia, problems with speech and movement, difficulty swallowing, inappropriate perception of heat, pain, and taste, as well as unstable blood pressure and gastrointestinal dysmotility. FD does not affect intelligence. Originally reported by Conrad Milton Riley and Richard Lawrence Day in 1949,[2] FD is one example of a group of disorders known as hereditary sensory and autonomic neuropathies HSAN.[3] All HSAN are characterized by widespread sensory dysfunction and variable autonomic dysfunction caused by incomplete development of sensory and autonomic neurons. The disorders are believed to be genetically distinct from each other. FD is seen almost exclusively in Ashkenazi Jews and is inherited in an autosomal recessive fashion.</obo:IAO_0000115>
        <obo:IAO_0000115>a disorder of autonomic nervous system (ANS) function. Most physicians view dysautonomia in terms of failure of the sympathetic or parasympathetic components of the ANS, but dysautonomia involving excessive ANS activities also can occur. Dysautonomia can be local, as in reflex sympathetic dystrophy, or generalized, as in pure autonomic failure. It can be acute and reversible, as in Guillain-Barre syndrome, or chronic and progressive. Several common conditions such as diabetes and alcoholism can include dysautonomia. Dysautonomia also can occur as a primary condition or in association with degenerative neurological diseases such as Parkinson&apos;s disease.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Familial_dysautonomia</obo:IAO_0000119>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/dysautonomia/dysautonomia.htm
</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12561</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000018 -->

    <Class rdf:about="&obo;ND_0000018">
        <rdfs:label>reflex sympathetic dystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000020"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Type I complex regional pain syndrome.  It does not have demonstrable nerve lesions.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12585</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000019 -->

    <Class rdf:about="&obo;ND_0000019">
        <rdfs:label>causalgia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000020"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12584</oboInOwl:hasDbXref>
        <rdfs:comment>consider merging with Synonym(s):   Reflex Sympathetic Dystrophy Syndrome, Causalgia (source http://www.ninds.nih.gov/disorders/reflex_sympathetic_dystrophy/reflex_sympathetic_dystrophy.htm)
</rdfs:comment>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/reflex_sympathetic_dystrophy/reflex_sympathetic_dystrophy.htm</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Type II complex regional pain syndrome.  It does have evidence of obvious nerve damage.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000020 -->

    <Class rdf:about="&obo;ND_0000020">
        <rdfs:label>complex regional pain syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Complex_regional_pain_syndrome</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12583</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Complex regional pain syndrome (CRPS) is a chronic progressive disease characterized by severe pain, swelling and changes in the skin. Though treatment is often unsatisfactory, early multimodal therapy can cause dramatic improvement or remission of the syndrome in some patients.[1] The International Association for the Study of Pain has proposed dividing CRPS into two types based on the presence of nerve lesion following the injury.

    Type I, formerly known as reflex sympathetic dystrophy (RSD), Sudeck&apos;s atrophy, reflex neurovascular dystrophy         (RND) or algoneurodystrophy, does not have demonstrable nerve lesions.
    Type II, formerly known as causalgia, has evidence of obvious nerve damage.

The cause of this syndrome is currently unknown. Precipitating factors include injury and surgery, although there are documented cases that have no demonstrable injury to the original site.</obo:IAO_0000115>
        <rdfs:comment>How should we reconcile the discrepancy between terms that are commonly referred to as a &apos;syndrome&apos;, but fit our criteria for being a disease?  We can include the additional terminology as synonyms, but which term gets to be used as the label?  I assume it should be the ontologically preferable label.</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000021 -->

    <Class rdf:about="&obo;ND_0000021">
        <rdfs:label>autonomic dysreflexia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <rdfs:comment>autonomic dysreflexia is characterized in NIF-Dysfunction as a syndrome

autonomic dysreflexia does not appear to fit the criteria for being a disease

autonomic dysreflexia is thought to result when nerve signals in the spinal cord are blocked due to lesions (such as those that can occur in MS patients) or other spinal cord damage</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12582</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000022 -->

    <Class rdf:about="&obo;ND_0000022">
        <rdfs:label>multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000007"/>
        <obo:IAO_0000118>Shy-Drager syndrome</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>NIF-Dysfunction lists multiple system atrophy as &apos;Shy-Drager syndrome&apos;.

*** THIS TERM IS A DUPLICATE OF TERM ND_0000129 ***</obo:IAO_0000232>
        <obo:IAO_0000119>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001764/</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12576</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Multiple system atrophy (MSA) is a rare condition that causes symptoms similar to Parkinson&apos;s disease. However, patients with MSA have more widespread damage to the part of the nervous system that controls important functions such as heart rate, blood pressure, and sweating.

The cause is unknown. MSA develops gradually and is most often diagnosed in men older than 60.

Synonyms for multiple system atrophy include: Shy-Drager syndrome Neurologic orthostatic hypotension; Shy-McGee-Drager syndrome; Parkinson&apos;s plus syndrome; MSA-P; and MSA-C</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000023 -->

    <Class rdf:about="&obo;ND_0000023">
        <rdfs:label>Charcot-Marie tooth disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000003"/>
        <obo:IAO_0000115>one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people in the United States.  CMT,  also known as hereditary motor and sensory neuropathy (HMSN) or peroneal muscular atrophy, comprises a group of disorders caused by mutations in genes that affect the normal function of the peripheral nerves.  The peripheral nerves lie outside the brain and spinal cord and supply the muscles and sensory organs in the limbs.  A typical feature includes weakness of the foot and lower leg muscles, which may result in foot drop and a high-stepped gait with frequent tripping or falls. Foot deformities, such as high arches and hammertoes (a condition in which the middle joint of a toe bends upwards), are also characteristic due to weakness of the small muscles in the feet.
</obo:IAO_0000115>
        <obo:IAO_0000115>Charcot–Marie–Tooth disease (CMT), known also as Morbus Charcot-Marie-Tooth, Charcot-Marie-Tooth neuropathy, hereditary motor and sensory neuropathy (HMSN), hereditary sensorimotor neuropathy (HSMN), or peroneal muscular atrophy, is an inherited disorder of nerves (neuropathy) that takes different forms. It is characterized by loss of muscle tissue and touch sensation, predominantly in the feet and legs but also in the hands and arms in the advanced stages of disease. Currently incurable, this disease is one of the most common inherited neurological disorders.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Charcot%E2%80%93Marie%E2%80%93Tooth_disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#nlx_dys_100316</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/charcot_marie_tooth/charcot_marie_tooth.htm</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000024 -->

    <Class rdf:about="&obo;ND_0000024">
        <rdfs:label>demyelinating disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000054"/>
                <someValuesFrom>
                    <Class>
                        <intersectionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;ND_0006019"/>
                            <Restriction>
                                <onProperty rdf:resource="&obo;BFO_0000118"/>
                                <someValuesFrom rdf:resource="&obo;ND_0006001"/>
                            </Restriction>
                        </intersectionOf>
                    </Class>
                </someValuesFrom>
            </Restriction>
        </rdfs:subClassOf>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12507</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Demyelinating_disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A neurological disease that is characterized by loss or dysfunction of myelin in the central or peripheral nervous system.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000025 -->

    <Class rdf:about="&obo;ND_0000025">
        <rdfs:label>central pontine myelinolysis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000024"/>
        <obo:IAO_0000115>Central pontine myelinolysis is neurological disease caused by severe damage of the myelin sheath of nerve cells in the brainstem, more precisely in the area termed the pons, predominately of iatrogenic etiology. It is characterized by acute paralysis, dysphagia (difficulty swallowing), and dysarthria (difficulty speaking), and other neurological symptoms.

It can also occur outside the pons. The term &quot;osmotic demyelination syndrome&quot; is similar to &quot;central pontine myelinolysis&quot;, but also includes areas outside the pons.

Central pontine myelinolysis is a complication of treatment of patients with profound, life-threatening hyponatremia (low sodium). It occurs as a consequence of a rapid rise in serum tonicity following treatment in individuals with chronic, severe hyponatraemia who have made intracellular adaptations to the prevailing hypotonicity. Hyponatremia should be corrected at a rate of no more than 8-10 mmol/L of sodium per day to prevent central pontine myelinolysis.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Central_pontine_myelinolysis</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12552</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>http://www.ncbi.nlm.nih.gov/mesh?term=central%20pontine%20myelinolysis%20</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000026 -->

    <Class rdf:about="&obo;ND_0000026">
        <rdfs:label>autoimmune demyelinating disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000024"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000113"/>
                <someValuesFrom rdf:resource="&obo;ND_0005503"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000118>demyelinating autoimmune disease</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A demyelinating autoimmune disease is a demyelinating disease that is caused by an autoimmune reaction.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12508</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000027 -->

    <Class rdf:about="&obo;ND_0000027">
        <rdfs:label>acute disseminated encephalomyelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000026"/>
        <rdfs:comment>Unless all infectious diseases should be placed under the class &apos;autoimmune disease&apos;, this term and its children should probably be placed under the class &apos;demyelinating infectious disease&apos; instead. AC</rdfs:comment>
        <rdfs:comment>Acute encephalomyelitis is a transient dymelinating disease course in which the patient has a single brief but intense attack of inflammation in the brain, or spinal cord, or optic nerve that causes damage to the myelin. MJ</rdfs:comment>
        <obo:IAO_0000115>Acute disseminated encephalomyelitis (ADEM) is an immune mediated disease of the brain. It usually occurs following a viral infection but may appear following vaccination, bacterial or parasitic infection, or even appear spontaneously. As it involves autoimmune demyelination, it is similar to multiple sclerosis, and is considered part of the Multiple sclerosis borderline diseases. The incidence rate is about 8 per 1,000,000 people per year. Although it occurs in all ages, most reported cases are in children and adolescents, with the average age around 5 to 8 years old. The mortality rate may be as high as 5%, full recovery is seen in 50 to 75% of cases, while up to 70 to 90% recover with some minor residual disability. The average time to recover is one to six months.

ADEM produces multiple inflammatory lesions in the brain and spinal cord, particularly in the white matter. Usually these are found in the subcortical and central white matter and cortical gray-white junction of both cerebral hemispheres, cerebellum, brainstem, and spinal cord, but periventricular white matter and gray matter of the cortex, thalami and basal ganglia may also be involved.

When the patient suffers more than one demyelinating episode, it is called Recurrent disseminated encephalomyelitis or Multiphasic disseminated encephalomyelitis (MDEM).</obo:IAO_0000115>
        <obo:IAO_0000118>ADEM</obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12510</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Acute_disseminated_encephalomyelitis</obo:IAO_0000119>
        <rdfs:comment>leukodystrophy?

Yes, according to http://ulf.org/types-of-leukodystrophy

MJ</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000028 -->

    <Class rdf:about="&obo;ND_0000028">
        <rdfs:label>post vaccinal encephalomyelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000027"/>
        <obo:IAO_0000115>Post vaccinal encephalomyelitis is acute disseminated encephalomyelitis that occurs after receiving a vaccination.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12511</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>post-vaccinal encephalomyelitis</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000029 -->

    <Class rdf:about="&obo;ND_0000029">
        <rdfs:label>post exanthem encephalomyelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000027"/>
        <obo:IAO_0000115>Post exanthem encephalomyelitis is acute disseminated encephalomyelitis that occurs after experiencing an exanthem infection.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12512</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;index=4480&amp;field=all&amp;HM=&amp;II=&amp;PA=&amp;form=&amp;input=</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000030 -->

    <Class rdf:about="&obo;ND_0000030">
        <rdfs:label>acute hemorrhagic leukoencephalitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000026"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Acute hemorrhagic leukoencephalitis (AHL, or AHLE), also known as acute necrotizing encephalopathy (ANE), acute hemorrhagic encephalomyelitis (AHEM), acute necrotizing hemorrhagic leukoencephalitis (ANHLE), Weston-Hurst syndrome, or Hurst&apos;s disease, is a hyperacute and frequently fatal form of ADEM. AHL is relatively rare (less than 100 cases have been reported in the medical literature as of 2006), it is seen in about 2% of ADEM cases, and is characterized by necrotizing vasculitis of venules and hemorrhage, and edema. Death is common in the first week and overall mortality is about 70%, but increasing evidence points to favorable outcomes after aggressive treatment with corticosteroids, immunoglobulins, cyclophosphamide, and plasma exchange. About 70% of survivors show residual neurological deficits, but some survivors have shown surprisingly little deficit considering the magnitude of the white matter affected. This disease has been occasionally associated with ulcerative colitis and Crohn&apos;s disease, septicemia associated with immune complex deposition, methanol poisoning, and other underlying conditions.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Acute_disseminated_encephalomyelitis#Acute_hemorrhagic_leukoencephalitis</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12513</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000031 -->

    <Class rdf:about="&obo;ND_0000031">
        <rdfs:label>diffuse cerebral sclerosis of Schilder</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000026"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12509</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Diffuse Cerebral Sclerosis of Schilder is a rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers&apos; Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73) </obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000032 -->

    <Class rdf:about="&obo;ND_0000032">
        <rdfs:label>primary progressive multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000033"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000054"/>
                <someValuesFrom rdf:resource="&obo;ND_0000202"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>The least common variant of multiple sclerosis, which is characterized by an immediate worsening in neurological functioning without intitial accute exacerbations and no return to homeostasis.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000118>progressive relapsing multiple sclerosis</obo:IAO_0000118>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000118>PPMS</obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12515</oboInOwl:hasDbXref>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000033 -->

    <Class rdf:about="&obo;ND_0000033">
        <rdfs:label>multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000026"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000054"/>
                <someValuesFrom rdf:resource="&obo;ND_0006009"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Multiple sclerosis (MS) is a demylinating disease of the central nervous system in which the bearer&apos;s immune system causes demylination of neurons which must be disseminated in both time and space. MS can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted.  Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus. 


</obo:IAO_0000116>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_sclerosis.htm</obo:IAO_0000119>
        <obo:IAO_0000115>An autoimmune demyelinating disease which is realized through marked episodes of neurological disability in the central nervous system, disseminated in both time and space following one of several predicable patterns of worsening.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12514</oboInOwl:hasDbXref>
        <obo:IAO_0000116>Based on underlying pathology and genetic markers, there seem to be two to four subtypes: a replasing (most comon) varaint, an immediately progressive variant, and possibly the Marbiug and Devic variants. The common clinical variants of RRMS, SPMS, and PPMS are actually distinct disease courses, which realize the relapsing and progressive types of MS.</obo:IAO_0000116>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000116>Defintion needs revison once the material basis is sorted out. </obo:IAO_0000116>
        <obo:IAO_0000118>MS</obo:IAO_0000118>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000036 -->

    <Class rdf:about="&obo;ND_0000036">
        <rdfs:label>relapsing multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000033"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000054"/>
                <someValuesFrom rdf:resource="&obo;ND_0000201"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000118>SPMS</obo:IAO_0000118>
        <obo:IAO_0000118>relapsing remitting multiple sclerosis</obo:IAO_0000118>
        <obo:IAO_0000115>A type of multiple sclerosis which presents clinically with an overall relapsing profile of neurological worsening, measured according to a disability scale, such as the Kurtze Expanded Disability Status Scale (EDSS). The most common variant of multiple sclerosis, which is characterized by acute relapses with a return to either non-worsening or declining neurological functioning, known as remission. During the relapsing remitting phase, remission can be at the same level of clinical functioning as before the relapse, or at lower level, but homeostasis is achieved. Whereas, during the secondary progressive phase, a gradual deterioration in functioning occurs between relapses. Sometimes acute exacerbations may dissapear altogether. It is hypothesized the start of the secondary progressive phase correlates to a particular threshold of accumulating permanent damage to axons or the lack of ability to remyelinate.</obo:IAO_0000115>
        <obo:IAO_0000118>RRMS</obo:IAO_0000118>
        <obo:IAO_0000118>secondary progressive multiple sclerosis </obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12518
and
http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12517</oboInOwl:hasDbXref>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000037 -->

    <Class rdf:about="&obo;ND_0000037">
        <rdfs:label>neuromyelitis optica</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000026"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/neuromyelitis_optica/neuromyelitis_optica.htm</obo:IAO_0000119>
        <obo:IAO_0000118>Devic&apos;s Syndrome</obo:IAO_0000118>
        <obo:IAO_0000118>Devic&apos;s Disease</obo:IAO_0000118>
        <rdfs:comment>Neuromyelitis optica is an autoimmune, inflammatory disease in which an organism&apos;s immune system attacks the optic nerves and spinal cord, casuing inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Although inflammation may also affect the brain, the lesions are different from those observed in the related condition multiple sclerosis.</rdfs:comment>
        <obo:IAO_0000118>NMO</obo:IAO_0000118>
        <obo:IAO_0000115>Neuromyelitis optica (NMO), also known as Devic&apos;s disease or Devic&apos;s syndrome, is an autoimmune, inflammatory disorder in which a person&apos;s own immune system attacks the optic nerves and spinal cord. This produces an inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Although inflammation may also affect the brain, the lesions are different from those observed in the related condition multiple sclerosis (MS). Spinal cord lesions lead to varying degrees of weakness or paralysis in the legs or arms, loss of sensation (including blindness), and/or bladder and bowel dysfunction.

Devic&apos;s disease is a rare disorder which resembles MS in several ways, but requires a different course of treatment for optimal results. NMO has also been suggested to be a variant form of acute disseminated encephalomyelitis. The likely target of the autoimmune attack at least in some patients with NMO has been identified; it is a protein of the nervous system cells called aquaporin 4.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Neuromyelitis_optica</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12519</oboInOwl:hasDbXref>
        <obo:IAO_0000115>an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren&apos;t yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord. </obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000038 -->

    <Class rdf:about="&obo;ND_0000038">
        <rdfs:label>transverse myelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000026"/>
        <obo:IAO_0000115>Transverse myelitis is inflammation of the spinal cord, which often targets insulating material covering nerve cell fibers (myelin). Transverse myelitis may result in injury across the spinal cord, causing diminished or absent sensation below the injury.

The disrupted transmission of nerve signals due to transverse myelitis can cause pain or other sensory problems, weakness or paralysis of muscles, or bladder and bowel dysfunction.

Several factors can cause transverse myelitis, including infections not directly affecting the spine and immune system disorders attacking the body&apos;s own tissues. It may also occur as an episode of other myelin disorders, such as multiple sclerosis.

Treatment for transverse myelitis includes anti-inflammatory drugs, medications to manage symptoms and rehabilitative therapy. Most people with transverse myelitis experience at least partial recovery.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12520</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.mayoclinic.com/health/transverse-myelitis/DS00854</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000039 -->

    <Class rdf:about="&obo;ND_0000039">
        <rdfs:label>paraneoplastic myelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000038"/>
        <obo:IAO_0000119>http://www.penncancer.org/pnd/subpage.cfm?s=1&amp;ss=22&amp;sss=12</obo:IAO_0000119>
        <obo:IAO_0000115>Paraneoplastic myelitis is an inflammation of the spinal cord. Any level of the spinal cord can be affected, from the cervical region (upper part of the cord) to the lumbar region (lower part). The inflammation causes problems in how the nerves function that carry information back and forth between the nerves in your arms and legs and the brain.

Patients may develop:
    loss of strength and sensation
    abnormal reflexes
    muscle twitches or sometimes jerking muscles
    thinning or decrease of muscle volume (atrophy) in the arms, legs and other parts of the body (neck, back) (Figure)
    control of the bladder and bowel movements can be affected

Paraneoplastic myelitis usually occurs in association with encephalitis.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12523</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000040 -->

    <Class rdf:about="&obo;ND_0000040">
        <rdfs:label>post infectious myelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000038"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12521</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Post infectious myelitis is transverse myelitis that occurs as the result of an infection.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;index=8798&amp;field=all&amp;HM=&amp;II=&amp;PA=&amp;form=&amp;input=</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6)
</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000041 -->

    <Class rdf:about="&obo;ND_0000041">
        <rdfs:label>post vaccinal myelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000040"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>Why is &apos;post vaccinal myelitis&apos; a subclass of &apos;post infectious myelitis&apos;?</rdfs:comment>
        <obo:IAO_0000115>Post vaccinal myelitis is transverse myelitis that occurs in response to a vaccination.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;index=8798&amp;field=all&amp;HM=&amp;II=&amp;PA=&amp;form=&amp;input=</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12522</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6)</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000042 -->

    <Class rdf:about="&obo;ND_0000042">
        <rdfs:label>hereditary central nervous system demyelinating disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000156"/>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;index=18793&amp;field=all&amp;HM=&amp;II=&amp;PA=&amp;form=&amp;input=
</oboInOwl:hasDbXref>
        <rdfs:comment>Recommnend deleting. The fact a disease (any disease, genetic or otherwise) is a CNS disease should be inferred. This is according to the hierarchical structure for diseases ND supports.

MJ</rdfs:comment>
        <rdfs:comment>See the comment for &apos;demyelinating autoimmune disease&apos;.  Perhaps this class should be labeled (or at least subsumed under) &apos;demyelinating genetic disease&apos; instead.

Also, add &apos;leukoencephalopathy with vanishing white matter&apos; and &apos;megalencephalic leukoencephalopathy with subcortical cysts&apos; as subclasses of &apos;hereditary central nervous system demyelinating disease&apos;.</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12526</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A Hereditary CNS demyelinating disease is a demyelinating central nervous system disease that is primarily due to an inherited genetic condition. (This is in contrast to autoimmune demyelinating conditions, such as multiple sclerosis, or conditions such as central pontine myelinolysis that are associated with acute acquired insult.)

Examples include:
    Alexander disease
    Canavan disease
    Krabbe disease
    leukoencephalopathy with vanishing white matter
    megalencephalic leukoencephalopathy with subcortical cysts
    metachromatic leukodystrophy
    X-linked adrenoleukodystrophy</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Inherited conditions characterized by a loss of MYELIN in the central nervous system.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Hereditary_CNS_demyelinating_disease</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000043 -->

    <Class rdf:about="&obo;ND_0000043">
        <rdfs:label>adrenoleukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/X-linked_adrenoleukodystrophy</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12527</oboInOwl:hasDbXref>
        <obo:IAO_0000118>X-linked ALD</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>ALD</obo:IAO_0000118>
        <obo:IAO_0000118>Siemerling-Creutzfeldt disease</obo:IAO_0000118>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/adrenoleukodystrophy/adrenoleukodystrophy.htm
</obo:IAO_0000119>
        <obo:IAO_0000118>Schilder&apos;s disease</obo:IAO_0000118>
        <obo:IAO_0000118>X-linked adrenoleukodystrophy</obo:IAO_0000118>
        <obo:IAO_0000115>one of a group of genetic disorders called the leukodystrophies that cause damage to the myelin sheath, an insulating membrane that surrounds nerve cells in the brain. People with ALD accumulate high levels of saturated, very long chain fatty acids (VLCFA) in the brain and adrenal cortex because they do not produce the enzyme that breaks down these fatty acids in the normal manner. The loss of myelin and the progressive dysfunction of the adrenal gland are the primary characteristics of ALD. ALD has two subtypes. The most common is the X-linked form (X-ALD), which involves an abnormal gene located on the X-chromosome. Women have two X-chromosomes and are the carriers of the disease, but since men only have one X-chromosome and lack the protective effect of the extra X-chromosome, they are more severely affected. Onset of X-ALD can occur in childhood or in adulthood. The childhood form is the most severe, with onset between ages 4 and 10. The most common symptoms are usually behavioral changes such as abnormal withdrawal or aggression, poor memory, and poor school performance. Other symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, difficulty swallowing, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. In the milder adult-onset form, which typically begins between ages 21 and 35, symptoms may include progressive stiffness, weakness or paralysis of the lower limbs, and ataxia. Although adult-onset ALD progresses more slowly than the classic childhood form, it can also result in deterioration of brain function. A mild form of ALD is occasionally seen in women who are carriers of the disorder.</obo:IAO_0000115>
        <obo:IAO_0000115>Adrenoleukodystrophy (ALD, also called Siemerling-Creutzfeldt Disease or Schilder&apos;s disease) is a rare, inherited disorder that leads to progressive brain damage, failure of the adrenal glands and eventually death. ALD is a disease in a group of genetic disorders called leukodystrophies. Adrenoleukodystrophy progressively damages the myelin sheath, a complex fatty neural tissue that insulates many nerves of the central and peripheral nervous systems. Without functional myelin, nerves are unable to aid in the conduction of an impulse, which leads to increasing disability.

There are several different types of the disease which can be inherited, but the most common form is an X-linked condition. X-linked ALD primarily affects males, but about one in five women with the disease gene develop some symptoms. Adrenomyeloneuropathy is a less-severe form of ALD, with onset of symptoms occurring in adolescence or adulthood. This form does not include cerebral involvement, and should be included in the differential diagnosis of all males with adrenal insufficiency. Although they share a similar name, X-linked ALD and neonatal adrenoleukodystrophy (NALD), a peroxisome biogenesis disorder, are completely different diseases.

Patients with X-linked ALD have defects in the ATP-binding cassette, sub-family D (ALD), member 1 transporter protein, which is encoded by the ABCD1 gene. The ABCD1 (aka ALDP) protein is indirectly involved in the breakdown of very long-chain fatty acids (VLCFAs) found in the normal diet. Lack of this protein can give rise to an over-accumulation of VLCFAs which can lead to damage to the brain, adrenal gland, and peripheral nervous system.

Although this disorder affects the growth and/or development of myelin, leukodystrophies are different from demyelinating disorders such as multiple sclerosis where myelin is formed normally but is lost by immunologic dysfunction or for other reasons.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000044 -->

    <Class rdf:about="&obo;ND_0000044">
        <rdfs:label>Alexander disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <obo:IAO_0000115>Alexander disease is a slowly progressing and fatal neurodegenerative disease. It is a very rare disorder which results from a genetic mutation and mostly affects infants and children, causing developmental delay and changes in physical characteristics.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/alexander_disease/alexander_disease.htm</obo:IAO_0000119>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Alexander_disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12528</oboInOwl:hasDbXref>
        <obo:IAO_0000115>one of a group of neurological conditions known as the leukodystrophies, disorders that are the result of abnormalities in myelin, the “white matter” that protects nerve fibers in the brain. Alexander disease is a progressive and usually fatal disease.  The destruction of white matter is accompanied by the formation of Rosenthal fibers, which are abnormal clumps of protein that accumulate in non-neuronal cells of the brain called astrocytes.  Rosenthal fibers are sometimes found in other disorders, but not in the same amount or area of the brain that are featured in Alexander disease.  The infantile form is the most common type of Alexander disease.  It has an onset during the first two years of life.  Usually there are both mental and physical developmental delays, followed by the loss of developmental milestones, an abnormal increase in head size, and seizures. The juvenile form of Alexander disease is less common and has an onset between the ages of two and thirteen.  These children may have excessive vomiting, difficulty swallowing and speaking, poor coordination, and loss of motor control.  Adult-onset forms of Alexander disease are rare, but have been reported.  The symptoms sometimes mimic those of Parkinson’s disease or multiple sclerosis.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000045 -->

    <Class rdf:about="&obo;ND_0000045">
        <rdfs:label>Canavan disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <obo:IAO_0000115>Canavan disease, also called Canavan-Van Bogaert-Bertrand disease, aspartoacylase deficiency or aminoacylase 2 deficiency, is an autosomal recessive degenerative disorder that causes progressive damage to nerve cells in the brain. Canavan disease is also one of the most common degenerative cerebreal diseases of infancy. This disease is one of a group of genetic disorders called leukodystrophies.

Leukodystrophies are characterized by degeneration of myelin in the phospholipid layer insulating the axon of a neuron. The gene associated with the disorder is located on human chromosome 17.</obo:IAO_0000115>
        <obo:IAO_0000115>one of the most common cerebral degenerative diseases of infancy, is a gene-linked, neurological birth disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Canavan disease has been classified as one of a group of genetic disorders known as the leukodystrophies but--unlike most leukodystrophies--both grey and white matter are severely affected in infants with Canavan disease. Recent research has indicated that the cells in the brain responsible for making myelin sheaths, known as oligodendrocytes, cannot proroperly complete this critical developmental task.  Myelin sheaths are the fatty covering that act as insulators around nerve fibers in the brain, as well as providing nutritional support for nerve cells.  In Canavan disease, many oligodendrocytes do not mature  and instead die, leaving nerve cell projections known as axons vulnerable and unable to properly function.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/canavan/canavan.htm</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12529</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Canavan_disease</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000046 -->

    <Class rdf:about="&obo;ND_0000046">
        <rdfs:label>type I Canavan disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000045"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12530</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Neonatal Form Onset is at birth and death occurs within few weeks of life.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.mazornet.com/genetics/canavan.htm</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000047 -->

    <Class rdf:about="&obo;ND_0000047">
        <rdfs:label>type II Canavan disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000045"/>
        <obo:IAO_0000115>Infantile Form Onset is at a few months of life and death occurs between ages three and four. This is the most common type of Canavan.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.mazornet.com/genetics/canavan.htm</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12531</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000048 -->

    <Class rdf:about="&obo;ND_0000048">
        <rdfs:label>type III Canavan disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000045"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12532</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://www.mazornet.com/genetics/canavan.htm</obo:IAO_0000119>
        <obo:IAO_0000115> Juvenile Form Onset after age five and death occurs at adolescence</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000049 -->

    <Class rdf:about="&obo;ND_0000049">
        <rdfs:label>globoid cell leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <obo:IAO_0000115>a rare, inherited degenerative disorder of the central and peripheral nervous systems.  It is characterized by the presence of globoid cells (cells that have more than one nucleus), the breakdown of the nerve’s protective myelin coating, and destruction of brain cells.  Krabbe disease is one of a group of genetic disorders called the leukodystrophies.  These disorders impair the growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers, and cause severe deterioration of mental and motor skills.  Myelin, which lends its color to the “white matter” of the brain, is a complex substance made up of at least 10 different enzymes.  Each of the leukodystrophies affects one (and only one) of these substances.  Krabbe disease is caused by a deficiency ofgalactocerebrosidase, an essential enzyme for myelin metabolism.  The disease most often affects infants, with onset before age 6 months, but can occur in adolescence or adulthood.  Symptoms include irritability, unexplained fever, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development.  Other symptoms include muscle weakness, spasticity, deafness, and blindness.  An autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES and PSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses (MeSH).
</obo:IAO_0000115>
        <obo:IAO_0000115>Krabbe disease (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare, often fatal degenerative disorder that affects the myelin sheath of the nervous system. This condition is inherited in an autosomal recessive pattern. The disease is named for the Danish neurologist Knud Haraldsen Krabbe.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/krabbe/krabbe.htm</obo:IAO_0000119>
        <obo:IAO_0000118>galactosylceramide lipidosis</obo:IAO_0000118>
        <obo:IAO_0000118>Krabbe disease</obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12533</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Krabbe_disease</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000050 -->

    <Class rdf:about="&obo;ND_0000050">
        <rdfs:label>classic globoid cell leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000049"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12534</oboInOwl:hasDbXref>
        <obo:IAO_0000115>An autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES andPSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000051 -->

    <Class rdf:about="&obo;ND_0000051">
        <rdfs:label>early onset globoid cell leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000049"/>
        <obo:IAO_0000115>Symptoms of early-onset GLD usually appear in babies between 2 and 12 months of age.</obo:IAO_0000115>
        <obo:IAO_0000119>http://marrow.org/Patient/Disease_and_Treatment/About_Your_Disease/Metabolic_Disorders/Krabbe_Disease.aspx</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12536</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000052 -->

    <Class rdf:about="&obo;ND_0000052">
        <rdfs:label>infantile globoid cell leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000049"/>
        <obo:IAO_0000119>http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi</obo:IAO_0000119>
        <obo:IAO_0000115>An autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES andPSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12535</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000053 -->

    <Class rdf:about="&obo;ND_0000053">
        <rdfs:label>late onset globoid cell leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000049"/>
        <obo:IAO_0000119>http://marrow.org/Patient/Disease_and_Treatment/About_Your_Disease/Metabolic_Disorders/Krabbe_Disease.aspx
</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12537</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Late-onset GLD can appear in people of any age.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000054 -->

    <Class rdf:about="&obo;ND_0000054">
        <rdfs:label>metachromatic leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12542</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Metachromatic leukodystrophy (MLD, also called Arylsulfatase A deficiency) is a lysosomal storage disease which is commonly listed in the family of leukodystrophies. Leukodystrophies affect the growth and/or development of myelin, the fatty covering which acts as an insulator around nerve fibers throughout the central and peripheral nervous systems. It involves sulfatide accumulation.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Metachromatic_leukodystrophy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000055 -->

    <Class rdf:about="&obo;ND_0000055">
        <rdfs:label>adult type metachromatic leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000054"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12545</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000056 -->

    <Class rdf:about="&obo;ND_0000056">
        <rdfs:label>infant type metachromatic leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000054"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12543</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000057 -->

    <Class rdf:about="&obo;ND_0000057">
        <rdfs:label>juvenile type metachromatic leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000054"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12544</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000058 -->

    <Class rdf:about="&obo;ND_0000058">
        <rdfs:label>Niemann-Pick disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>sphingomyelinase deficiency</obo:IAO_0000118>
        <oboInOwl:hasDbXref>birnlex_12538</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002187/</obo:IAO_0000119>
        <obo:IAO_0000115>A group of autosomal recessive disorders in which harmful quantities of lipids accumulate in the viscera and the central nervous system. They can be caused by deficiencies of enzyme activities ( SPHINGOMYELIN PHOSPHODIESTERASE) or defects in intracellular transport, resulting in the accumulation of SPHINGOMYELINS and CHOLESTEROL. There are various subtypes based on their clinical and genetic differences (MeSH).</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12538</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Niemann-Pick disease refers to a group of diseases passed down through families (inherited) in which fatty substances called lipids collect in the cells of the spleen, liver, and brain.

There are four most commonly recognized forms of the disease: Types A, B, C, and D. Types A and B are also called Type I. Types C and D are also known as Type II.

Each type involves different organs and may or may not involve the central nervous system or respiratory system. Each one can cause different symptoms and may occur at different times throughout life, from infancy to adulthood.

Causes, incidence, and risk factors

Niemann-Pick disease Type A and B occur when cells in the body lack an enzyme called acid sphingomyelinase (ASM). ASM helps break down (metabolize) a fatty substance called sphingomyelin, which is found in every cell of the body.

If ASM is missing or does not work properly, sphingomyelin builds up inside cells. This leads to cell death and makes it hard for organs to work properly. Type A occurs in all races and ethnicities, but higher rates are seen in the Ashkenazi (Eastern European) Jew population.

Niemann-Pick Type C occurs when the body cannot properly break down cholesterol and other fats (lipids). This leads to too much cholesterol in the liver and spleen and excessive amounts of other lipids in the brain.

There may be reduced ASM activity in some cells. Type C Niemann-Pick disease has been reported in all ethnic groups but it is most common among Puerto Ricans of Spanish descent.

Type D Niemann-Pick involves a defect that interferes with the movement of cholesterol between brain cells. It is now thought to be a variant of type C. This type of Niemann-Pick disease has only been found in the French Canadian population of Yarmouth County, Nova Scotia.

There may also be an adult-onset form of Niemann-Pick disease. It is sometimes referred to as Type E disease.

Symptoms

Type A usually begins in the first few months of life. Symptoms may include:
    Abdominal (belly area) swelling within 3 - 6 months
    Cherry red spot in the eye
    Feeding difficulties
    Loss of early motor skills (gets worse over time)

Type B symptoms are usually milder and occur in late childhood or adolescence. Abdominal swelling may occur in early childhood, but there is almost no brain and nervous system involvement, such as loss of motor skills. Some patients may have repeated respiratory infections.

Type C usually affects school-aged children, but the disease may occur any time between early infancy to adulthood. Symptoms may include:
    Difficulty moving limbs (dystonia)
    Enlarged spleen
    Enlarged liver
    Jaundice at (or shortly after) birth
    Learning difficulties and intellectual decline (dementia)
    Seizures
    Slurred, irregular speech
    Sudden loss of muscle tone which may lead to falls (cataplexy)
    Tremors
    Trouble moving the eyes up and down (vertical supranuclear gaze palsy)
    Unsteady gait, clumsiness, walking problems (ataxia)

Symptoms of Type D are similar to Type C.

Type E occurs in adults. Symptoms include swelling of the spleen and brain and nervous system (neurological) problems. Little is known about this rare type of Niemann-Pick disease.

Symptoms and disease progression of all forms of Niemann-Pick vary from person to person. Other, more common, diseases may cause symptoms similar to Niemann-Pick.

A person in the early stages of the disease may show only a few symptoms. Not every symptom will be seen in the later stages of the disease.
Signs and tests

Type A and B are diagnosed by measuring the amount of ASM in white blood cells. The test can be done using a blood or bone marrow sample. Such testing can tell who has the disease, but does not reveal who may be carriers. DNA tests can be done to diagnose carriers of Type A and B.

A skin biopsy is usually used to diagnose Type C and Type D Niemann-Pick. Laboratory scientists will watch how the skin cells grow and study how they move and store cholesterol. DNA tests may also be done to look for the two genes that cause Niemann-Pick disease Type C.

Other tests might include:
    Bone marrow aspiration
    Liver biopsy (usually not necessary)
    Slit-lamp eye exam
    Sphingomyelinase assays</obo:IAO_0000115>
        <rdfs:comment>Also include &apos;type D Niemann-Pick disease&apos; and possibly &apos;type E Niemann-Pick disease&apos; as subclasses of &apos;Niemann-Pick disease&apos;.  Perhaps types A and B should be subsumed under &apos;type I Niemann-Pick disease&apos; while types C and D should be subsumed under &apos;type II Niemann-Pick disease&apos;.</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000059 -->

    <Class rdf:about="&obo;ND_0000059">
        <rdfs:label>type A Niemann-Pick disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000058"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12539</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Niemann-Pick_Disease,_Type_A</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>The classic infantile form of Niemann-Pick Disease, caused by mutation in SPHINGOMYELIN PHOSPHODIESTERASE. It is characterized by accumulation of SPHINGOMYELINS in the cells of the RETICULOENDOTHELIAL SYSTEM and other cell throughout the body leading to cell death. Clinical signs include JAUNDICE, hepatosplenomegaly, and severe brain damage (MeSH).</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000060 -->

    <Class rdf:about="&obo;ND_0000060">
        <rdfs:label>type B Niemann-Pick disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000058"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12540</oboInOwl:hasDbXref>
        <obo:IAO_0000115>http://neurolex.org/wiki/Category:Niemann-Pick_Disease,_Type_B</obo:IAO_0000115>
        <obo:IAO_0000115>An allelic disorder of TYPE A NIEMANN-PICK DISEASE, a late-onset form. It is also caused by mutation in SPHINGOMYELIN PHOSPHODIESTERASE but clinical signs involve only visceral organs (non-neuropathic type) (MeSH).</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000061 -->

    <Class rdf:about="&obo;ND_0000061">
        <rdfs:label>type C Niemann-Pick disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000058"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Niemann-Pick_Disease,_Type_C</obo:IAO_0000119>
        <obo:IAO_0000115>An autosomal recessive lipid storage disorder that is characterized by accumulation of CHOLESTEROL and SPHINGOMYELINS in cells of the VISCERA and the CENTRAL NERVOUS SYSTEM. Type C (or C1) and type D are allelic disorders caused by mutation of gene (NPC1) encoding a protein that mediate intracellular cholesterol transport from lysosomes. Clinical signs include hepatosplenomegaly and chronic neurological symptoms. Type D is a variant in people with a Nova Scotia ancestry (MeSH).</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12541</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000062 -->

    <Class rdf:about="&obo;ND_0000062">
        <rdfs:label>Pelizaeus-Merzbacher disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0002022"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Pelizaeus%E2%80%93Merzbacher_disease</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12546</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A rare, slowly progressive disorder of myelin formation. Subtypes are referred to as classic, congenital, transitional, and adult forms of this disease. The classic form is X-chromosome linked, has its onset in infancy and is associated with a mutation of the proteolipid protein gene. Clinical manifestations include TREMOR, spasmus nutans, roving eye movements, ATAXIA, spasticity, and NYSTAGMUS, CONGENITAL. Death occurs by the third decade of life. The congenital form has similar characteristics but presents early in infancy and features rapid disease progression. Transitional and adult subtypes have a later onset and less severe symptomatology. Pathologic features include patchy areas of demyelination with preservation of perivascular islands (trigoid appearance) (MeSH).</obo:IAO_0000115>
        <obo:IAO_0000115>Pelizaeus–Merzbacher disease (PMD) is a rare central nervous system disorder in which coordination, motor abilities, and intellectual function are delayed to variable extents.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Pelizaeus-Merzbacher_Disease</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000063 -->

    <Class rdf:about="&obo;ND_0000063">
        <rdfs:label>adult Pelizaeus-Merzbacher disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000062"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12550</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000064 -->

    <Class rdf:about="&obo;ND_0000064">
        <rdfs:label>atypical Pelizaeus-Merzbacher disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000062"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12562</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000065 -->

    <Class rdf:about="&obo;ND_0000065">
        <rdfs:label>classic Pelizaeus-Merzbacher disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000062"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12547</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000066 -->

    <Class rdf:about="&obo;ND_0000066">
        <rdfs:label>transitional Pelizaeus-Merzbacher disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000062"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12548</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000067 -->

    <Class rdf:about="&obo;ND_0000067">
        <rdfs:label>polyradiculoneuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000024"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12553</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Polyradiculoneuropathy</obo:IAO_0000119>
        <obo:IAO_0000115>Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy ( GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots (MeSH).</obo:IAO_0000115>
        <rdfs:comment>See the comment for &apos;demyelinating autoimmune disease&apos;.  Perhaps this class should be relocated under the class &apos;demyelinating autoimmune disease&apos; since inflamation is an autoimmune response.</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Polyradiculoneuropathy</obo:IAO_0000119>
        <obo:IAO_0000115>Polyradiculoneuropathy describes a condition in which polyneuropathy and polyradiculopathy occur together. An example is Guillain-Barré syndrome.

Treatment with a single course of intravenous immunoglobulin (IVIG) infusions has been demonstrated to be a potentially effective treatment (reported to have caused prolonged remission in a case associated with systemic lupus (Systemic lupus erythematosus)).</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000068 -->

    <Class rdf:about="&obo;ND_0000068">
        <rdfs:label>alpha synucleinopathy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000113"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005509"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006037"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <rdfs:comment>Besides Parkinson&apos;s disease, the filamentous inclusions of two additional neurodegenerative diseases, namely, dementia with Lewy bodies and multiple system atrophy, have also been found to be made of alpha-synuclein. Recombinant alpha-synuclein has been shown to assemble into filaments with similar morphologies to those found in the human diseases and with a cross-beta fiber diffraction pattern. The new work has established the alpha-synucleinopathies as a major class of neurodegenerative disease.

From: http://www.ncbi.nlm.nih.gov/pubmed/11193145</rdfs:comment>
        <rdfs:comment>def [proposed] is hypothetical</rdfs:comment>
        <obo:IAO_0000115>Alpha-synucleinopathy is a neurological disease ................. that results in the degeneration of populations of nerve cells that develop Lewy bodies and Lewy neurites as a result of filamentous inclusions made of the protein alpha-synuclein.

*** NEEDS REVIEW ***</obo:IAO_0000115>
        <obo:IAO_0000118>alpha-synucleinopathies</obo:IAO_0000118>
        <obo:IAO_0000118>α-synucleinopathies</obo:IAO_0000118>
        <obo:IAO_0000118>α-synucleinopathy</obo:IAO_0000118>
        <obo:IAO_0000119>http://www.ncbi.nlm.nih.gov/pubmed/18362284</obo:IAO_0000119>
        <obo:IAO_0000118>alpha-synucleinopathy</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>[PROPOSED] initially affects the medulla oblongata and progresses to more rostral brain areas in a hierarchical sequence (&quot;Braak hypothesis&quot;). Predominant involvement of the amygdala is also described.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000069 -->

    <Class rdf:about="&obo;ND_0000069">
        <rdfs:label>Guillain-Barre syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000067"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12554</oboInOwl:hasDbXref>
        <rdfs:comment>Add the other 5 subtypes.</rdfs:comment>
        <obo:IAO_0000115>Guillain–Barré syndrome (GBS), sometimes called Landry&apos;s paralysis, is an acute inflammatory demyelinating polyneuropathy (AIDP), a disorder affecting the peripheral nervous system. Ascending paralysis, weakness beginning in the feet and hands and migrating towards the trunk, is the most typical symptom. It can cause life-threatening complications, particularly if the breathing muscles are affected or if there is dysfunction of the autonomic nervous system. The disease is usually triggered by an acute infection. Guillain–Barré syndrome is a form of peripheral neuropathy.

The diagnosis is usually made by nerve conduction studies. With prompt treatment by intravenous immunoglobulins or plasmapheresis, together with supportive care, the majority will recover completely. Guillain–Barré syndrome is rare, at 1–2 cases per 100,000 people annually, but is one of the leading causes of acute non-trauma-related paralysis in the world. The syndrome is named after the French physicians Georges Guillain and Jean Alexandre Barré, who described it in 1916.

Six different subtypes of Guillain–Barré syndrome exist.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000070 -->

    <Class rdf:about="&obo;ND_0000070">
        <rdfs:label>Miller-Fisher syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000069"/>
        <obo:IAO_0000115>Miller Fisher syndrome (MFS) is a rare variant of GBS and manifests as a descending paralysis, proceeding in the reverse order of the more common form of GBS. It usually affects the eye muscles first and presents with the triad of ophthalmoplegia, ataxia, and areflexia. Anti-GQ1b antibodies are present in 90% of cases.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12555</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000071 -->

    <Class rdf:about="&obo;ND_0000071">
        <rdfs:label>hereditary sensory and autonomic neuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000067"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12556</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Hereditary sensory and autonomic neuropathy (HSAN) or hereditary sensory neuropathy (HSN) is a condition used to describe any of the types of this disease which inhibit sensation.

Five different clinical entities have been described under hereditary sensory and autonomic neuropathies – all characterized by progressive loss of function that predominantly affects the peripheral sensory nerves.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Hereditary_sensory_and_autonomic_neuropathy</obo:IAO_0000119>
        <rdfs:comment>Add &apos;type 3 hereditary sensory and autonomic neuropathy&apos; as a subclass of &apos;hereditary sensory and autonomic neuropathy&apos;.</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000072 -->

    <Class rdf:about="&obo;ND_0000072">
        <rdfs:label>type 1 hereditary sensory and autonomic neuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000071"/>
        <obo:IAO_0000118>hereditary sensory radicular neuropathy</obo:IAO_0000118>
        <obo:IAO_0000118>thevenard syndrome</obo:IAO_0000118>
        <obo:IAO_0000118>ulcero-mutilating neuropathy</obo:IAO_0000118>
        <obo:IAO_0000115>Type 1 is the most common of the hereditary sensory and autonomic neuropathies (HSAN). Current names are: hereditary sensory neuropathy type I (HSN I), hereditary sensory and autonomic neuropathy type I (HSAN I). Historical names include: Hereditary sensory radicular neuropathy, ulcero-mutilating neuropathy, thevenard syndrome, familial trophoneurosis, mal perforant du pied, and familial syringomyelia. Sub-type 1C is also currently known as Charcot-Marie-Tooth type 2B syndrome (HMSN 2B).

Type 1 is transmitted as autosomal dominant trait and is characterized by a sensory deficit in the distal portion of the lower extremities, chronic perforating ulcerations of the feet and progressive destruction of underlying bones. Sweating abnormalities occur but other autonomic features are not found in this type. Symptoms appear in late childhood on early adolescence with trophic ulcers as pain sensation is affected more. Many patients have accompanying nerve deafness and atrophy of the peroneal muscles. Histopathologic examination reveals a marked reduction in the number of unmyelinated fibers. Motor nerve conduction velocities are normal, but the sensory nerve action potentials are absent.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12557</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Hereditary_sensory_and_autonomic_neuropathy#Type_1</obo:IAO_0000119>
        <obo:IAO_0000118>familial syringomyelia</obo:IAO_0000118>
        <obo:IAO_0000118>mal perforant du pied</obo:IAO_0000118>
        <obo:IAO_0000118>familial trophoneurosis</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000073 -->

    <Class rdf:about="&obo;ND_0000073">
        <rdfs:label>type 2 hereditary sensory and autonomic neuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000071"/>
        <obo:IAO_0000118>congenital sensory neuropathy</obo:IAO_0000118>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Hereditary_sensory_and_autonomic_neuropathy#Type_2.2C_Congenital_sensory_neuropathy</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12558</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Type 2, congenital sensory neuropathy (also historically known as Morvan&apos;s disease), is characterized by onset of symptoms in early infancy or childhood. Upper &amp; lower extremities are affected with chronic ulcerations and multiple injuries to fingers and feet. Pain sensation is affected predominantly and deep tendon reflexes are reduced. Autoamputation of the distal phalanges is common and so is neuropathic joint degeneration. The NCV shows reduced or absent sensory nerve action potentials and nerve biopsy shows total loss of myelinated fibers and reduced numbers of unmyelinated fibers. It is inherited as an autosomal recessive condition.</obo:IAO_0000115>
        <obo:IAO_0000118>Morvan&apos;s disease</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000074 -->

    <Class rdf:about="&obo;ND_0000074">
        <rdfs:label>type 4 hereditary sensory and autonomic neuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000071"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12559</oboInOwl:hasDbXref>
        <obo:IAO_0000118>congenital insensitivity to pain with anhidrosis</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Hereditary_sensory_and_autonomic_neuropathy#Type_4.2C_Congenital_insensitivity_to_pain_with_anhidrosis</obo:IAO_0000119>
        <obo:IAO_0000115>Type 4, congenital insensitivity to pain with anhidrosis (CIPA), is an autosomal recessive condition and affected infants present with episodes of hyperthermia unrelated to environmental temperature, anhidrosis and insensitivity to pain. Palmar skin is thickened and charcot joints are commonly present. NCV shows motor and sensory nerve action potentials to be normal. The histopathology of peripheral nerve biopsy reveals absent small unmyelinated fibers and mitochondria are abnormally enlarged.</obo:IAO_0000115>
        <obo:IAO_0000118>CIPA</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000075 -->

    <Class rdf:about="&obo;ND_0000075">
        <rdfs:label>type 5 hereditary sensory and autonomic neuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000071"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Hereditary_sensory_and_autonomic_neuropathy#Type_5.2C_Congenital_insensitivity_to_pain_with_partial_anhidrosis</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12560</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Type 5, congenital insensitivity to pain with partial anhidrosis, also manifests with congenital insensitivity to pain &amp; anhidrosis. There is a selective absence of small myelinated fibers differentiating it from Type IV (CIPA).</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>congenital insensitivity to pain with partial anhidrosis</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000076 -->

    <Class rdf:about="&obo;ND_0000076">
        <rdfs:label>progressive multifocal leukoencephalopathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000155"/>
        <rdfs:comment>See the following article for evidence supporting making &apos;progressive multifocal leukoencephalopathy&apos; a subclass of &apos;infectious demyelinating disease&apos;.

Robert Weissert
&quot;Progressive multifocal leukoencephalopathy&quot;
Journal of Neuroimmunology
Volume 231, Issues 1-2, February 2011, Pages 73-77
Special Issue on Advances in Clinical Neuroimmunology </rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Progressive_multifocal_leukoencephalopathy</obo:IAO_0000119>
        <rdfs:comment>See the comment for &apos;demyelinating autoimmune disease&apos;.  Perhaps this class should be subsumed under the class &apos;demyelinating infectious disease&apos;.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12551</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Progressive multifocal leukoencephalopathy (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal viral disease that is characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal).

It occurs almost exclusively in people with severe immune deficiency, such as transplant patients on immunosuppressive medications, patients receiving certain kinds of chemotherapy, patients receiving natalizumab (Tysabri) for multiple sclerosis, psoriasis patients on long-term efalizumab (Raptiva) or AIDS patients.

It is caused by a virus, the JC virus, which is normally present and kept under control by the immune system. Immunosuppressive drugs prevent the immune system from controlling the virus.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000077 -->

    <Class rdf:about="&obo;ND_0000077">
        <rdfs:label>subacute combined degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000024"/>
        <obo:IAO_0000119>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001737/</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>subacute combined degeneration of the spinal cord</obo:IAO_0000118>
        <obo:IAO_0000118>SCD</obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12564</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Subacute combined degeneration is a disorder of the spine, brain, and nerves that involves weakness, abnormal sensations, mental problems, and vision difficulties.

Causes, incidence, and risk factors

Subacute combined degeneration of the spinal cord is caused by a vitamin B12 deficiency. (For specific information on vitamin B12 deficiency, see the article on pernicious anemia.)

Subacute combined degeneration primarily affects the spinal cord but its effects on the brain and the peripheral (body) nerves are the reason for the term “combined”. At first, the disease damages the covering of the nerves (the myelin sheath). It later affects the entire nerve cell.

How a lack of vitamin B12 damages nerves is unclear. However, experts believe the lack of this vitamin causes abnormal fatty acids to form around cells and nerves.

You have a higher risk for this condition if you cannot absorb vitamin B12 from the intestines or if you have:
    Pernicious anemia
    Disorders of the small intestine, including Crohn&apos;s disease
    Malabsorptive conditions, which can occur after gastrointestinal surgery

Symptoms include:
    Abnormal sensations (tingling and numbness)
    Weakness of the legs, arms, or other areas
These symptoms slowly get worse and are usually felt on both sides of the body.

Other symptoms include:
    Clumsiness, stiff, or awkward movements
    Change in mental state such as memory problems, irritability, apathy, confusion, or dementia
    Decreased vision
    Depression
    Sleepiness
    Unsteady gait and loss of balance</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000078 -->

    <Class rdf:about="&obo;ND_0000078">
        <rdfs:label>epilepsy disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <rdfs:comment>This class was just called &apos;epilepsy&apos; in NIF-Dysfunction, but that term is being used to label the syndrome associated with epilepsy disease in ND.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Epilepsy disease is a neurological disease where a greater than normal disposition to have seizures is present in an organism.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12718</oboInOwl:hasDbXref>
        <rdfs:comment>Epilepsies are classified in five ways:

    By their first cause (or etiology).
    By the observable manifestations of the seizures, known as semiology.
    By the location in the brain where the seizures originate.
    As a part of discrete, identifiable medical syndromes.
    By the event that triggers the seizures, such as reading or music

In 1981, the International League Against Epilepsy (ILAE) proposed a classification scheme for individual seizures that remains in common use. This classification is based on observation (clinical and EEG) rather than the underlying pathophysiology or anatomy and is outlined later on in this article. In 1989, the ILAE proposed a classification scheme for epilepsies and epileptic syndromes. This can be broadly described as a two-axis scheme having the cause on one axis and the extent of localization within the brain on the other. Since 1997, the ILAE have been working on a new scheme that has five axes: ictal phenomenon, (pertaining to an epileptic seizure), seizure type, syndrome, etiology, impairment.

From: http://en.wikipedia.org/wiki/Epilepsy#Classification</rdfs:comment>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000079 -->

    <Class rdf:about="&obo;ND_0000079">
        <rdfs:label>benign neonatal epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12734</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000080 -->

    <Class rdf:about="&obo;ND_0000080">
        <rdfs:label>familial benign neonatal epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000079"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12735</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000081 -->

    <Class rdf:about="&obo;ND_0000081">
        <rdfs:label>non familial benign neonatal epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000079"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12736</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000082 -->

    <Class rdf:about="&obo;ND_0000082">
        <rdfs:label>generalized epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12737</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000083 -->

    <Class rdf:about="&obo;ND_0000083">
        <rdfs:label>absence epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000082"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12742</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000084 -->

    <Class rdf:about="&obo;ND_0000084">
        <rdfs:label>generalized convulsive epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000082"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12738</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000085 -->

    <Class rdf:about="&obo;ND_0000085">
        <rdfs:label>generalized nonconvulsive epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000082"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12739</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000086 -->

    <Class rdf:about="&obo;ND_0000086">
        <rdfs:label>atonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000085"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12740</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000087 -->

    <Class rdf:about="&obo;ND_0000087">
        <rdfs:label>tonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000085"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12741</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000088 -->

    <Class rdf:about="&obo;ND_0000088">
        <rdfs:label>infantile spasms</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000082"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12744</oboInOwl:hasDbXref>
        <rdfs:comment>Should this term be made singular?</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000089 -->

    <Class rdf:about="&obo;ND_0000089">
        <rdfs:label>tonic clonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000082"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12743</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000090 -->

    <Class rdf:about="&obo;ND_0000090">
        <rdfs:label>Landau-Kleffner syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A syndrome characterized by the onset of isolated language dysfunction in otherwise normal children (age of onset 4-7 years) and epileptiform discharges on ELECTROENCEPHALOGRAPHY. Seizures, including atypical absence ( EPILEPSY, ABSENCE), complex partial ( EPILEPSY, COMPLEX PARTIAL), and other types may occur. The electroencephalographic abnormalities and seizures tend to resolve by puberty. The language disorder may also resolve although some individuals are left with severe language dysfunction, including APHASIA and auditory AGNOSIA.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12743</oboInOwl:hasDbXref>
        <obo:IAO_0000119>Menkes, Textbook of Child Neurology, 5th ed, pp749-50; J Child Neurol 1997 Nov;12(8):489-495</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000091 -->

    <Class rdf:about="&obo;ND_0000091">
        <rdfs:label>myoclonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000115>A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic (i.e., occurring secondary to known disease processes such as infections, hypoxic-ischemic injuries, trauma, etc.).</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12719</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Myoclonic_Epilepsy</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000092 -->

    <Class rdf:about="&obo;ND_0000092">
        <rdfs:label>infantile myoclonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000091"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12720</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000093 -->

    <Class rdf:about="&obo;ND_0000093">
        <rdfs:label>juvenile myoclonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000091"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Juvenile_Myoclonic_Epilepsy</obo:IAO_0000119>
        <obo:IAO_0000115>A disorder characterized by the onset of myoclonus in adolescence, a marked increase in the incidence of absence seizures (see EPILEPSY, ABSENCE), and generalized major motor seizures (see EPILEPSY, TONIC-CLONIC). The myoclonic episodes tend to occur shortly after awakening. Seizures tend to be aggravated by sleep deprivation and alcohol consumption. Hereditary and sporadic forms have been identified.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12721</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000094 -->

    <Class rdf:about="&obo;ND_0000094">
        <rdfs:label>progressive myoclonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000091"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A heterogeneous group of primarily familial disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12722</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Progressive_Myoclonic_Epilepsy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000095 -->

    <Class rdf:about="&obo;ND_0000095">
        <rdfs:label>Lafora progressive myoclonic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000094"/>
        <obo:IAO_0000115>A form of stimulus sensitive myoclonic epilepsy inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid (Lafora) bodies are found in neurons, liver, skin, bone, and muscle.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Lafora_Progressive_Myoclonic_Epilepsy</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12723</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000096 -->

    <Class rdf:about="&obo;ND_0000096">
        <rdfs:label>myoclonic epilepsy with ragged red fibers</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000094"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:MERRF_Syndrome</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12724</oboInOwl:hasDbXref>
        <obo:IAO_0000115>MERRF syndrome (or Myoclonic Epilepsy with Ragged Red Fibers) is a mitochondrial disease. It is extremely rare, and has varying degrees of expressivity owing to heteroplasmy.</obo:IAO_0000115>
        <oboInOwl:hasSynonym>Myoclonic Epilepsy with Ragged Red Fibers</oboInOwl:hasSynonym>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/MERRF_syndrome</obo:IAO_0000119>
        <obo:IAO_0000115>A mitochondrial encephalomyopathy characterized clinically by a mixed seizure disorder, myoclonus, progressive ataxia, spasticity, and a mild myopathy. Dysarthria, optic atrophy, growth retardation, deafness, and dementia may also occur. This condition tends to present in childhood and to be transmitted via maternal lineage. Muscle biopsies reveal ragged-red fibers and respiratory chain enzymatic defects.</obo:IAO_0000115>
        <oboInOwl:hasSynonym>MERRF syndrome</oboInOwl:hasSynonym>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000097 -->

    <Class rdf:about="&obo;ND_0000097">
        <rdfs:label>Unverricht-Lundborg syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000094"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12725</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>An autosomal recessive condition characterized by recurrent myoclonic and generalized seizures, ATAXIA, slowly progressive intellectual deterioration, dysarthria, and intention tremor. Myoclonic seizures are severe and continuous, and tend to be triggered by movement, stress, and sensory stimuli. The age of onset is between 8 and 13 years, and the condition is relatively frequent in the Baltic region, especially Finland.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Unverricht-Lundborg_Syndrome</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000098 -->

    <Class rdf:about="&obo;ND_0000098">
        <rdfs:label>partial epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000115>Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12726</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Partial_Epilepsy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000099 -->

    <Class rdf:about="&obo;ND_0000099">
        <rdfs:label>complex partial epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12728</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic (cryptogenic partial complex epilepsy) or occur as a secondary manifestation of a focal cortical lesion (symptomatic partial complex epilepsy).</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Complex_Partial_Epilepsy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000100 -->

    <Class rdf:about="&obo;ND_0000100">
        <rdfs:label>frontal lobe epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Frontal_Lobe_Epilepsy</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12729</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A localization-related (focal) form of epilepsy characterized by seizures which arise in the frontal lobe. A variety of clinical syndromes exist depending on the exact location of the seizure focus. Simple or complex motor movements may occur, and most commonly involve the face and upper extremities. Seizures in the anterior frontal regions may be associated with head and eye turning, typically away from the side of origin of the seizure. Frontal lobe seizures may be idiopathic (cryptogenic) or caused by an identifiable disease process such as traumatic injuries, neoplasms, or other macroscopic or microscopic lesions of the frontal lobes (symptomatic frontal lobe seizures).</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000101 -->

    <Class rdf:about="&obo;ND_0000101">
        <rdfs:label>motor partial epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12730</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Motor_Partial_Epilepsy</obo:IAO_0000119>
        <obo:IAO_0000115>A disorder characterized by recurrent localized paroxysmal discharges of cerebral neurons that give rise to seizures that have motor manifestations. The majority of partial motor seizures originate in the FRONTAL LOBE (see also EPILEPSY, FRONTAL LOBE). Motor seizures may manifest as tonic or clonic movements involving the face, one limb or one side of the body. A variety of more complex patterns of movement, including abnormal posturing of extremities, may also occur.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000102 -->

    <Class rdf:about="&obo;ND_0000102">
        <rdfs:label>rolandic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Rolandic_Epilepsy</obo:IAO_0000119>
        <obo:IAO_0000115>An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and dysarthria. The episodes tend to occur at night and may become secondarily generalized. In most cases, affected children are neurologically and developmentally normal. The electroencephalogram shows characteristic high-voltage sharp waves over the central temporal regions, which are more prominent during drowsiness and sleep. In general, seizures do not continue beyond mid-adolescence.</obo:IAO_0000115>
        <obo:IAO_0000115>In neurology and pediatrics, benign rolandic epilepsy or benign (childhood) epilepsy with centrotemporal (EEG) spikes (also known as sylvian seizures) is the most common epilepsy syndrome in childhood. Most children will outgrow the syndrome (it starts around the age of 3-13 with a peak around 8–9 years and stops around age 14-18), hence the label benign. The seizures start around the central sulcus of the brain (also called the centrotemporal area, located around the Rolandic fissure, after Luigi Rolando).</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12732</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Rolandic_epilepsy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000103 -->

    <Class rdf:about="&obo;ND_0000103">
        <rdfs:label>sensory partial epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12731</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A disorder characterized by recurrent focal onset seizures which have sensory (i.e., olfactory, visual, tactile, gustatory, or auditory) manifestations. Partial seizures that feature alterations of consciousness are referred to as complex partial seizures ( EPILEPSY, COMPLEX PARTIAL).</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Sensory_Partial_Epilepsy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000104 -->

    <Class rdf:about="&obo;ND_0000104">
        <rdfs:label>simple partial epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12727</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000105 -->

    <Class rdf:about="&obo;ND_0000105">
        <rdfs:label>temporal partial epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000098"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12733</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000106 -->

    <Class rdf:about="&obo;ND_0000106">
        <rdfs:label>post traumatic epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000115>Recurrent seizures causally related to CRANIOCEREBRAL TRAUMA. Seizure onset may be immediate but is typically delayed for several days after the injury and may not occur for up to two years. The majority of seizures have a focal onset that correlates clinically with the site of brain injury. Cerebral cortex injuries caused by a penetrating foreign object ( CRANIOCEREBRAL TRAUMA, PENETRATING) are more likely than closed head injuries ( HEAD INJURIES, CLOSED) to be associated with epilepsy. Concussive convulsions are nonepileptic phenomena that occur immediately after head injury and are characterized by tonic and clonic movements.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Post-Traumatic_Epilepsy</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12745</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000107 -->

    <Class rdf:about="&obo;ND_0000107">
        <rdfs:label>reflex epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000115>A subtype of epilepsy characterized by seizures that are consistently provoked by a certain specific stimulus. Auditory, visual, and somatosensory stimuli as well as the acts of writing, reading, eating, and decision making are examples of events or activities that may induce seizure activity in affected individuals.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Reflex_Epilepsy</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12746</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000108 -->

    <Class rdf:about="&obo;ND_0000108">
        <rdfs:label>seizure</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000061"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12748</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Seizures</obo:IAO_0000119>
        <obo:IAO_0000115>Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000109 -->

    <Class rdf:about="&obo;ND_0000109">
        <rdfs:label>status epilepticus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000078"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Status_Epilepticus</obo:IAO_0000119>
        <obo:IAO_0000115>A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity.
</obo:IAO_0000115>
        <rdfs:comment>Make this a syndrome only.</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12750</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000110 -->

    <Class rdf:about="&obo;ND_0000110">
        <rdfs:label>epilepsia partialis continua</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000109"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A variant of epilepsy characterized by continuous focal jerking of a body part over a period of hours, days, or even years without spreading to other body regions. Contractions may be aggravated by movement and are reduced, but not abolished during sleep. ELECTROENCEPHALOGRAPHY demonstrates epileptiform (spike and wave) discharges over the hemisphere opposite to the affected limb in most instances. The repetitive movements may originate from the CEREBRAL CORTEX or from subcortical structures (e.g., BRAIN STEM; BASAL GANGLIA). This condition is associated with Russian Spring and Summer encephalitis (see ENCEPHALITIS, TICK BORNE); Rasmussen syndrome (see ENCEPHALITIS); MULTIPLE SCLEROSIS; DIABETES MELLITUS; BRAIN NEOPLASMS; and CEREBROVASCULAR DISORDERS.
</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Epilepsia_Partialis_Continua</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12751</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000111 -->

    <Class rdf:about="&obo;ND_0000111">
        <rdfs:label>metabolic nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Brain dysfunction or damage caused by acquired (i.e., non-inborn) metabolic disorders. Associated conditions include ENDOCRINE DISEASES; WATER-ELECTROLYTE IMBALANCE; KIDNEY DISEASES; LIVER DISEASES; anoxia ( HYPOXIA, BRAIN); nutritional disorders (see NUTRITIONAL AND METABOLIC DISEASES); an encephalopathy associated with HEMODIALYSIS; and other disorders.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Metabolic_Nervous_System_Disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12705</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000112 -->

    <Class rdf:about="&obo;ND_0000112">
        <rdfs:label>inborn metabolic brain disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000111"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12706</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Brain disorders resulting from inborn metabolic errors, primarily from enzymatic defects which lead to substrate accumulation, product reduction, or increase in toxic metabolites through alternate pathways. The majority of these conditions are familial, however spontaneous mutation may also occur in utero.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Inborn_Metabolic_Brain_Disease</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000113 -->

    <Class rdf:about="&obo;ND_0000113">
        <rdfs:label>neurodegenerative disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000001"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006042"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Neurodegenerative_disease</obo:IAO_0000119>
        <obo:IAO_0000115>A neurological disease that is characterized by the atrophy or death of neurons or related structures progressively affecting the functioning of the nervous system.</obo:IAO_0000115>
        <obo:IAO_0000115>Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_2086</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000114 -->

    <Class rdf:about="&obo;ND_0000114">
        <rdfs:label>Huntingtons disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000113"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006041"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <rdfs:comment>Consider adding a class of diseases named &apos;polyglutamine disease&apos; and make Huntingtons disease a child of polyglutamine disease.  Also add the classes &apos;dentato-rubral and pallido-luysian atrophy&apos; (DRPLA) and &apos;spino-cerebellar ataxia&apos; (SCA) and make them children of polyglutamine disease.

From the paper, &quot;Protein aggregation and neurodegenerative disease&quot;</rdfs:comment>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Huntingtons_disease</obo:IAO_0000119>
        <obo:IAO_0000115>Huntington&apos;s disease, chorea, or disorder (HD), is a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline and dementia. It typically becomes noticeable in middle age. HD is the most common genetic cause of abnormal involuntary writhing movements called chorea. It is much more common in people of Western European descent than in those of Asian or African ancestry. The disease is caused by an autosomal dominant mutation on either of an individual&apos;s two copies of a gene called Huntingtin, which means any child of an affected parent has a 50% risk of inheriting the disease. In the rare situations where both parents have an affected copy, the risk increases to 75%, and when either parent has two affected copies, the risk is 100% (all children will be affected). Physical symptoms of Huntington&apos;s disease can begin at any age from infancy to old age, but usually begin between 35 and 44 years of age. About 6% of cases start before the age of 21 years with an akinetic-rigid syndrome; they progress faster and vary slightly. The variant is classified as juvenile, akinetic-rigid or Westphal variant HD.

Symptoms of the disease can vary between individuals and among affected members of the same family, but the symptoms progress predictably for most individuals. The earliest symptoms are a general lack of coordination and an unsteady gait. As the disease advances, uncoordinated, jerky body movements become more apparent, along with a decline in mental abilities and behavioral and psychiatric problems. Physical abilities are gradually impeded until coordinated movement becomes very difficult. Mental abilities generally decline into dementia.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.mayoclinic.com/health/huntingtons-disease/DS00401</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Huntington%27s_disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12500</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Huntington&apos;s disease is an inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain. Huntington&apos;s disease has a broad impact on a person&apos;s functional abilities and usually results in movement, thinking (cognitive) and psychiatric disorders.
</obo:IAO_0000115>
        <obo:IAO_0000115>A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000115 -->

    <Class rdf:about="&obo;ND_0000115">
        <rdfs:label>akinetic rgid variant of Huntingtons disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000114"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12504</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000116 -->

    <Class rdf:about="&obo;ND_0000116">
        <rdfs:label>juvenile onset Huntingtons disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000114"/>
        <obo:IAO_0000118>juvenile-onset Huntingtons disease</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12505</oboInOwl:hasDbXref>
        <rdfs:comment>Are late-onset and juvenile-onset two different diseases or should they be eliminated?</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000117 -->

    <Class rdf:about="&obo;ND_0000117">
        <rdfs:label>late onset Huntingtons disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000114"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>Are late-onset and juvenile-onset two different diseases or should they be eliminated?</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12506</oboInOwl:hasDbXref>
        <obo:IAO_0000118>late-onset Huntingtons disease</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000118 -->

    <Class rdf:about="&obo;ND_0000118">
        <rdfs:label>Lewy body disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000068"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005505"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005508"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003003"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006038"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000068"/>
        <obo:IAO_0000118>LBD</obo:IAO_0000118>
        <obo:IAO_0000118>Lewy body dementia</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>DLB</obo:IAO_0000118>
        <obo:IAO_0000118>dementia with Lewy bodies</obo:IAO_0000118>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Lewy_Body_Disease</obo:IAO_0000119>
        <obo:IAO_0000118>senile dementia of Lewy type</obo:IAO_0000118>
        <obo:IAO_0000118>cortical Lewy body disease</obo:IAO_0000118>
        <obo:IAO_0000115>Lewy body disease is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia as well as visual hallucinations or fluctuations or REM sleep behavior disorder or Parkonsinism occur caused by neurodegeneration as a result of deposition of Lewy bodies in the cerebral cortex and limbic structures.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12502</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present.</obo:IAO_0000115>
        <obo:IAO_0000118>diffuse Lewy body disease</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000119 -->

    <Class rdf:about="&obo;ND_0000119">
        <rdfs:label>motor neuron disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000113"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003001"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006032"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Motor_Neuron_Disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12565</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Motor_neurone_disease</obo:IAO_0000119>
        <obo:IAO_0000115>The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons, the cells that control voluntary muscle activity including speaking, walking, breathing, swallowing and general movement of the body.

Forms of motor neuron disease include:
    amyotrophic lateral sclerosis (ALS) (sometimes called Lou Gehrig&apos;s disease)
    primary lateral sclerosis (PLS)
    progressive muscular atrophy (PMA)
    bulbar
        pseudobulbar palsy - spastic
        progressive bulbar palsy - spastic and flaccid
</obo:IAO_0000115>
        <obo:IAO_0000115>Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy ( BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000120 -->

    <Class rdf:about="&obo;ND_0000120">
        <rdfs:label>amyotrophic lateral sclerosis</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000119"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006033"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000119"/>
        <obo:IAO_0000118>Lou Gehrigs disease</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis</obo:IAO_0000119>
        <obo:IAO_0000115>A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts.</obo:IAO_0000115>
        <obo:IAO_0000118>Lou Gehrig&apos;s disease</obo:IAO_0000118>
        <obo:IAO_0000118>ALS</obo:IAO_0000118>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Amyotrophic_Lateral_Sclerosis</obo:IAO_0000119>
        <obo:IAO_0000115>Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig&apos;s disease, is a form of motor neuron disease caused by the degeneration of neurons located in the ventral horn of the spinal cord and the cortical neurons that provide their afferent input. The condition is often called Lou Gehrig&apos;s disease in North America, after the famous New York Yankees baseball player who was diagnosed with the disease in 1939. The disorder is characterized by rapidly progressive weakness, muscle atrophy and fasciculations, spasticity, dysarthria, dysphagia, and respiratory compromise. Sensory function generally is spared, as is autonomic, and oculomotor activity. ALS is a progressive, fatal, neurodegenerative disease with most affected patients dying of respiratory compromise and pneumonia after 2 to 3 years; although some perish within a year from the onset of symptoms, and occasional individuals have a more indolent course and survive for many years.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12566</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000121 -->

    <Class rdf:about="&obo;ND_0000121">
        <rdfs:label>progressive bulbar palsy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000119"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006034"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000119"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Progressive_Bulbar_Palsy</obo:IAO_0000119>
        <obo:IAO_0000115>A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12567</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Progressive bulbar palsy (also known simply as PBP) is a medical condition. It belongs to a group of disorders known as motor neuron diseases (Lapiedra 2002). PBP is a disease that attacks the nerves supplying the bulbar muscles. These disorders are characterized by the degeneration of motor neurons in the cerebral cortex, spinal cord, brain stem, and pyramidal tracts. This specifically involves the glossopharyngeal nerve (IX), vagus nerve (X), and hypoglossal nerve (XII) (Hughes 1998).

This disorder should not be confused with pseudobulbar palsy or progressive spinal muscular atrophy (Hughes 1998). The term Infantile progressive bulbar palsy is used to describe progressive bulbar palsy in children.

Some neurologists consider this disorder to be a subset of amyotrophic lateral sclerosis (ALS), but others disagree with that classification.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Progressive_bulbar_palsy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000122 -->

    <Class rdf:about="&obo;ND_0000122">
        <rdfs:label>spinal muscular atrophy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000119"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006035"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000119"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Spinal_muscular_atrophy</obo:IAO_0000119>
        <obo:IAO_0000115>A group of recessively inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Spinal_Muscular_Atrophy_(SMA)</obo:IAO_0000119>
        <obo:IAO_0000115>Spinal Muscular Atrophy (SMA) is a neuromuscular disease characterized by degeneration of motor neurons, resulting in progressive muscular atrophy (wasting away) and weakness. The clinical spectrum of SMA ranges from early infant death to normal adult life with only mild weakness. These patients often require comprehensive medical care involving multiple disciplines, including pediatric pulmonology, pediatric neurology, pediatric orthopedic surgery, Lower Extremity &amp; Spinal Orthosis, pediatric critical care, and physical medicine and rehabilitation; and physical therapy, occupational therapy, respiratory therapy, and clinical nutrition. Genetic counseling is also helpful for the parents and family members. Sensation and the ability to feel are not affected. Intellectual activity is normal and it is often observed that patients with SMA are unusually bright and sociable.
The term &quot;juvenile spinal muscular atrophy&quot; refers to Kugelberg-Welander syndrome.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12568</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000123 -->

    <Class rdf:about="&obo;ND_0000123">
        <rdfs:label>Kennedy syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000122"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#nlx_dys_2011001</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000124 -->

    <Class rdf:about="&obo;ND_0000124">
        <rdfs:label>childhood spinal muscular atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000122"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12569</oboInOwl:hasDbXref>
        <rdfs:comment>Remove the direct reference to age of onset from the disease label. Eliminate this term and make all subtypes of SMA sister-calsses.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000125 -->

    <Class rdf:about="&obo;ND_0000125">
        <rdfs:label>type I spinal muscular atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000124"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Type_I_Spinal_Muscular_Atrophy</obo:IAO_0000119>
        <obo:IAO_0000115>A severe type of spinal muscular atrophy, with on set of symptoms generally in infancy. Children with Type I SMA never sit.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12570</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000126 -->

    <Class rdf:about="&obo;ND_0000126">
        <rdfs:label>type II spinal muscular atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000124"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12571</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Type_II_Spinal_Muscular_Atrophy</obo:IAO_0000119>
        <obo:IAO_0000115>Form of intermediate spinal muscular atrophy of medium severity. Children with type 2 SMA can sit but do not walk.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000127 -->

    <Class rdf:about="&obo;ND_0000127">
        <rdfs:label>type III spinal muscular atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000124"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12572</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000128 -->

    <Class rdf:about="&obo;ND_0000128">
        <rdfs:label>type IV spinal muscular atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000122"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#nlx_dys_2011002</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000129 -->

    <Class rdf:about="&obo;ND_0000129">
        <rdfs:label>multiple system atrophy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000068"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003003"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006040"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000068"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Multiple_system_atrophy</obo:IAO_0000119>
        <obo:IAO_0000115>Multiple system atrophy (MSA) is a degenerative neurological disorder. MSA is associated with the degeneration of nerve cells in specific areas of the brain. This cell degeneration causes problems with movement, balance and other autonomic functions of the body such as bladder control or blood pressure regulation. The cause of MSA is unknown.

*** LIST THE SPECIFIC AREAS OF THE BRAIN AFFECTED ***</obo:IAO_0000115>
        <obo:IAO_0000232>This class already appears in NIF-Dysfunction!!!  It is a duplicate of ND_0000022.</obo:IAO_0000232>
        <obo:IAO_0000118>MSA</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12573</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000130 -->

    <Class rdf:about="&obo;ND_0000130">
        <rdfs:label>olivopontocerebellar atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000129"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12574</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Olivopontocerebellar_Atrophy</obo:IAO_0000119>
        <obo:IAO_0000115>A group of inherited and sporadic disorders which share progressive ataxia in combination with atrophy of the CEREBELLUM; PONS; and inferior olivary nuclei. Additional clinical features may include MUSCLE RIGIDITY; NYSTAGMUS, PATHOLOGIC; RETINAL DEGENERATION; MUSCLE SPASTICITY; DEMENTIA; URINARY INCONTINENCE; and OPHTHALMOPLEGIA. The familial form has an earlier onset (second decade) and may feature spinal cord atrophy. The sporadic form tends to present in the fifth or sixth decade, and is considered a clinical subtype of MULTIPLE SYSTEM ATROPHY.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000131 -->

    <Class rdf:about="&obo;ND_0000131">
        <rdfs:label>familial olivopontocerebellar atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000130"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12575</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000132 -->

    <Class rdf:about="&obo;ND_0000132">
        <rdfs:label>striatonigral degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000129"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Striatonigral_Degeneration</obo:IAO_0000119>
        <obo:IAO_0000115>A sporadic neurodegenerative disease with onset in middle-age characterized clinically by Parkinsonian features (e.g., MUSCLE RIGIDITY; HYPOKINESIA; stooped posture) and HYPOTENSION. This condition is considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Pathologic features include a prominent loss of neurons in the zona compacta of the SUBSTANTIA NIGRA and PUTAMEN.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12577</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000133 -->

    <Class rdf:about="&obo;ND_0000133">
        <rdfs:label>nervous system paraneoplastic syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Paraneoplastic syndromes of the nervous system are a group of rare disorders that develop in some people with cancer.

Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system attack nerve or muscle cells. Cancers commonly associated with these disorders include lung, breast and ovarian cancer.

Depending on the location of the cell damage, these syndromes can cause problems with muscle movement or coordination, sensory perception, memory or thinking skills, or sleep.

In cases where extensive cell damage has occurred, paraneoplastic syndromes of the nervous system can&apos;t be reversed. However, treatment of the underlying cancer and other interventions may prevent further damage, improve symptoms and result in better quality of life. </obo:IAO_0000115>
        <obo:IAO_0000116>From NIF-Dysfunction:

Note that all of teh progeny of this class are in fact neurodegenerative diseases.  In holding  with the &quot;realist&quot; orientation and the effort to represent the CORE subsumptive hierarchy as a related set of functional or function-structure classes - as opposed to using causal relations to specify nervous system disease - Nervous System Paraneoplastic Syndromes have been made a sub-class of neurodegerative disease as opposed to metastatic nervous system neoplastic disease.  Causal relations - such as specify a specific neoplastic condition as the cause for the resulting degeration of nervous system structure and function - will be provided via ObjectProperties.  Certain disorders which are in fact Nervous System Paraneoplastic Syndromes - e.g., Lambert-Eaton Myasthenic Syndrome, Transverse Myelitis, Opsoclonus-Myoclonus Syndrome - are left as children of the functional disease categories based on the affected function (BB: 2007-10-06).</obo:IAO_0000116>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12643</oboInOwl:hasDbXref>
        <rdfs:comment>Make sister class of neurodegenerative disease.</rdfs:comment>
        <obo:IAO_0000119>http://www.mayoclinic.com/health/paraneoplastic-syndromes/DS00840</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000134 -->

    <Class rdf:about="&obo;ND_0000134">
        <rdfs:label>limbic encephalitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000133"/>
        <obo:IAO_0000115>Limbic encephalitis is a form of encephalitis.

In a small number of cases, the pathogens responsible for encephalitis attack primarily the limbic system (a collection of structures at the base of the brain responsible for emotions and many other basic functions), often causing memory deficits similar to those observed in Alzheimer&apos;s disease or Creutzfeldt-Jakob disease (although limbic encephalitis does not cause the same cognitive deficits as these diseases. However, for 20% of people with the diagnosis of limbic encephalitis an MRI will not show any neurological abnormalities.

60% of the time, limbic encephalitis is paraneoplastic in origin.

Paraneoplastic limbic encephalitis (PLE) is a particularly severe form of limbic encephalitis caused by neoplasms most commonly associated with small cell lung carcinoma. Whereas the majority of encephalitides are viral in nature, PLE is often associated with cancer. In fact, it is thought that up to 1 in 100 people with cancer have paraneoplastic limbic encephalitis which is commonly misdiagnosed as neurological diseases such as Alzheimer&apos;s.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>Should this class be labeled &apos;limbic encephalitis&apos; or &apos;paraneoplastic limbic encephalitis&apos;?  The latter term is more consistent with the labels of its sister classes.</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12644</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Limbic_encephalitis</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000135 -->

    <Class rdf:about="&obo;ND_0000135">
        <rdfs:label>paraneoplastic cerebellar degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000133"/>
        <obo:IAO_0000115>Paraneoplastic cerebellar degeneration is a paraneoplastic phenomenon associated with lung, ovarian, breast, and other cancers.

It is believed to be due to an autoimmune reaction targeted against components of the central nervous system (specifically Purkinje cells and large brain stem nuclei). It is thought to be caused by an anti-neuronal antibody known as anti-Yo but in lung paraneoplastic cerebellar degeneration, it is thought to be caused by antibody called &quot;anti-Hu&quot;.

One of the better characterized paraneoplastic neurologic syndrome is cerebellar ataxia caused by Purkinji cell drop-out in the cerebellum; it is manifested by dysarthria, limb and gait ataxia, and nystagmus. Radiologic imaging reveals cerebellar atrophy. Many antibodies have been associated with this syndrome including anti-Yo, anti-Tr and antibodies to glutamate receptor. A large number of patients with neoplasm-associated cerebellar ataxia who display anti-Yo anti-bodies in the serum typically have a breast or ovarian cancer.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Paraneoplastic_Cerebellar_Degeneration</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12645</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Paraneoplastic_cerebellar_degeneration</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000136 -->

    <Class rdf:about="&obo;ND_0000136">
        <rdfs:label>paraneoplastic polyneuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000133"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12646</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A diffuse or multifocal peripheral neuropathy related to the remote effects of a neoplasm, most often carcinoma or lymphoma. Pathologically, there are inflammatory changes in peripheral nerves. The most common clinical presentation is a symmetric distal mixed sensorimotor polyneuropathy. (Adams et al., Principles of Neurology, 6th ed, p1334)</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>It is worth noting that all of the definitions of &apos;paraneoplastic polyneuropathy&apos; that I was able to find were exact replicas of the definition found in (Adams et al., Principles of Neurology, 6th ed, p1334).</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000137 -->

    <Class rdf:about="&obo;ND_0000137">
        <rdfs:label>neuronal ceroid lipofuscinosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <obo:IAO_0000115>Neuronal Ceroid Lipofuscinoses (NCL) is the general name for a family of at least eight genetically separate neurodegenerative disorders that result from excessive accumulation of lipopigments (lipofuscin) in the body&apos;s tissues. These lipopigments are made up of fats and proteins. Their name comes from the word stem lipo-, which is a variation on &quot;lipid&quot; or &quot;fat&quot;, and from the term pigment, used because the substances take on a greenish-yellow color when viewed under an ultraviolet light microscope. These lipofuscin materials build up in neuronal cells and many organs, including the liver, spleen, myocardium, and kidneys.</obo:IAO_0000115>
        <rdfs:comment>There have been at least 9 types of neuronal ceroid lipofuscinosis identified based on the associated gene.  These subtypes should be added to the ontology as well.

See http://en.wikipedia.org/wiki/Neuronal_ceroid_lipofuscinosis for a list of these subtypes.</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Neuronal_ceroid_lipofuscinosis</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12831</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000138 -->

    <Class rdf:about="&obo;ND_0000138">
        <rdfs:label>neuronal intranuclear hyaline inclusion disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://radiopaedia.org/articles/neuronal-intranuclear-hyaline-inclusion-disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#nlx_dys_100201</oboInOwl:hasDbXref>
        <rdfs:comment>Very little information about neuronal intranuclear hyaline inclusion disease is readily available online.</rdfs:comment>
        <obo:IAO_0000115>Neuronal intranuclear hyaline inclusion disease (NIHID) is a rare childhood neurodegenerative disease, usually with unremarkable imaging. 
Epidemiology

Typically NIHID presents in childhood (3 - 12 years of age) 2-3 although adult onset has also been described 3. Hereditary cases have been described, and an autosomal recessive pattern of inheritance is suspected 1-2.
Clinical presentation

The clinical presentation of patients with NIHID can be varied and includes 1-3:

    pyramidal tract signs
    extrapyramidal sings including parkinsonism
    abnormal ocular movements and oculogyric crises
    generalised cognitive degeneration and behavioural changes
    peripheral neuropathy
        severe muscle atrophy and weakness
        sensory impairment in the distal limbs
        dysphagia
    autonomic neuropathy
        episodic intestinal pseudoobstruction
        urinary and faecal incontinence
    cardiomyopathy : reported but uncommon
    epilepsy : reported but uncommon

The diagnosis can be made using peripheral nerve biopsy (e.g. sural nerve)1 or myenteric plexus biopsy (e.g rectal biopsy)2-3. 
Pathology

NIHID is characterised by accumulation of eosinophilic intranuclear inclusions which can be found widely within both the central and peripheral nervous system including sympathetic and myenteric ganglion neurons, dorsal root ganglion neurons, and spinal motor neurons 1-3. 

It is believed to be due to abnormal proteolysis, although the exact mechanism has as yet not been established 2-3.

The intranuclear inclusions fluoresce under ultraviolet light and are composed of uniform, fine straight filaments haphazardly arranged 3. 
Radiographic features

Usually imaging is non-contributory 3 and its primary role is to exclude other entities which may mimic the condition clinically (see below).

Severe cerebellar cortical atrophy has been reported, particularly involving the vermis 3. 
Treatment and prognosis

Neuronal intranuclear hyaline inclusion disease (NIHID) is slowly progressive and has no proven therapy. Death usually occurs before the age of 30 years 3. 
Differential diagnosis

Clinically the differential diagnosis includes 3:

    juvenile parkinsonism
    spinocerebellar degneration
    GM2 gangliosidosis
    infantile neuroaxonal dystrophy</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000139 -->

    <Class rdf:about="&obo;ND_0000139">
        <rdfs:label>Parkinsons disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000068"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005505"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000171"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_62907"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003001"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006021"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000068"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_2098</oboInOwl:hasDbXref>
        <obo:IAO_0000118>Parkinson disease</obo:IAO_0000118>
        <obo:IAO_0000118>PD</obo:IAO_0000118>
        <obo:IAO_0000118>Parkinsons</obo:IAO_0000118>
        <obo:IAO_0000118>paralysis agitans</obo:IAO_0000118>
        <obo:IAO_0000115>belongs to a group of conditions called motor system disorders, which are the result of the loss of dopamine-producing brain cells. The four primary symptoms of PD are tremor, or trembling in hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia, or slowness of movement; and postural instability, or impaired balance and coordination. (A disease characterized as a progressive motor disability manifested by tremors, shaking, muscular rigidity, and lack of postural reflexes. (PSY) * A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) (MSH) * progressive, degenerative disorder of the nervous system characterized by tremors, rigidity, bradykinesia, postural instability, and gait abnormalities; caused by a loss of neurons and a decrease of dopamine in the basal ganglia. (CSP) )</obo:IAO_0000115>
        <obo:IAO_0000118>Parkinson&apos;s</obo:IAO_0000118>
        <rdfs:comment>Should we include &apos;idiopathic Parkinsons disease&apos; (IPD) as a sub class or super class of Parkinsons disease?</rdfs:comment>
        <obo:IAO_0000118>Parkinson&apos;s disease</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Parkinsons disease is a neurological disease where abnormal movement [tremor, rigidity, bradykinesia, postural instability] occurs resulting in a movement disorder caused by neurodegeneration as a result of death of dopaminergic cells in the substantia nigra.


----------
Parkinsons disease is a degenerative disorder of the central nervous system. It results from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain; the cause of cell-death is unknown. Early in the course of the disease, the most obvious symptoms are movement-related, including shaking, rigidity, slowness of movement and difficulty with walking and gait. Later, cognitive and behavioural problems may arise, with dementia commonly occurring in the advanced stages of the disease. Other symptoms include sensory, sleep and emotional problems. PD is more common in the elderly with most cases occurring after the age of 50.

The main motor symptoms are collectively called parkinsonism, or a &quot;parkinsonian syndrome&quot;. Parkinson&apos;s disease is often defined as a parkinsonian syndrome that is idiopathic (having no known cause), although some atypical cases have a genetic origin. Many risk and protective factors have been investigated: the clearest evidence is for an increased risk of PD in people exposed to certain pesticides and a reduced risk in tobacco smokers. The pathology of the disease is characterized by the accumulation of a protein called alpha-synuclein into inclusions called Lewy bodies in neurons, and from insufficient formation and activity of dopamine produced in certain neurons within parts of the midbrain. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used for confirmation.

Modern treatments are effective at managing the early motor symptoms of the disease, mainly through the use of levodopa and dopamine agonists. As the disease progresses and dopamine neurons continue to be lost, a point eventually arrives at which these drugs become ineffective at treating the symptoms and at the same time produce a complication called dyskinesia, marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at alleviating symptoms. Surgery and deep brain stimulation have been used to reduce motor symptoms as a last resort in severe cases where drugs are ineffective. Research directions include a search of new animal models of the disease and investigations of the potential usefulness of gene therapy, stem cell transplants and neuroprotective agents. Medications to treat non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, also exist.

The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy in 1817.</obo:IAO_0000115>
        <obo:IAO_0000118>idiopathic parkinsonism</obo:IAO_0000118>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm</obo:IAO_0000119>
        <rdfs:comment>The main pathological characteristic of PD is cell death in the substantia nigra and more specifically the ventral part of the pars compacta, affecting up to 70% of the cells by the time the patient dies. The mechanisms by which the brain cells are lost are varied. One mechanism consists of an abnormal accumulation of the protein alpha-synuclein bound to ubiquitin in the damaged cells. This protein accumulation forms inclusions called Lewy bodies.

According to the Braak staging Lewy bodies first appear in the olfactory bulb, medulla oblongata and pontine tegmentum, individuals at this stage being asymptomatic. As the disease evolves, Lewy bodies later attain the substantia nigra, areas of the midbrain and basal forebrain, and finally reach areas of the neocortex.

From:
http://en.wikipedia.org/wiki/Braak_staging</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Parkinson%27s_disease</obo:IAO_0000119>
        <obo:IAO_0000118>primary parkinsonism</obo:IAO_0000118>
        <rdfs:comment>Parkinson&apos;s disease is the second most common neurodegenerative disease, after Alzheimer&apos;s disease. Neuropathologically, it is characterized by the degeneration of populations of nerve cells that develop filamentous inclusions in the form of Lewy bodies and Lewy neurites. Recent work has shown that the filamentous inclusions of Parkinson&apos;s disease are made of the protein alpha-synuclein and that rare, familial forms of Parkinson&apos;s disease are caused by missense mutations in the alpha-synuclein gene.

From: http://www.ncbi.nlm.nih.gov/pubmed/11193145</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000140 -->

    <Class rdf:about="&obo;ND_0000140">
        <rdfs:label>Picks disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000167"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006027"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000167"/>
        <obo:IAO_0000115>Pick&apos;s disease, is a rare neurodegenerative disease that causes progressive destruction of nerve cells in the brain. Symptoms include loss of speech (aphasia), and dementia. While some of the symptoms can initially be alleviated, the disease progresses and patients often die within two to ten years. A defining characteristic of the disease is build up of tau proteins in neurons, accumulating into silver-staining, spherical aggregations known as &quot;Pick bodies&quot;.

While the term Pick&apos;s disease was once used to represent a class of clinical syndromes with symptoms attributable to frontal and temporal lobe dysfunction, it is now used among professionals to mean a specific pathology that is just one of the causes of frontotemporal lobar degeneration. Some people still use the term Pick&apos;s disease to mean the more general clinical syndrome of frontotemporal lobar degeneration, but this has previously led to confusion among both professionals and patients and so its use should be restricted to the specific pathological subtype described below. It is also known as Pick disease and PiD (not to be confused with Pelvic Inflammatory Disease (PID) or Parkinson&apos;s Disease (PD)).</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Pick%27s_disease</obo:IAO_0000119>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/picks/picks.htm</obo:IAO_0000119>
        <rdfs:comment>NIF-Dysfunction does not provide a definition for Picks disease.

*** TO DO ***
Picks disease should be made a subclass of frontotemporal dementia.</rdfs:comment>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#nlx_dys_090801</oboInOwl:hasDbXref>
        <obo:IAO_0000115> a clinical syndrome associated with shrinking of the frontal and temporal anterior lobes of the brain. Originally known as Pick’s disease, the name and classification of FTD has been a topic of discussion for over a century.  The current designation of the syndrome groups together Pick’s disease, primary progressive aphasia, and semantic dementia as FTD.  Some doctors propose adding corticobasal degeneration and progressive supranuclear palsy to FTD and calling the group Pick Complex.  These designations will continue to be debated.  As it is defined today, the symptoms of FTD fall into two clinical patterns that involve either (1) changes in behavior, or (2) problems with language.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000141 -->

    <Class rdf:about="&obo;ND_0000141">
        <rdfs:label>prion disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000180"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005037"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000180"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Prion#Prion_disease</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12686</oboInOwl:hasDbXref>
        <rdfs:comment>Infectious dementia caused by prion disease is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by a prion infection.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Prions cause neurodegenerative disease by aggregating extracellularly within the central nervous system to form plaques known as amyloid, which disrupt the normal tissue structure. This disruption is characterized by &quot;holes&quot; in the tissue with resultant spongy architecture due to the vacuole formation in the neurons. Other histological changes include astrogliosis and the absence of an inflammatory reaction. While the incubation period for prion diseases is generally quite long, once symptoms appear the disease progresses rapidly, leading to brain damage and death. Neurodegenerative symptoms can include convulsions, dementia, ataxia (balance and coordination dysfunction), and behavioural or personality changes.

All known prion diseases, collectively called transmissible spongiform encephalopathies (TSEs), are untreatable and fatal. A vaccine has been developed in mice, however, that may provide insight into providing a vaccine in humans to resist prion infections. Additionally, in 2006 scientists announced that they had genetically engineered cattle lacking a necessary gene for prion production – thus theoretically making them immune to BSE, building on research indicating that mice lacking normally occurring prion protein are resistant to infection by scrapie prion protein.

Many different mammalian species can be affected by prion diseases, as the prion protein (PrP) is very similar in all mammals. Due to small differences in PrP between different species it is unusual for a prion disease to be transmitted from one species to another. The human prion disease variant Creutzfeldt-Jakob disease, however, is believed to be caused by a prion which typically infects cattle, causing Bovine spongiform encephalopathy and is transmitted through infected meat.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000142 -->

    <Class rdf:about="&obo;ND_0000142">
        <rdfs:label>bovine spngiform encephalopathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12690</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Bovine_spongiform_encephalopathy</obo:IAO_0000119>
        <obo:IAO_0000115>Bovine spongiform encephalopathy (BSE), commonly known as mad-cow disease, is a fatal neurodegenerative disease in cattle that causes a spongy degeneration in the brain and spinal cord. BSE has a long incubation period, about 30 months to 8 years, usually affecting adult cattle at a peak age onset of four to five years, all breeds being equally susceptible.

The disease may be most easily transmitted to human beings by eating food contaminated with the brain, spinal cord or digestive tract of infected carcasses. However, it should also be noted that the infectious agent, although most highly concentrated in nervous tissue, can be found in virtually all tissues throughout the body, including blood. In humans, it is known as new variant Creutzfeldt–Jakob disease (vCJD or nvCJD), and by October 2009, it had killed 166 people in the United Kingdom, and 44 elsewhere.

A British inquiry into BSE concluded that the epizootic was caused by cattle, who are normally herbivores, being fed the remains of other cattle in the form of meat and bone meal (MBM), which caused the infectious agent to spread. There are studies indicating that the cause of BSE may be from the contamination of MBM from sheep with scrapie that were processed in the same slaughterhouse. The epidemic was probably accelerated by the recycling of infected bovine tissues prior to the recognition of BSE. The origin of the disease itself remains unknown. The infectious agent is distinctive for the high temperatures at which it remains viable; this contributed to the spread of the disease in the United Kingdom, which had reduced the temperatures used during its rendering process. Another contributory factor was the feeding of infected protein supplements to very young calves.</obo:IAO_0000115>
        <obo:IAO_0000115>a progressive neurological disorder of cattle that results from infection by an unusual transmissible agent called a prion. The nature of the transmissible agent is not well understood. Currently, the most accepted theory is that the agent is a modified form of a normal protein known as prion protein. For reasons that are not yet understood, the normal prion protein changes into a pathogenic (harmful) form that then damages the central nervous system of cattle.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.cdc.gov/ncidod/dvrd/bse/</obo:IAO_0000119>
        <rdfs:comment>Should the term &apos;new variant Creutzfeldt–Jakob disease&apos; be included in ND?</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000143 -->

    <Class rdf:about="&obo;ND_0000143">
        <rdfs:label>chronic wasting disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <obo:IAO_0000115>Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy (TSE) of mule deer, whitetailed deer, elk (wapiti), and moose. TSEs are caused by unusual infectious agents known as prions. To date, CWD has been found mainly in cervids (members of the deer family). First recognized as a clinical &quot;wasting&quot; syndrome in 1967 in mule deer in a wildlife research facility in northern Colorado, USA, it was identified as a TSE in 1978 and has spread to a dozen states and two Canadian provinces. CWD is typified by chronic weight loss leading to death. There is no known relationship between CWD and any other TSE of animals or people.

Although there have been reports in the popular press of humans being affected by CWD, a study by the CDC suggests that &quot;[m]ore epidemiologic and laboratory studies are needed to monitor the possibility of such transmissions.&quot;

Most cases of CWD occur in adult animals. The disease is progressive and always fatal. The most obvious and consistent clinical sign of CWD is weight loss over time. Behavioral changes also occur in the majority of cases, including decreased interactions with other animals, listlessness, lowering of the head, blank facial expression, repetitive walking in set patterns, and a smell like meat starting to rot. In elk, behavioral changes may also include hyperexcitability and nervousness. Affected animals continue to eat grain but may show decreased interest in hay. Excessive salivation and grinding of the teeth also are observed. Most deer show increased drinking and urination.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12695</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Chronic_wasting_disease</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000144 -->

    <Class rdf:about="&obo;ND_0000144">
        <rdfs:label>Creutzfeldt-Jakob disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000141"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <rdfs:comment>Creutzfeldt–Jakob disease or CJD is a degenerative neurological disorder (brain disease) that is incurable and invariably fatal. CJD is at times called a human form of mad cow disease, given that bovine spongiform encephalopathy is believed to be the cause of variant Creutzfeldt–Jakob disease in humans.

CJD is the most common among the types of transmissible spongiform encephalopathy found in humans. In CJD, the brain tissue develops holes and takes on a sponge-like texture. This is due to a type of infectious protein called a prion. Prions are misfolded proteins which replicate by converting their properly folded counterparts.

Types of CJD include:
    sporadic (sCJD)
    variant (vCJD) This type is more likely to be acquired. It can be iatrogenic.
    familial (fCJD)

The first symptom of CJD is rapidly progressive dementia, leading to memory loss, personality changes and hallucinations. This is accompanied by physical problems such as speech impairment, jerky movements (myoclonus), balance and coordination dysfunction (ataxia), changes in gait, rigid posture, and seizures. The duration of the disease varies greatly, but sporadic (non-inherited) CJD can be fatal within months or even weeks (Johnson, 1998). In some people, the symptoms can continue for years. In most patients, these symptoms are followed by involuntary movements and the appearance of an atypical diagnostic electroencephalogram tracing. Most victims die 6 months after initial symptoms appear, often of pneumonia due to impaired coughing reflexes. About 15% of patients survive 2 or more years.

The symptoms of CJD are caused by the progressive death of the brain&apos;s nerve cells, which is associated with the build-up of abnormal prion proteins forming amyloids. When brain tissue from a CJD patient is examined under a microscope, many tiny holes can be seen where whole areas of nerve cells have died. The word &quot;spongiform&quot; in &quot;transmissible spongiform encephalopathies&quot; refers to the sponge-like appearance of the brain tissue.

Source: http://en.wikipedia.org/wiki/Creutzfeldt%E2%80%93Jakob_disease</rdfs:comment>
        <rdfs:comment>Should &apos;iatrogenic Creutzfeldt–Jakob disease&apos; (iCJD) be included as its own subtype of CJD?

Should &apos;new variant Creutzfeldt-Jakob disease&apos; be included as its own subtype of CJD?

_____________________________

The class &apos;infectious dementia caused by Creutzfeldt-Jakob disease&apos; was eliminated in favor of this term.</rdfs:comment>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Creutzfeldt-Jakob_Syndrome</obo:IAO_0000119>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/cjd/detail_cjd.htm</obo:IAO_0000119>
        <obo:IAO_0000115>a(A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12687</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>a rare, degenerative, invariably fatal brain disorder. It affects about one person in every one million people per year worldwide; in the United States there are about 200 cases per year. CJD usually appears in later life and runs a rapid course.</obo:IAO_0000115>
        <obo:IAO_0000115>Creutzfeldt-Jakob disease is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by a prion infection associated with Creutzfeldt-Jakob disease.

*** NEEDS REVISION ***</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000145 -->

    <Class rdf:about="&obo;ND_0000145">
        <rdfs:label>familial Creutzfeldt-Jakob disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000144"/>
        <obo:IAO_0000115>Variant Creutzfeldt-Jakob disease (vCJD) is a rare and fatal human neurodegenerative condition. As with Creutzfeldt-Jakob disease, vCJD is classified as a Transmissible Spongiform Encephalopathy (TSE) because of characteristic spongy degeneration of the brain and its ability to be transmitted. vCJD is a new disease that was first described in March 1996.

Before the identification of vCJD, CJD was recognized to exist in only three forms. Sporadic cases, which have an unknown cause and occur throughout the world at the rate of about one per million people, account for 85–90% of CJD cases. Familial cases are associated with a gene mutation and make up 5–10% of all CJD cases. Iatrogenic cases result from the accidental transmission of the causative agent via contaminated surgical equipment or as a result of cornea or dura mater transplants or the administration of human-derived pituitary growth hormones. Less than 5% of CJD cases are iatrogenic.

In contrast to the traditional forms of CJD, vCJD has affected younger patients (average age 29 years, as opposed to 65 years), has a relatively longer duration of illness (median of 14 months as opposed to 4.5 months) and is strongly linked to exposure, probably through food, to a TSE of cattle called Bovine Spongiform Encephalopathy (BSE).</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.who.int/mediacentre/factsheets/fs180/en/</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12688</oboInOwl:hasDbXref>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000146 -->

    <Class rdf:about="&obo;ND_0000146">
        <rdfs:label>variant Creutzfeldt-Jakob disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000144"/>
        <obo:IAO_0000119>http://www.alzheimer-europe.org/Dementia/Other-forms-of-dementia/Infectious-Diseases/Human-Prion-Diseases/Familial-CJD</obo:IAO_0000119>
        <obo:IAO_0000115>Familial CJD is an inherited form of Creutzfeldt-Jakob disease, resulting from several types of mutations on prion gene. Like other forms of CJD, familial CJD is characterised by dementia and neurological problems such as unsteadiness.

The symptoms and course of familial CJD will vary depending on the type of Prp mutation involved. There may even be a great variation in the symptoms within affected members of the same family. Sometimes, the symptom pattern is similar to that found in sporadic CJD, namely: early symptoms may be like those of depression-mood swings, memory lapses, social withdrawal and lack of interest. However rapid progression to dementia and neurological symptoms are distinctive. Within weeks the patient may become unsteady on their feet, lacking in coordination and clumsy. Later symptoms may include blurred vision or even blindness, rigidity in the limbs, sudden jerky movements and incontinence. Difficulty in speaking, slurred speech and difficulty in swallowing may also occur. Eventually the person will need full time care. Familial CJD often strikes at an earlier age than the sporadic form: the average age of onset is 52 compared to 65. The course of the disease is often longer and the patient may survive for several years after the onset of symptoms. </obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12689</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000147 -->

    <Class rdf:about="&obo;ND_0000147">
        <rdfs:label>fatal familial insomnia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Fatal_familial_insomnia</obo:IAO_0000119>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12692</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Fatal familial insomnia (FFI) is a very rare autosomal dominant inherited prion disease of the brain. It is almost always caused by a mutation to the protein PrPC, but it can also develop spontaneously in patients without the inherited mutation in a variant called sporadic fatal insomnia (SFI). The mutated protein, called PrPSc, has been found in just 40 families worldwide, affecting about 100 people; if only one parent has the gene, the offspring have a 50% chance of inheriting it and developing the disease. The disease&apos;s genesis and the patient&apos;s progression into complete sleeplessness is untreatable and ultimately fatal. The first recorded victim was an Italian man, deceased in Venice in the year 1765.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000148 -->

    <Class rdf:about="&obo;ND_0000148">
        <rdfs:label>Gerstmann-Straussler-Scheinker disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <obo:IAO_0000115>Gerstmann-Straussler-Scheinker disease (GSS) is an extremely rare, neurodegenerative brain disorder. It is almost always inherited and is found in only a few families around the world. Onset of the disease usually occurs between the ages of 35 and 55. In the early stages, patients may experience varying levels of ataxia (lack of muscle coordination), including clumsiness, unsteadiness, and difficulty walking. As the disease progresses, the ataxia becomes more pronounced and most patients develop dementia. Other symptoms may include dysarthria (slurring of speech), nystagmus (involuntary movements of the eyes), spasticity (rigid muscle tone), and visual disturbances, sometimes leading to blindness. Deafness also can occur. In some families, parkinsonian features are present. GSS belongs to a family of human and animal diseases known as the transmissible spongiform encephalopathies (TSEs). Other TSEs include Creutzfeldt-Jakob disease, kuru, and fatal familial insomnia.

There is no cure for GSS, nor are there any known treatments to slow progression of the disease. Current therapies are aimed at alleviating symptoms and making the patient as comfortable as possible.

GSS is a slowly progressive condition usually lasting from 2 to 10 years. The disease ultimately causes severe disability and finally death, often after the patient goes into a coma or has a secondary infection such as aspiration pneumonia due to an impaired ability to swallow. </obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12691</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/gss/gss.htm</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000149 -->

    <Class rdf:about="&obo;ND_0000149">
        <rdfs:label>kuru</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/kuru/kuru.htm</obo:IAO_0000119>
        <obo:IAO_0000115>a rare and fatal brain disorder that occurred at epidemic levels during the 1950s-60s among the Fore people in the highlands of New Guinea. The disease was the result of the practice of ritualistic cannibalism among the Fore, in which relatives prepared and consumed the tissues (including brain) of deceased family members. Brain tissue from individuals with kuru was highly infectious, and the disease was transmitted either through eating or by contact with open sores or wounds.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12693</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Kuru is an incurable degenerative neurological disorder that is a type of transmissible spongiform encephalopathy, caused by a prion found in humans. The term &quot;kuru&quot; derives from the Fore word &quot;kuria/guria&quot; (&quot;to shake&quot;), a reference to the body tremors that are a classic symptom of the disease; it is also known among the Fore as the laughing sickness due to the pathologic bursts of laughter people would display when afflicted with the disease. It is now widely accepted that Kuru was transmitted among members of the Fore tribe of Papua New Guinea via cannibalism.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Kuru_%28disease%29</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000150 -->

    <Class rdf:about="&obo;ND_0000150">
        <rdfs:label>scrapie</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000141"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Scrapie</obo:IAO_0000119>
        <obo:IAO_0000115>A prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques.</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12694</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Scrapie</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>The NIF-Dysfunction definition of &apos;scrapie&apos; is incorrect.  It has been mistakenly copied from the NIF-Dysfunction definition of &apos;kuru&apos;.</rdfs:comment>
        <obo:IAO_0000115>Scrapie is a fatal, degenerative disease that affects the nervous systems of sheep and goats. It is one of several transmissible spongiform encephalopathies (TSEs), which are related to bovine spongiform encephalopathy (BSE or &quot;mad cow disease&quot;) and chronic wasting disease of deer. Like other spongiform encephalopathies, scrapie is caused by a prion. Scrapie has been known since the 18th century (1732) and does not appear to be transmissible to humans.

The name scrapie is derived from one of the clinical signs of the condition, wherein affected animals will compulsively scrape off their fleece against rocks, trees or fences. The disease apparently causes an itching sensation in the animals. Other clinical signs include excessive lip-smacking, altered gaits, and convulsive collapse.

Scrapie is infectious and transmissible among similar animals, and so one of the most common ways to contain scrapie (since it is incurable) is to quarantine and destroy those affected. However, scrapie tends to persist in flocks and can also arise apparently spontaneously in flocks that have not previously had cases of the disease. The mechanism of transmission between animals and other aspects of the biology of the disease are only poorly understood and these are active areas of research. Recent studies suggest that prions may be spread through urine and persist in the environment for decades.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000151 -->

    <Class rdf:about="&obo;ND_0000151">
        <rdfs:label>tauopathy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000113"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005502"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000082"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_50801"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006023"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Tauopathy</obo:IAO_0000119>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Tauopathy</obo:IAO_0000119>
        <obo:IAO_0000115>Neurodegenerative disorders involving deposition of abnormal tau protein isoforms ( TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy ( SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration (MeSH).</obo:IAO_0000115>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12696</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Tauopathies are a class of neurodegenerative diseases resulting from the pathological aggregation of tau protein in the human brain.

The best known of these illnesses is Alzheimer&apos;s disease (AD), where tau protein is deposited within neurons in the form of neurofibrillary tangles (NFTs). They were first described by the eponymous Alois Alzheimer in one of his patients suffering from the disorder. Tangles are formed by hyperphosphorylation of a microtubule-associated protein known as tau, causing it to aggregate in an insoluble form. (These aggregations of hyperphosphorylated tau protein are also referred to as PHF, or &quot;paired helical filaments&quot;). The precise mechanism of tangle formation is not completely understood, and it is still controversial whether tangles are a primary causative factor in the disease or play a more peripheral role. AD is also classified as an amyloidosis because of the presence of senile plaques.

The degree of NFT involvement in AD is defined by Braak stages. Braak stages I and II are used when NFT involvement is confined mainly to the transentorhinal region of the brain, stages III and IV when there&apos;s also involvement of limbic regions such as the hippocampus, and V and VI when there&apos;s extensive neocortical involvement. This should not be confused with the degree of senile plaque involvement, which progresses differently.

Other conditions in which neurofibrillary tangles are commonly observed include:

    Progressive supranuclear palsy although with straight filament rather than PHF tau
    Dementia pugilistica (chronic traumatic encephalopathy)
    Frontotemporal dementia and parkinsonism linked to chromosome 17 however without detectable β-amyloid plaques.
    Lytico-Bodig disease (Parkinson-dementia complex of Guam)
    Tangle-predominant dementia, with NFTs similar to AD, but without plaques. Tends to appear in the very old.
    Ganglioglioma and gangliocytoma
    Meningioangiomatosis
    Subacute sclerosing panencephalitis
    As well as lead encephalopathy, tuberous sclerosis, Hallervorden-Spatz disease, and lipofuscinosis

In Pick&apos;s disease and corticobasal degeneration tau proteins are deposited in the form of inclusion bodies within swollen or &quot;ballooned&quot; neurons. Argyrophilic grain disease (AGD), another type of dementia, is marked by the presence of abundant argyrophilic grains and coiled bodies on microscopic examination of brain tissue. Some consider it to be a type of Alzheimer disease. It may co-exist with other tauopathies such as progressive supranuclear palsy and corticobasal degeneration.

Some other tauopathies include:

    Frontotemporal dementia
    Frontotemporal lobar degeneration

The non-Alzheimer&apos;s tauopathies are sometimes grouped together as &quot;Pick&apos;s complex&quot;.</obo:IAO_0000115>
        <rdfs:comment>There have been many more subtypes of tauopathy than the two that are included in NIF-Dysfunction.  These additional tauopathies should probably be added to ND.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000152 -->

    <Class rdf:about="&obo;ND_0000152">
        <rdfs:label>Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000186"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005500"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000082"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_50801"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005502"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000082"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_50801"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom>
                            <Class>
                                <unionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0006007"/>
                                    <rdf:Description rdf:about="&obo;ND_0006008"/>
                                </unionOf>
                            </Class>
                        </allValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000186"/>
        <obo:IAO_0000118>primary degenerative dementia of the Alzheimers type</obo:IAO_0000118>
        <obo:IAO_0000115>An amyloidopathy where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrillary tangles in the medial temporal lobes.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>senile dementia of the Alzheimers type</obo:IAO_0000118>
        <rdfs:comment>an age-related, non-reversible brain disorder that develops over a period of years. Initially, people experience memory loss and confusion, which may be mistaken for the kinds of memory changes that are sometimes associated with normal aging. However, the symptoms of AD gradually lead to behavior and personality changes, a decline in cognitive abilities such as decision-making and language skills, and problems recognizing family and friends. AD ultimately leads to a severe loss of mental function.</rdfs:comment>
        <obo:IAO_0000118>old-timers&apos; disease</obo:IAO_0000118>
        <obo:IAO_0000118>AD</obo:IAO_0000118>
        <obo:IAO_0000118>Alzheimer&apos;s disease</obo:IAO_0000118>
        <obo:IAO_0000118>Alzheimer disease</obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_2092</oboInOwl:hasDbXref>
        <obo:IAO_0000118>Alzheimer&apos;s</obo:IAO_0000118>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/alzheimersdisease/alzheimersdisease.htm</obo:IAO_0000119>
        <obo:IAO_0000118>Alzheimers</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000153 -->

    <Class rdf:about="&obo;ND_0000153">
        <rdfs:label>semantic aphasia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000167"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006029"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000167"/>
        <rdfs:comment>*** TO DO ***
Revise definition.
Confirm that this is a disease and not just a syndrome.</rdfs:comment>
        <obo:IAO_0000118>SD</obo:IAO_0000118>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Semantic_dementia</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>aphasia characterized by the loss of recognition of the meaning of words and phrases.</obo:IAO_0000115>
        <obo:IAO_0000115>Semantic dementia (SD) is a progressive neurodegenerative disorder characterized by loss of semantic memory in both the verbal and non-verbal domains. The most common presenting symptoms are in the verbal domain however (with loss of word meaning) and it is therefore often characterized (incorrectly) as a primary language disorder (a so-called progressive fluent aphasia).
SD patients sometimes show symptoms of surface dyslexia, a relatively selective impairment in reading low-frequency words with exceptional or atypical spelling-to-sound correspondences. 
SD is one of the three canonical clinical syndromes associated with frontotemporal lobar degeneration. SD is a clinically-defined syndrome, but is associated with predominantly temporal lobe atrophy (left greater than right) and hence is sometimes called temporal variant FTLD (tvFTLD).

The majority of patients with SD will have ubiquitin-positive, TDP-43 positive, tau-negative inclusions, although other pathologies have been described more infrequently, namely tau-positive Pick&apos;s disease and Alzheimer&apos;s pathology.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.merriam-webster.com/medical/semantic%20aphasia</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000154 -->

    <Class rdf:about="&obo;ND_0000154">
        <rdfs:label>febrile seizure</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000108"/>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12749</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Febrile_Seizures</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or &quot;seizure disorder.&quot; 

Convulsions brought on by a fever in infants or small children. During a febrile seizure, a child often loses consciousness and shakes.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/febrile_seizures/febrile_seizures.htm</obo:IAO_0000119>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000155 -->

    <Class rdf:about="&obo;ND_0000155">
        <rdfs:label>infectious demyelinating disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000024"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>demyelinating infectious disease</obo:IAO_0000118>
        <obo:IAO_0000115>A demyelinating disease that is caused be an infectious agent.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000156 -->

    <Class rdf:about="&obo;ND_0000156">
        <rdfs:label>genetic demyelinating disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000024"/>
        <obo:IAO_0000118>demyelinating genetic disease</obo:IAO_0000118>
        <obo:IAO_0000115>A demyelinating disease that has a strong genetic etiology.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000157 -->

    <Class rdf:about="&obo;ND_0000157">
        <rdfs:label>primary progressive aphasia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000167"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006028"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000167"/>
        <rdfs:comment>Synonym(s):   Pick&apos;s Disease, Primary Progressive Aphasia, Semantic Dementia, Dementia - Semantic
consider merging terms source for it:http://www.ninds.nih.gov/disorders/picks/picks.htm</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Primary progressive aphasia (PPA) is a type of dementia characterized most prominently by an insidious and progressive disorder of language and speech abilities.</obo:IAO_0000115>
        <rdfs:comment>*** TO DO ***
Revise definition.
Also see: http://www.brain.northwestern.edu/ppa/
Confirm that this is a disease and not just a syndrome.</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Primary_progressive_aphasia</obo:IAO_0000119>
        <obo:IAO_0000118>PPA</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000158 -->

    <Class rdf:about="&obo;ND_0000158">
        <rdfs:label>dementia caused by syphilis</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000180"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005039"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000180"/>
        <obo:IAO_0000115>Infectious dementia caused by syphilis is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by a syphilis infection.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://alzheimers.about.com/od/typesofdementia/a/neurosyphilis.htm</obo:IAO_0000119>
        <obo:IAO_0000115>a slow progressive, destructive infection of the brain and the spinal cord. Neurosyphilis has 4 different forms; asymptomatic, meningovascular, tabes dorsalis, and general paresis. Tapes dorsalis: symptoms include peripheral neuropathy, pain in the extrematies, incontinence and ataxia- shakey and unsteady movements.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000159 -->

    <Class rdf:about="&obo;ND_0000159">
        <rdfs:label>neurodegenerative disease resulting in dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000113"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000006"/>
        <obo:IAO_0000116>I believe this class is unecessary, it overlaps with &apos;disease resulting in dementia&apos;.

-MJ</obo:IAO_0000116>
        <obo:IAO_0000115>Neurodegenerative dementia is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>neurodegenerative dementia</obo:IAO_0000118>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000160 -->

    <Class rdf:about="&obo;ND_0000160">
        <rdfs:label>frontotemporal dementia with motor neuron disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000167"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003003"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006026"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000167"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Frontotemporal dementia with motor neuron disease is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of tau in the frontal and temporal cortices and where abnormal movement [tremor, rigidity, bradykinesia, postural instability] also occurs resulting in a movement disorder caused by neurodegeneration as a result of ________.

*** DOUBLE-CHECK THE MOVEMENT DISORDER, ITS CAUSE, AND ITS SYMPTOMS ***</obo:IAO_0000115>
        <obo:IAO_0000118>FTD-MND</obo:IAO_0000118>
        <rdfs:comment>Should be inferred to be a subtype of motor neuron disease.</rdfs:comment>
        <obo:IAO_0000119>Nakano, Imaharu. &quot;frontotemporal dementia with motor neuron disease .&quot; Neuropathology 1.1 (2000): 68-75. Print.</obo:IAO_0000119>
        <obo:IAO_0000115>ALS with Dementia</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000161 -->

    <Class rdf:about="&obo;ND_0000161">
        <rdfs:label>atypical Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000152"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003005"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006008"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000152"/>
        <obo:IAO_0000115>Atypical Alzheimers disease is a type of Alzheimers disease where episodic memory loss is not present but other cognitive deficits [visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrillary tangles in the medial temporal lobes.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000162 -->

    <Class rdf:about="&obo;ND_0000162">
        <rdfs:label>frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000161"/>
        <obo:IAO_0000115>Frontal variant of Alzheimers disease is a neurodegenerative disease where _________ occur with at least one other cognitive deficit [visual spatial, attention, orientation, executive function, functional] resulting in dementia caused by atypical Azlheimers disease.

*** REVISE ***</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>Which super class should be referenced in each disease definition?  Should it be the top level disease type (i.e. neurological disease), the immediate parent class (i.e. atypical Alzheimers disease), or an alternate super class (i.e. nerodegenerative disease)?</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000163 -->

    <Class rdf:about="&obo;ND_0000163">
        <rdfs:label>logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000161"/>
        <obo:IAO_0000115> speech rate was slow, with long word-finding pauses. Grammar and articulation were preserved, although phonological paraphasias could be present. Repetition and comprehension were impaired for sentences but preserved for single words, and naming was moderately affected. Investigation of phonological loop functions showed that patients were severely impaired in digit, letter, and word span tasks. Performance did not improve with pointing, was influenced by word length, and did not show the normal phonological similarity effect. Atrophy or decreased blood flow was consistently found in the posterior portion of the left superior and middle temporal gyri and inferior parietal lobule.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Logopenic_progressive_aphasia</obo:IAO_0000119>
        <obo:IAO_0000115>Logopenic progressive aphasia (LPA) is a form of primary progressive aphasia characterized by slow speech and impaired syntactic comprehension and naming. It is similar to Wernicke&apos;s aphasia and is associated with atrophy to the left posterior temporal cortex and inferior parietal lobule. It is suspected that an atypical form of Alzheimer&apos;s disease is the most common cause of logopenic progressive aphasia.</obo:IAO_0000115>
        <rdfs:comment>Should be inferred to be a subtype of primary progressive aphasia.</rdfs:comment>
        <obo:IAO_0000119>http://www.neurology.org/content/71/16/1227</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000164 -->

    <Class rdf:about="&obo;ND_0000164">
        <rdfs:label>primary progressive nonfluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000161"/>
        <obo:IAO_0000118>primary progressive non-fluent aphasia</obo:IAO_0000118>
        <obo:IAO_0000118>PNFA</obo:IAO_0000118>
        <obo:IAO_0000115>Primary progressive nonfluent aphasia is a neurodegenerative dementia where progressive difficulties with speech production [hesitant or effortful speech, speech apraxia, stutter, anomia, phonemic paraphasia, agrammatism] occur with at least one other cognitive deficit [visual spatial, attention, orientation, exceutive function, functional] resulting in a dementia syndrome caused by atypical Azlheimers disease.</obo:IAO_0000115>
        <rdfs:comment>Should be inferred to be a subtype of primary progressive aphasia.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>In classical PNFA, atrophy of left perisylvian areas is seen. Comprehensive meta-analyses on MRI and FDG-PET studies identified alterations in the whole left frontotemporal network for phonological and syntactical processing as the most consistent finding. Based on these imaging methods, progressive nonfluent aphasia can be regionally dissociated from the other subtypes of frontotemporal lobar degeneration, frontotemporal dementia and semantic dementia.

From: http://en.wikipedia.org/wiki/Progressive_nonfluent_aphasia#Imaging</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000165 -->

    <Class rdf:about="&obo;ND_0000165">
        <rdfs:label>posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000161"/>
        <obo:IAO_0000115>Posterior cortical atrophy (PCA), also called Benson&apos;s syndrome, is most usually considered to be an atypical variant of Alzheimer&apos;s disease. The disease causes atrophy of the back (posterior) part of the cerebral cortex, resulting in the progressive disruption of complex visual processing.

Despite being caused by the same disease process, the effects of posterior cortical atrophy and typical Alzheimer’s disease upon the behaviour, thought processes and skills of individuals with each condition are very different. Typical Alzheimer’s disease is most commonly associated with deterioration in memory, language, perception and a host of other skills and abilities. By contrast, individuals with posterior cortical atrophy tend to have well preserved memory and language but instead show a progressive, dramatic and relatively selective decline in vision and/or literacy skills such as spelling, writing and arithmetic.

In rare cases, PCA can also be due to other diseases including dementia with Lewy bodies and Creutzfeldt–Jakob disease.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Posterior_cortical_atrophy</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000166 -->

    <Class rdf:about="&obo;ND_0000166">
        <rdfs:label>genetic frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000167"/>
        <obo:IAO_0000118>genetic FTD</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Genetic frontotemporal dementia is frontotemporal dementia that is caused by one or more genetic defects.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000167 -->

    <Class rdf:about="&obo;ND_0000167">
        <rdfs:label>frontotemporal dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000151"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005502"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000082"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_61824"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006020"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000151"/>
        <obo:IAO_0000118>FTD</obo:IAO_0000118>
        <obo:IAO_0000115>Frontotemporal dementia is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of tau in the frontal and temporal cortices.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000168 -->

    <Class rdf:about="&obo;ND_0000168">
        <rdfs:label>Parkinson dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000139"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003001"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006039"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000139"/>
        <obo:IAO_0000115>Parkinsons dementia is a neurological disease where abnormal movement [tremor, rigidity, bradykinesia, postural instability] occurs resulting in a movement disorder caused by neurodegeneration as a result of death of dopaminergic cells in the substantia nigra, which is followed by cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] that represent a decline from previous levels of functioning resulting in dementia years after the diagnosis of Parkinsons disease caused by neurodegeneration as a result of deposition of Lewy bodies in the cerebral cortex and limic structures.</obo:IAO_0000115>
        <obo:IAO_0000118>PD-D</obo:IAO_0000118>
        <obo:IAO_0000118>Parkinsons dementia</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>PDD</obo:IAO_0000118>
        <obo:IAO_0000118>Parkinsons disease dementia</obo:IAO_0000118>
        <obo:IAO_0000118>Parkinson disease dementia</obo:IAO_0000118>
        <obo:IAO_0000118>Parkinson&apos;s dementia</obo:IAO_0000118>
        <obo:IAO_0000118>Parkinson&apos;s disease dementia</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000169 -->

    <Class rdf:about="&obo;ND_0000169">
        <rdfs:label>corticobasal degeneration</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000151"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003003"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006024"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000151"/>
        <obo:IAO_0000115>Corticobasal degeneration is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, exceutive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia associated with other asymmetrical cortical signs [apraxia, cortical sensory, dysphasia, speech apraxia] and where abnormal movement [akinetic rigid syndrome, hyperkinetic movement disorder, alien limb] occurs resulting in a movement disorder caused by neurodegeneration in the anterior frontal lobe, basal ganglia, and premotor area of the cerebral cortex associated with astroglial inclusions due to a tauopathy.</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Corticobasal_Degeneration</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>CBGD</obo:IAO_0000118>
        <obo:IAO_0000118>corticobasal ganglionic degeneration</obo:IAO_0000118>
        <obo:IAO_0000118>CBD</obo:IAO_0000118>
        <obo:IAO_0000115>A rare neurological disease in which several regions of the brain deteriorate. The cortex is severely affected, especially the fronto-parietal regions, located near the center-top of the head. Other, deeper brain regions are also affected, including parts of the basal ganglia, hence the name &quot;corticobasal&quot; degeneration. The combined loss of brain tissue in all these areas causes the symptoms and findings seen in people with CBD.</obo:IAO_0000115>
        <rdfs:comment>*** TO DO ***
Should corticobasal degeneration be made a subtype of tauopathy???</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000170 -->

    <Class rdf:about="&obo;ND_0000170">
        <rdfs:label>frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000166"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>frontotemporal dementia and Parkinsonism linked to chromosome 17</obo:IAO_0000118>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Frontotemporal_dementia_and_parkinsonism_linked_to_chromosome_17</obo:IAO_0000119>
        <rdfs:comment>caused by MAPT mutations</rdfs:comment>
        <obo:IAO_0000115>Frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) is an autosomal dominant neurodegenerative disorder, which has three cardinal features: behavioral and personality changes, cognitive impairment, and motor symptoms. It is caused by mutations in the MAPT gene, which encodes a microtubule-associated protein tau. Over 100 families with 38 different mutations in the MAPT gene have been identified worldwide. The phenotype of FTDP-17 varies not only between families carrying different mutations but also between and within families carrying the same mutations. The pathogenetic mechanisms underlying the disorder are thought to be related to the altered proportion of tau isoforms or to the ability of tau to bind microtubules and to promote microtubule assembly.</obo:IAO_0000115>
        <obo:IAO_0000118>FTDP-17</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000171 -->

    <Class rdf:about="&obo;ND_0000171">
        <rdfs:label>FTDU-17 caused by caused by progranulin mutations</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000166"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>FTDU-17 caused by caused by progranulin mutations is frontotemporal dementia that is caused by progranulin mutations on chromosome 17.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000172 -->

    <Class rdf:about="&obo;ND_0000172">
        <rdfs:label>progressive supranuclear palsy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000151"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005502"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003003"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006030"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000151"/>
        <rdfs:comment>PSP cases are often split into two subgroups, PSP-Richardson, the classic type, and PSP-Parkinsonism, where a short-term response to levodopa can be obtained.</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Progressive_supranuclear_palsy</obo:IAO_0000119>
        <obo:IAO_0000115>A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei.</obo:IAO_0000115>
        <obo:IAO_0000118>Steele-Richardson-Olszewski syndrome</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12697</oboInOwl:hasDbXref>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Progressive_Supranuclear_Palsy</obo:IAO_0000119>
        <obo:IAO_0000118>PSP</obo:IAO_0000118>
        <obo:IAO_0000115>Progressive supranuclear palsy is a degenerative tauopathic disease involving the gradual deterioration and death of specific areas of the brain.  The affected brain cells are both neurons and glial cells. The neurons display neurofibrillary tangles, which are clumps of tau protein, a normal part of a brain cell&apos;s internal structural skeleton. These tangles are often different from those seen in Alzheimer&apos;s disease, but may be structurally similar when they occur in the cerebral cortex.  Their chemical composition is usually different, however, and is similar to that of tangles seen in corticobasal degeneration.  Lewy bodies are seen in some cases, but it is not clear whether this is a variant or an independent co-existing process.

The principal areas of the brain affected are:

    the basal ganglia, particularly the subthalamic nucleus, substantia nigra and globus pallidus;
    the brainstem, particularly the portion of the midbrain where &quot;supranuclear&quot; eye movement resides;
    the cerebral cortex, particularly that of the frontal lobes;
    the dentate nucleus of the cerebellum;
    and the spinal cord, particularly the area where some control of the bladder and bowel resides.

The initial symptoms in two-thirds of cases are loss of balance, lunging forward when mobilizing, fast walking, bumping into objects or people, and falls.

Other common early symptoms are changes in personality, general slowing of movement, and visual symptoms.

Later symptoms and signs are dementia (typically including loss of inhibition and ability to organize information), slurring of speech, difficulty swallowing, and difficulty moving the eyes, particularly in the vertical direction. The latter accounts for some of the falls experienced by these patients as they are unable to look up or down.

Some of the other signs are poor eyelid function, contracture of the facial muscles, a backward tilt of the head with stiffening of the neck muscles, sleep disruption, urinary incontinence and constipation.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000173 -->

    <Class rdf:about="&obo;ND_0000173">
        <rdfs:label>vascular disease resulting in dementia</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000181"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006022"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000006"/>
        <obo:IAO_0000115>Vascular dementia is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia caused by ischemia.</obo:IAO_0000115>
        <obo:IAO_0000115> imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described.
</obo:IAO_0000115>
        <obo:IAO_0000118>VD</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>Gerontol Geriatr 1998 Feb;31(1):36-44</obo:IAO_0000119>
        <obo:IAO_0000118>vascular dementia</obo:IAO_0000118>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000174 -->

    <Class rdf:about="&obo;ND_0000174">
        <rdfs:label>disease resulting in dementia associated with Parkinsonism</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000159"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003001"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000159"/>
        <obo:IAO_0000115>Dementia associated with Parkinsonism is a neurological disease where cognitive deficits [memory, visual spatial, attention, orientation, executive function, functional] occur that represent a decline from previous levels of functioning resulting in dementia along with motor deficits resulting in Parkinsonism caused by neurodegeneration in the brain and/or spinal cord.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>dementia associated with Parkinsonism</obo:IAO_0000118>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000175 -->

    <Class rdf:about="&obo;ND_0000175">
        <rdfs:label>normal pressure hydrocephalus</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000001"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;elevated_cerebral_spinal_fluid_pressure"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND_0004000"/>
                        <someValuesFrom rdf:resource="&obo;ND_0003000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006025"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000118>symptomatic hydrocephalus</obo:IAO_0000118>
        <obo:IAO_0000115>Normal pressure hydrocephalus occurs when there is an increase in intracranial pressure (ICP) due to an abnormal accumulation of cerebrospinal fluid (CSF) in the ventricles of the brain, which can cause ventriculomegaly. The ICP gradually falls but still maintains a slightly elevated level and the CSF pressure reaches a high normal level of 150 to 200 mmH2O. Measurements of CSF, therefore, are not usually elevated. Because of this equilibration, patients do not exhibit the classic signs that accompany increased intracranial pressure such as headache, nausea, vomiting, or altered consciousness. (Though some studies have shown pressure elevations to occur only intermittently). However, the enlarged ventricles put increased pressure on the adjacent cortical tissue and cause myriad effects in the patient.

Although the exact mechanism is unknown, normal-pressure hydrocephalus is thought to be a form of communicating hydrocephalus with impaired CSF reabsorption at the arachnoid granulations.

There are 2 types of normal pressure hydrocephalus: idiopathic and secondary. The term idiopathic means that it has no known cause. The secondary type of NPH can be due to a subarachnoid haemorrhage, head trauma, tumour, CNS infection, or a complication of cranial surgery.

NPH may exhibit a classic triad of clinical findings (known as the Adams triad or Hakim&apos;s triad) of urinary incontinence, gait disturbance, and dementia (commonly referred to as &quot;wet, wobbly and wacky&quot; or &quot;weird walking water&quot;).</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Normal_pressure_hydrocephalus</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>NPH</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000176 -->

    <Class rdf:about="&obo;ND_0000176">
        <rdfs:label>genetic Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000152"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom rdf:resource="&obo;OGMS_0000047"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000152"/>
        <obo:IAO_0000115>Genetic Alzheimers disease is a neurological disease where episodic memory loss occurs with at least one other cognitive deficit [visual spatial, attention, orientation, executive function, functional] that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrillary tangles in the medial temporal lobes due to a genetic defect.



*** ALTERNATE DEFINITION ***

Genetic Alzheimers disease is Alzheimers disease in which the deposition of amyloid plaques and neurofibrillary tangles in the medial temporal lobes is due to a[n identified???] genetic defect.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000177 -->

    <Class rdf:about="&obo;ND_0000177">
        <rdfs:label>genetic Alzheimers disease caused by presenilin 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000176"/>
        <obo:IAO_0000115>Genetic Alzheimers disease caused by presenilin 1 is a neurological disease where episodic memory loss occurs with at least one other cognitive deficit [visual spatial, attention, orientation, exceutive function, functional] that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrilary tangles in the medial temporal lobes due to a genetic defect in presenilin 1.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000178 -->

    <Class rdf:about="&obo;ND_0000178">
        <rdfs:label>genetic Alzheimers disease caused by presenilin 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000176"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Genetic Alzheimers disease caused by presenilin 2 is a neurological disease where episodic memory loss occurs with at least one other cognitive deficit [visual spatial, attention, orientation, exceutive function, functional] that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrilary tangles in the medial temporal lobes due to a genetic defect in presenilin 2.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000179 -->

    <Class rdf:about="&obo;ND_0000179">
        <rdfs:label>genetic Alzheimers disease caused by APP</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000176"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Genetic Alzheimers disease caused by APP is a neurological disease where episodic memory loss occurs with at least one other cognitive deficit [visual spatial, attention, orientation, exceutive function, functional] that represent a decline from previous levels of functioning resulting in dementia caused by neurodegeneration as a result of deposition of amyloid plaques and neurofibrilary tangles in the medial temporal lobes due to a genetic defect in APP.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000180 -->

    <Class rdf:about="&obo;ND_0000180">
        <rdfs:label>infectious neurological disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000001"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0006019"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                                        <someValuesFrom>
                                            <Class>
                                                <unionOf rdf:parseType="Collection">
                                                    <rdf:Description rdf:about="&obo;NCBITaxon_10239"/>
                                                    <rdf:Description rdf:about="&obo;NCBITaxon_2"/>
                                                </unionOf>
                                            </Class>
                                        </someValuesFrom>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </allValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <rdfs:comment>Make the following subclasses:

viral
&gt; HIV

bacterial
&gt; syphilis

fungal
&gt; example of agent</rdfs:comment>
        <obo:IAO_0000115>Infectious neurological disease is a neurological disease caused by an infectious agent.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>Double-check the logical definition!  What about prions?

Alexander P. Cox</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000181 -->

    <Class rdf:about="&obo;ND_0000181">
        <rdfs:label>vascular neurological disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Vascular neurological disease is a neurological disease caused by a cerebrovascular accident (e.g. ischemia or hemorrhage).</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000182 -->

    <Class rdf:about="&obo;ND_0000182">
        <rdfs:label>genetic neurological disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Genetic neurological disease is a neurological disease caused by a genetic mutation.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000116>Idea here will be to have a defined class that will allow a reasoner to infer any neurological disease which is also considered to be predominantly genetic in orgin vs. aquired.</obo:IAO_0000116>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000183 -->

    <Class rdf:about="&obo;ND_0000183">
        <rdfs:label>autoimmune neurological disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000001"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0006019"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000118"/>
                                        <someValuesFrom rdf:resource="&obo;ND_0006017"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </allValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000116>Not sure if logical def. is correct. If any neurological disease has an autoimmune process as part, then the resaoner should infer it&apos;s also an autoimmune neurological disease. I think that is too weak.
-MJ

Weakness in this regard allows the reasoner to recognize more neurological diseases as autoimmune neurological diseases.  This seems to be a good thing to me!
Perhaps your concern is that the current textual definition stipulates that the disease be CAUSED by the autoimmune process.  On this reading, we probably would not want a neurological disease whose realization includes an autoimmune process that is of only peripheral interest/importance to the disease to be included among the children of &apos;autoimmune neurological disease&apos;.  In this regard, we might need a more restrictive logical definition in order to capture the intended extension of the current textual definition.  I think that we would need a new relation that captures the proper sort of causation that is at work here.  The relation &apos;has material basis&apos; captures a sort of causality, but is not applicable to processes.  Perhaps we can develop a similar relation to connect diseases to processes.  Of course, the &apos;realizes&apos; relation seems to already have a sort of causality built into its meaning so we would need a way to distinguish the two relations.
-APC</obo:IAO_0000116>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Autoimmune neurological disease is a neurological disease caused by an autoimmune process.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000184 -->

    <Class rdf:about="&obo;ND_0000184">
        <rdfs:label>neoplastic neurological disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Neoplastic neurological disease is a neurological disease caused by neoplasticism.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000185 -->

    <Class rdf:about="&obo;ND_0000185">
        <rdfs:label>paraneoplastic neurological disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Paraneoplastic neurological disease is a neurological disease caused by paraneoplasticism.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000186 -->

    <Class rdf:about="&obo;ND_0000186">
        <rdfs:label>amyloidopathy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000113"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000113"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0005504"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000082"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_50801"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000113"/>
        <obo:IAO_0000232>Is this term unique to neurological diseases?  According to the following wikipedia entry, amyloidosis can occur in other organs such as the heart.  Does this pose a problem for our classification schema?

http://en.wikipedia.org/wiki/Amyloidosis

&quot;In medicine, amyloidosis refers to a variety of conditions wherein amyloid proteins are abnormally deposited in organs or tissues and cause harm. A protein is described as being amyloid if, due to an alteration in its secondary structure, it takes on a particular aggregated insoluble form, similar to the beta-pleated sheet. Symptoms vary widely depending upon where in the body amyloid deposits accumulate. Amyloidosis may be inherited or acquired.&quot;</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Amyloidopathy is a neurological disease that results in the degeneration of populations of nerve cells due to the formation of extracellular amyloid plaques.

*** NEEDS REVIEW ***</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000187 -->

    <Class rdf:about="&obo;ND_0000187">
        <rdfs:label>FTD caused by CHMP2B mutations</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000166"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>FTD caused by CHMP2B mutations is frontotemporal dementia that is caused by CHMP2B mutations.</obo:IAO_0000115>
        <obo:IAO_0000115>Early personality change is the most common feature which can include less concern for others, an unkempt appearance, disinhibition, inappropriate emotional responses and restlessness which later can be accompanied by aggression. Apathy can also occur as the disease progresses. Hyperorality is also common, encompassing mouthing of non-food objects, over-eating of sweet foods and chain smoking. A progressive aphasia develops during the course of the disease, although normally not with features of PNFA or SD. It is characterised by reduced spontaneous speech with relative preservation of reading and repetition, most consistent with a dynamic aphasia. An overt motor syndrome develops late in the disease course which can include parkinsonian features, dystonia, pyramidal signs and myoclonus, ultimately leaving the patients bedridden. None of the patients have had any clinical signs of either upper or lower motor neuron impairment, and no neurophysiological EMG studies have been done so far in the Danish FTD-3 patients. A new branch of the FTD-3 family was recently identified and clinical descriptions of a further two cases were similar to those previously reported [21]. The average age of onset for FTD-3 is 58 years of age and the mean duration is 10 years. Ongoing neuropsychological studies indicate that some of the patients can have impaired memory function in the earlier phases of the disease, but this is not a prominent feature and most often not a subjective complaint by the patients.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182073/?tool=pubmed</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000188 -->

    <Class rdf:about="&obo;ND_0000188">
        <rdfs:label>cerebral amyloid angiopathy</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000186"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000054"/>
                        <allValuesFrom rdf:resource="&obo;ND_0006036"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000186"/>
        <obo:IAO_0000118>congophilic angiopathy</obo:IAO_0000118>
        <obo:IAO_0000118>amyloid angiopathy</obo:IAO_0000118>
        <obo:IAO_0000115>Cerebral amyloid angiopathy (CAA), also known as congophilic angiopathy, is a form of angiopathy in which amyloid deposits form in the walls of the blood vessels of the central nervous system.  The amyloid material is only found in the brain and as such the disease is not related to other forms of amyloidosis.</obo:IAO_0000115>
        <obo:IAO_0000115>A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia ( BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalizedAMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Cerebral_amyloid_angiopathy</obo:IAO_0000119>
        <obo:IAO_0000119>Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>CAA</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000189 -->

    <Class rdf:about="&obo;ND_0000189">
        <rdfs:label>chronic inflammatory demyelinating polyneuropathy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000067"/>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <oboInOwl:hasDbXref>http://ontology.neuinfo.org/NIF/Dysfunction/NIF-Dysfunction.owl#birnlex_12556</oboInOwl:hasDbXref>
        <obo:IAO_0000115>Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated inflammatory disorder of the peripheral nervous system. The disorder is sometimes called chronic relapsing polyneuropathy. CIDP is closely related to Guillain-Barré syndrome and it is considered the chronic counterpart of that acute disease. Its symptoms are also similar to progressive inflammatory neuropathy. An asymmetrical variant of CIDP is known as Lewis-Sumner syndrome.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000118>chronic inflammatory demyelinating polyradiculoneuropathy</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>CIDP</obo:IAO_0000118>
        <obo:IAO_0000118>chronic relapsing polyneuropathy</obo:IAO_0000118>
        <rdfs:comment>An example of a demylinating disease that affects the PNS. MJ</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Chronic_inflammatory_demyelinating_polyneuropathy</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000201 -->

    <Class rdf:about="&obo;ND_0000201">
        <rdfs:label>relapsing multiple sclerosis disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006009"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000117"/>
                <someValuesFrom>
                    <Class>
                        <unionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;ND_0006051"/>
                            <rdf:Description rdf:about="&obo;ND_0006054"/>
                        </unionOf>
                    </Class>
                </someValuesFrom>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000115>A disease course which realizes relapsing multiple sclerosis. </obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0000202 -->

    <Class rdf:about="&obo;ND_0000202">
        <rdfs:label>primary progressive multiple sclerosis disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006009"/>
        <obo:IAO_0000115>A disease course which realizes primary progressive multiple sclerosis. </obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001000 -->

    <Class rdf:about="&obo;ND_0001000">
        <rdfs:label>diagnosis of mild cognitive impairment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001062"/>
        <obo:IAO_0000119>Adapted from: http://en.wikipedia.org/wiki/Mild_cognitive_impairment</obo:IAO_0000119>
        <obo:IAO_0000115>*** REVISE ***

A diagnosis of cognitive impairments beyond those expected based on the age and education of the individual, but which are not significant enough to interfere with their daily activities.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001001 -->

    <Class rdf:about="&obo;ND_0001001">
        <rdfs:label>diagnosis of dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001062"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient has dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001002 -->

    <Class rdf:about="&obo;ND_0001002">
        <rdfs:label>diagnosis of infectious dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001001"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of an infectious agent.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001003 -->

    <Class rdf:about="&obo;ND_0001003">
        <rdfs:label>diagnosis of vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001001"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of ischemia.

-OR -

A diagnosis that a patient has vascular dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001004 -->

    <Class rdf:about="&obo;ND_0001004">
        <rdfs:label>diagnosis of neurodegenerative dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001001"/>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of a neurodegenerative process (disorder???, disease???).</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001005 -->

    <Class rdf:about="&obo;ND_0001005">
        <rdfs:label>diagnosis of infectious dementia due to HIV</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001002"/>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of an HIV infection.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001006 -->

    <Class rdf:about="&obo;ND_0001006">
        <rdfs:label>diagnosis of infectious dementia due to syphilis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001002"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of an infection of syphilis.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001007 -->

    <Class rdf:about="&obo;ND_0001007">
        <rdfs:label>diagnosis of infectious dementia due to prion disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001002"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of a prion infection.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001008 -->

    <Class rdf:about="&obo;ND_0001008">
        <rdfs:label>diagnosis of infectious dementia due to Creutzfeldt-Jakob disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001002"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of a prion infection associated with Creutzfeldt-Jakob disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001009 -->

    <Class rdf:about="&obo;ND_0001009">
        <rdfs:label>diagnosis of possible ischemic vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001003"/>
        <obo:IAO_0000115>A diagnosis that a patient possibly has ischemic vascular dementia.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001010 -->

    <Class rdf:about="&obo;ND_0001010">
        <rdfs:label>diagnosis of probable ischemic vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001003"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient probably has ischemic vascular dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001011 -->

    <Class rdf:about="&obo;ND_0001011">
        <rdfs:label>diagnosis of definite ischemic vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001003"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient definitely has ischemic vascular dementia.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001012 -->

    <Class rdf:about="&obo;ND_0001012">
        <rdfs:label>diagnosis of possible normal pressure hydrocephalus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis of dementia in a patient that is hypothesized to be the result of normal pressure hydrocephalus.

- OR -

A diagnosis that a patient possibly has normal pressure hydrocephalus.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001013 -->

    <Class rdf:about="&obo;ND_0001013">
        <rdfs:label>diagnosis of probable normal pressure hydrocephalus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000119>A diagnosis that a patient probably has normal pressure hydrocephalus.</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001014 -->

    <Class rdf:about="&obo;ND_0001014">
        <rdfs:label>diagnosis of definite normal pressure hydrocephalus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000119>A diagnosis that a patient definitely has normal pressure hydrocephalus.</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001015 -->

    <Class rdf:about="&obo;ND_0001015">
        <rdfs:label>diagnosis of possible frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient possibly has frontotemporal dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001016 -->

    <Class rdf:about="&obo;ND_0001016">
        <rdfs:label>diagnosis of probable frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient probably has frontotemporal dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001017 -->

    <Class rdf:about="&obo;ND_0001017">
        <rdfs:label>diagnosis of definite frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient definitely has frontotemporal dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001018 -->

    <Class rdf:about="&obo;ND_0001018">
        <rdfs:label>diagnosis of possible dementia with Lewy bodies</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient possibly has dementia with Lewy bodies.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001019 -->

    <Class rdf:about="&obo;ND_0001019">
        <rdfs:label>diagnosis of probable dementia with Lewy bodies</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has dementia with Lewy bodies.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001020 -->

    <Class rdf:about="&obo;ND_0001020">
        <rdfs:label>diagnosis of definite dementia with Lewy bodies</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000115>A diagnosis that a patient definitely has dementia with Lewy bodies.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001021 -->

    <Class rdf:about="&obo;ND_0001021">
        <rdfs:label>diagnosis of possible Parkinson dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient possibly has Parkinson dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001022 -->

    <Class rdf:about="&obo;ND_0001022">
        <rdfs:label>diagnosis of possible corticobasal degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient possibly has corticobasal degeneration.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001023 -->

    <Class rdf:about="&obo;ND_0001023">
        <rdfs:label>diagnosis of possible frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000115>A diagnosis that a patient possibly has frontotemporal dementia with Parkinsonism linked to chromosome 17.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001024 -->

    <Class rdf:about="&obo;ND_0001024">
        <rdfs:label>diagnosis of possible multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient possibly has multiple system atrophy.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001025 -->

    <Class rdf:about="&obo;ND_0001025">
        <rdfs:label>diagnosis of possible progressive supranuclear palsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient possibly has progressive supranuclear palsy.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001026 -->

    <Class rdf:about="&obo;ND_0001026">
        <rdfs:label>diagnosis of probable Parkinson dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient probably has Parkinson dementia.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001027 -->

    <Class rdf:about="&obo;ND_0001027">
        <rdfs:label>diagnosis of probable corticobasal degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has corticobasal degeneration.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001028 -->

    <Class rdf:about="&obo;ND_0001028">
        <rdfs:label>diagnosis of probable frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient probably has frontotemporal dementia with Parkinsonism linked to chromosome 17.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001029 -->

    <Class rdf:about="&obo;ND_0001029">
        <rdfs:label>diagnosis of probable multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient probably has multiple system atrophy.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001030 -->

    <Class rdf:about="&obo;ND_0001030">
        <rdfs:label>diagnosis of probable progressive supranuclear palsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has progressive supranuclear palsy.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001031 -->

    <Class rdf:about="&obo;ND_0001031">
        <rdfs:label>diagnosis of definite Parkinson dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient definitely has Parkinson dementia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001032 -->

    <Class rdf:about="&obo;ND_0001032">
        <rdfs:label>diagnosis of definite corticobasal degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient definitely has corticobasal degeneration.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001033 -->

    <Class rdf:about="&obo;ND_0001033">
        <rdfs:label>diagnosis of definite frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001004"/>
        <obo:IAO_0000115>A diagnosis that a patient definitely has frontotemporal dementia with Parkinsonism linked to chromosome 17.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001034 -->

    <Class rdf:about="&obo;ND_0001034">
        <rdfs:label>diagnosis of definite multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient definitely has multiple system atrophy.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001035 -->

    <Class rdf:about="&obo;ND_0001035">
        <rdfs:label>diagnosis of definite progressive supranuclear palsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient definitely has progressive supranuclear palsy.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001036 -->

    <Class rdf:about="&obo;ND_0001036">
        <rdfs:label>diagnosis of possible Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient possibly has Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001037 -->

    <Class rdf:about="&obo;ND_0001037">
        <rdfs:label>diagnosis of possible atypical Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient possibly has atypical Alzheimers disease.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001038 -->

    <Class rdf:about="&obo;ND_0001038">
        <rdfs:label>diagnosis of probable Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001039 -->

    <Class rdf:about="&obo;ND_0001039">
        <rdfs:label>diagnosis of possible frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient possibly has frontal variant of Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001040 -->

    <Class rdf:about="&obo;ND_0001040">
        <rdfs:label>diagnosis of possible logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient possibly has logopenic aphasia.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001041 -->

    <Class rdf:about="&obo;ND_0001041">
        <rdfs:label>diagnosis of possible posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient possibly has posterior cortical atrophy.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001042 -->

    <Class rdf:about="&obo;ND_0001042">
        <rdfs:label>diagnosis of possible primary progressive non-fluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient possibly has primary progressive non-fluent aphasia.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001043 -->

    <Class rdf:about="&obo;ND_0001043">
        <rdfs:label>diagnosis of probable atypical Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has atypical Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001044 -->

    <Class rdf:about="&obo;ND_0001044">
        <rdfs:label>diagnosis of probable frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has frontal variant of Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001045 -->

    <Class rdf:about="&obo;ND_0001045">
        <rdfs:label>diagnosis of probable logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has logopenic aphasia.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001046 -->

    <Class rdf:about="&obo;ND_0001046">
        <rdfs:label>diagnosis of probable posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient probably has posterior cortical atrophy.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001047 -->

    <Class rdf:about="&obo;ND_0001047">
        <rdfs:label>diagnosis of probable primary progressive non-fluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient probably has primary progressive non-fluent aphasia.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001048 -->

    <Class rdf:about="&obo;ND_0001048">
        <rdfs:label>diagnosis of definite Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient definitely has Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001049 -->

    <Class rdf:about="&obo;ND_0001049">
        <rdfs:label>diagnosis of definite atypical Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient definitely has atypical Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001050 -->

    <Class rdf:about="&obo;ND_0001050">
        <rdfs:label>diagnosis of definite frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient definitely has frontal variant of Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001051 -->

    <Class rdf:about="&obo;ND_0001051">
        <rdfs:label>diagnosis of definite logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient definitely has logopenic aphasia.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001052 -->

    <Class rdf:about="&obo;ND_0001052">
        <rdfs:label>diagnosis of definite posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis that a patient definitely has posterior cortical atrophy.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001053 -->

    <Class rdf:about="&obo;ND_0001053">
        <rdfs:label>diagnosis of definite primary progressive non-fluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000115>A diagnosis that a patient definitely has primary progressive non-fluent aphasia.</obo:IAO_0000115>
        <obo:IAO_0000232>creation date: 2011-09-01</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001054 -->

    <Class rdf:about="&obo;ND_0001054">
        <rdfs:label>diagnosis of neurological disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001061"/>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>diagnosis of nervous system disease</obo:IAO_0000118>
        <obo:IAO_0000115>A diagnosis which indicates a neurological disease is hypothosized to inhere in an organsim.</obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001055 -->

    <Class rdf:about="&obo;ND_0001055">
        <rdfs:label>diagnosis of peripheral nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis which inidicates that a neurological disease which affects the peripheral nervous system is hypothosized to inhere in an organism.</obo:IAO_0000115>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001056 -->

    <Class rdf:about="&obo;ND_0001056">
        <rdfs:label>diagnosis of central nervous system disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis which inidicates a neurological disease which affects the central nervous system is hypothosized to adhere in an organism.

(From Mark Jensen)

A diagnosis of a disease affecting either the spinal cord (myelopathy) or the brain (encephalopathy) or both in a patient.

(From http://en.wikipedia.org/wiki/Central_nervous_system_disease)</obo:IAO_0000115>
        <obo:IAO_0000232>MJ: We should eliminate the CNS vs PNS distinction in the diagnosis branch.</obo:IAO_0000232>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001057 -->

    <Class rdf:about="&obo;ND_0001057">
        <rdfs:label>diagnosis of peripheral nervous system disease that affects the muscle</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001055"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient has a peripheral nervous system disease that affects the muscle.</obo:IAO_0000115>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001058 -->

    <Class rdf:about="&obo;ND_0001058">
        <rdfs:label>diagnosis of peripheral nervous system disease that affects the nerve</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001055"/>
        <obo:IAO_0000115>A diagnosis that a patient has a peripheral nervous system disease that affects the nerve.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001059 -->

    <Class rdf:about="&obo;ND_0001059">
        <rdfs:label>diagnosis of central nervous system disease that affects the spinal cord</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001056"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis that a patient has a central nervous system disease that affects the patient&apos;s spinal cord.</obo:IAO_0000115>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001060 -->

    <Class rdf:about="&obo;ND_0001060">
        <rdfs:label>diagnosis of central nervous system disease that affects the brain</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001056"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis of a disorder of the brain, a disease of the brain, or a syndrome of global brain dysfunction in a patient.</obo:IAO_0000115>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000420"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001061 -->

    <Class rdf:about="&obo;ND_0001061">
        <rdfs:label>diagnosis of disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000073"/>
        <obo:IAO_0000115>A diagnosis which indicates that a disease is hypothosized to inhere in an organsim.</obo:IAO_0000115>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001062 -->

    <Class rdf:about="&obo;ND_0001062">
        <rdfs:label>diagnosis of syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000073"/>
        <rdfs:comment>Is the presence of a syndrome hypothosized?  Since a syndrome is a pattern of signs and symptoms, which are by definition observed or reported, is there a need to hypothesize their occurrence?  Perhaps the pattern can be hypothesized, but this too will typically (if not always) be observed or reported.

Perhaps the definition should be changed to: &quot;A diagnosis which indicates that a syndrome is exhibited by an organsim.&quot;?</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A diagnosis which indicates that a syndrome is hypothosized to inhere in an organsim.</obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001063 -->

    <Class rdf:about="&obo;ND_0001063">
        <rdfs:label>diagnosis of disorder</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000073"/>
        <obo:IAO_0000115>A diagnosis which indicates that a disorder is either observed to inhere or hypothosized to inhere in an organsim.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001064 -->

    <Class rdf:about="&obo;ND_0001064">
        <rdfs:label>diagnosis of possible multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <disjointWith rdf:resource="&obo;ND_0001065"/>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis of possible MS is an assertion made my a qualified clinican that an organism may bear the disease multiple sclerosis.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001065 -->

    <Class rdf:about="&obo;ND_0001065">
        <rdfs:label>diagnosis of multiple scelrosis</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0001054"/>
                    <Class>
                        <unionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;ND_0001070"/>
                            <rdf:Description rdf:about="&obo;ND_0001071"/>
                            <rdf:Description rdf:about="&obo;ND_0001072"/>
                        </unionOf>
                    </Class>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001054"/>
        <obo:IAO_0000118>diagnosis of definite multiple sclerosis</obo:IAO_0000118>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000115>A named class for organizational purposes, either a diagnosis of relapsing remitting multiple sclerosis or secondary progressive multiple sclerosis or primary progressive multiple sclerosis.</obo:IAO_0000115>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
        <obo:IAO_0000411 rdf:resource="&obo;IAO_0000421"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001066 -->

    <Class rdf:about="&obo;ND_0001066">
        <rdfs:label>diagnosis of clinically isolated syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001064"/>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001067 -->

    <Class rdf:about="&obo;ND_0001067">
        <rdfs:label>diagnosis of optic neuritis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001066"/>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001068 -->

    <Class rdf:about="&obo;ND_0001068">
        <rdfs:label>diagnosis of acute disseminated encephalomyelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001066"/>
        <oboInOwl:hasDbXref>birnlex_12510</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000115>characterized by a brief but widespread attack of inflammation in the brain and spinal cord that damages myelin – the protective covering of nerve fibers.  ADEM often follows viral or bacterial infections, or less often, vaccination for measles, mumps, or rubella.  The symptoms of ADEM appear rapidly, beginning with encephalitis-like symptoms such as fever, fatigue, headache, nausea and vomiting, and in the most severe cases, seizures and coma.  ADEM typically damages white matter (brain tissue that takes its name from the white color of myelin), leading to neurological symptoms such as visual loss (due to inflammation of the optic nerve) in one or both eyes, weakness even to the point of paralysis, and difficulty coordinating voluntary muscle movements (such as those used in walking).  ADEM is sometimes misdiagnosed as a severe first attack of multiple sclerosis (MS), since the symptoms and the appearance of the white matter injury on brain imaging may be similar.  However, ADEM has several features which differentiate it from MS.  First, unlike MS patients, persons with ADEM will have rapid onset of fever, a history of recent infection or immunization, and some degree of impairment of consciousness, perhaps even coma; these features are not typically seen in MS.  Children are more likely than adults to have ADEM, whereas MS is a rare diagnosis in children.  In addition, ADEM usually consists of a single episode or attack of widespread myelin damage, while MS features many attacks over the course of time. </obo:IAO_0000115>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/acute_encephalomyelitis/acute_encephalomyelitis.htm</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001069 -->

    <Class rdf:about="&obo;ND_0001069">
        <rdfs:label>diagnosis of brainstem syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001066"/>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001070 -->

    <Class rdf:about="&obo;ND_0001070">
        <rdfs:label>diagnosis of secondary progressive multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001065"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;ND#is_about"/>
                <someValuesFrom>
                    <Class>
                        <intersectionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;OBI_0100026"/>
                            <Restriction>
                                <onProperty rdf:resource="&obo;BFO_0000056"/>
                                <someValuesFrom rdf:resource="&obo;ND_0006051"/>
                            </Restriction>
                        </intersectionOf>
                    </Class>
                </someValuesFrom>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A diagnosis which asserts an organism bears relasping multiple sclerosis and is participating in a relasping multiple sclerosis disease course that has a secondary progressive multiple sclerosis process profile at the time the diagnosis is made.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001071 -->

    <Class rdf:about="&obo;ND_0001071">
        <rdfs:label>diagnosis of primary progressive multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001065"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;ND#is_about"/>
                <someValuesFrom>
                    <Class>
                        <intersectionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;OBI_0100026"/>
                            <Restriction>
                                <onProperty rdf:resource="&obo;BFO_0000056"/>
                                <someValuesFrom rdf:resource="&obo;ND_0000202"/>
                            </Restriction>
                        </intersectionOf>
                    </Class>
                </someValuesFrom>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <oboInOwl:hasDbXref>birnlex_12516</oboInOwl:hasDbXref>
        <obo:IAO_0000115>A diagnosis which asserts an organsim bears the disease primary progressive multiple sclerosis and is participating in a primary progressive multiple sclerosis disease course at the time the diagnosis is made.</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/multiple_sclerosis/detail_multiple_sclerosis.htm#193393215</obo:IAO_0000119>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001072 -->

    <Class rdf:about="&obo;ND_0001072">
        <rdfs:label>diagnosis of relapsing remitting multiple sclerosis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001065"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;ND#is_about"/>
                <someValuesFrom>
                    <Class>
                        <intersectionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;OBI_0100026"/>
                            <Restriction>
                                <onProperty rdf:resource="&obo;BFO_0000056"/>
                                <someValuesFrom rdf:resource="&obo;ND_0006054"/>
                            </Restriction>
                        </intersectionOf>
                    </Class>
                </someValuesFrom>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000119>http://www.ninds.nih.gov/disorders/multiple_sclerosis/detail_multiple_sclerosis.htm#193393215  </obo:IAO_0000119>
        <oboInOwl:hasDbXref>birnlex_12518</oboInOwl:hasDbXref>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
        <obo:IAO_0000115>A diagnosis which asserts an organism bears relasping multiple sclerosis and is participating in a relasping multiple sclerosis disease course that has a relapsing remitting multiple sclerosis process profile at the time the diagnosis is made.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001073 -->

    <Class rdf:about="&obo;ND_0001073">
        <rdfs:label>diagnosis of transverse myelitis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001066"/>
        <obo:IAO_0000115>inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence (MeSH).
</obo:IAO_0000115>
        <obo:IAO_0000119>http://neurolex.org/wiki/Category:Transverse_Myelitis</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <oboInOwl:hasDbXref>birnlex_12520</oboInOwl:hasDbXref>
        <obo:IAO_0000232>Change entity URI</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001100 -->

    <Class rdf:about="&obo;ND_0001100">
        <rdfs:label>diagnostic guideline</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;IAO_0000033"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A directive information entity the concretization of which is realized in a diagnostic process and which has a set of diagnostic criteria that consist of clinical findings that have been agreed upon by the medical community to provide sufficient, necessary, or sufficient and necessary warrant for a clinician to reach a particular diagnosis concerning a patient whose clinical picture satisfies the relevant diagnostic criteria.  A diagnostic guideline has as parts the objective of accurately diagnosing patients according to its diagnostic criteria and the directive for the clinician to make the associated diagnosis when the diagnostic criteria have been determined to be satisfied.

Alexander P. Cox</obo:IAO_0000115>
        <obo:IAO_0000232>This class belongs in the domain of OGMS, will be a subtype of IAO_0000033:&apos;directive information entity&apos;. Refer to:

http://code.google.com/p/ogms/wiki/DiagnosisGuideline

http://code.google.com/p/ogms/issues/detail?id=75

https://groups.google.com/forum/?fromgroups=#!topic/ogms-discuss/9oVK5dLdZQs</obo:IAO_0000232>
        <obo:IAO_0000115>A directive information entity that specifies how to establish a diagnosis according to one or more clinical findings, the concretization of which is realized in a diagnostic process.

Mark Jensen</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001101 -->

    <Class rdf:about="&obo;ND_0001101">
        <rdfs:label>diagnostic guideline for mild cognitive impairment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001100"/>
        <obo:IAO_0000115>*** REVISE ***

Cognitive impairments beyond those expected based on the age and education of the individual, but which are not significant enough to interfere with their daily activities.

The diagnosis of MCI requires considerable clinical judgement as well as a comprehensive clinical assessment including clinical observation, neuroimaging, blood tests and neuropsychological testing in order to rule out an alternate diagnosis.

MCI is diagnosed when there is:

1. Evidence of memory impairment
2. Preservation of general cognitive and functional abilities
3. Absence of diagnosed dementia</obo:IAO_0000115>
        <obo:IAO_0000119>http://www.mejfm.com/journal/Oct2004/Dementia.htm</obo:IAO_0000119>
        <obo:IAO_0000115>Memory complaint, preferably corroborated by an informant
Objective memory impairment (below 1.5 standard deviations)
Normal general cognitive functioning
Intact activities of daily living
Not demented</obo:IAO_0000115>
        <obo:IAO_0000119>Adapted from: http://en.wikipedia.org/wiki/Mild_cognitive_impairment</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001102 -->

    <Class rdf:about="&obo;ND_0001102">
        <rdfs:label>diagnostic guideline for dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001101"/>
        <obo:IAO_0000115>*** REVISE ***

A diagnosis of dementia in a patient based on findings from blood tests, neuroimaging, and cognitive testing that indicate the presence of cognitive deficits [visual spatial, attention, orientation, exceutive function, functional] severe enough to interfere with the patient&apos;s daily life in a previously unimpaired person.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001103 -->

    <Class rdf:about="&obo;ND_0001103">
        <rdfs:label>diagnostic guideline for infectious dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001102"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001104 -->

    <Class rdf:about="&obo;ND_0001104">
        <rdfs:label>diagnostic guideline for vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001102"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://www.strokecenter.org/professionals/stroke-diagnosis/stroke-assessment-scales/dsm-iv-criteria-for-the-diagnosis-of-vascular-dementia/</obo:IAO_0000119>
        <obo:IAO_0000115>A. The development of multiple cognitive deficits manifested by both:

Memory impairment (impaired ability to learn new information or to recall previously learned information)
One or more of the following cognitive disturbances:
(a) aphasia (language disturbance)

(b) apraxia (impaired ability to carry out motor activities depite intact motor function)

(c) agnosia (failure to recognize or identify objects despite intact sensory function)

(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting)
B. The cognitive deficits in criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning.

C. Focal neurological signs and symptoms (e.g., exggeration of deep tendon reflexes, extensor plantar response, psuedobulbar palsy, gait abnormalities, weakness of an extremity) or laboratory evidence indicative of cerebrovascular disease (e.g., multiple infarctions involving cortex and underlyig white matter) that are judged to be etiologically related to the disturbance.

D. The deficits do not ocurr exclusively during the course of a delirium.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001105 -->

    <Class rdf:about="&obo;ND_0001105">
        <rdfs:label>diagnostic guideline for neurodegenerative dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001102"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001106 -->

    <Class rdf:about="&obo;ND_0001106">
        <rdfs:label>diagnostic guideline for infectious dementia due to HIV</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001103"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001107 -->

    <Class rdf:about="&obo;ND_0001107">
        <rdfs:label>diagnostic guideline for infectious dementia due to syphilis</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001103"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001108 -->

    <Class rdf:about="&obo;ND_0001108">
        <rdfs:label>diagnostic guideline for infectious dementia due to prion disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001103"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001109 -->

    <Class rdf:about="&obo;ND_0001109">
        <rdfs:label>diagnostic guideline for infectious dementia due to Creutzfeldt-Jakob disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001103"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001110 -->

    <Class rdf:about="&obo;ND_0001110">
        <rdfs:label>diagnostic guideline for possible ischemic vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001104"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>*** REVISE ***

Dementia with no other cause plus focal signs without imaging findings or no clear temporal relationship.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001111 -->

    <Class rdf:about="&obo;ND_0001111">
        <rdfs:label>diagnostic guideline for probable ischemic vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001110"/>
        <obo:IAO_0000115>*** REVISE ***

Dementia with no other cause plus evidence of CVD by history, examination or imaging and a relationship between onset or progression of dementia (onset within 3 months or stepwise course).</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001112 -->

    <Class rdf:about="&obo;ND_0001112">
        <rdfs:label>diagnostic guideline for definite ischemic vascular dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001111"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001113 -->

    <Class rdf:about="&obo;ND_0001113">
        <rdfs:label>diagnostic guideline for possible normal pressure hydrocephalus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001100"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>*** REVISE ***

Diagnosis of NPH is usually first led by a lumbar puncture, followed by the evaluation of clinical response to removal of CSF. This can be followed by a CT, MRI, and continuous external lumbar CSF drainage during 3 or 4 days.

    Lumbar puncture is usually the first step in diagnosis and the CSF opening pressure is measured carefully. In most cases, CSF pressure is usually above 155 mmH2O. Clinical improvement after removal of CSF (30 mL or more) has a high predictive value for subsequent success with shunting. This is called the &quot;lumbar tap test&quot; or Miller Fisher test. On the contrary, a &quot;negative&quot; test has a very low predictive accuracy, as many patients may improve after a shunt in spite of lack of improvement after CSF removal.

    Infusion test is a test with higher sensitivity and specificity than a lumbar puncture. The outflow conductance (Cout) of the cerebrospinal fluid (CSF) system is a parameter considered to be predictive in selection for hydrocephalus surgery. Cout can be determined through an infusion test.

    In some centers, External lumbar drainage has been shown to have the highest sensitivity and specificity with regards to predicting a successful outcome following surgery.

    CT scan may show enlarged ventricles without convolutional atrophy.

    MRI may show some degree of transependymal migration of CSF surrounding the ventricles on T2/FLAIR sequence. Imaging however cannot differentiate between pathologies with similar clinical picture like Alzheimer&apos;s dementia, vascular dementia or Parkinson&apos;s disease.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Normal_pressure_hydrocephalus#Diagnosis</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001114 -->

    <Class rdf:about="&obo;ND_0001114">
        <rdfs:label>diagnostic guideline for probable normal pressure hydrocephalus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001113"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001115 -->

    <Class rdf:about="&obo;ND_0001115">
        <rdfs:label>diagnostic guideline for definite normal pressure hydrocephalus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001114"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001116 -->

    <Class rdf:about="&obo;ND_0001116">
        <rdfs:label>diagnostic guideline for possible frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000115>*** REVISE ***

Insidious onset, slow progression
Impaired behavior: 
-loss of personal awareness, Disinhibition, mental rigidity, Hyperorality, Stereotypy, Perseveration, utilization behavior, Distractibility, poor social judgment
Altered affect:
-Depression, Anxiety, Delusions, Somatic preoccupations, Apathy, Amimia
Speech disorder:
-Reduced, stereotypic, echolalic, perseveration, mutism
Physical signs:
-Primitive reflexes, Incontinence, Parkinsonism</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001117 -->

    <Class rdf:about="&obo;ND_0001117">
        <rdfs:label>diagnostic guideline for probable frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001116"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001118 -->

    <Class rdf:about="&obo;ND_0001118">
        <rdfs:label>diagnostic guideline for definite frontotemporal dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001117"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001119 -->

    <Class rdf:about="&obo;ND_0001119">
        <rdfs:label>diagnostic guideline for possible dementia with Lewy bodies</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Dementia plus one of the following: fluctuation, visual hallucination, parkinsonism, REM sleep behavioral disorder.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001120 -->

    <Class rdf:about="&obo;ND_0001120">
        <rdfs:label>diagnostic guideline for probable dementia with Lewy bodies</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001119"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Dementia plus two or more of the following: fluctuation, visual hallucination, parkinsonism, REM sleep behavioral disorder.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001121 -->

    <Class rdf:about="&obo;ND_0001121">
        <rdfs:label>diagnostic guideline for definite dementia with Lewy bodies</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001120"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001122 -->

    <Class rdf:about="&obo;ND_0001122">
        <rdfs:label>diagnostic guideline for possible Parkinson dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>From the article &quot;Clinical Diagnostic Criteria for Dementia Associated with Parkinson’s Disease&quot;.
Movement Disorders
Vol. 22, No. 12, 2007, pp. 1689-1707 © 2007 Movement Disorder Society</obo:IAO_0000119>
        <obo:IAO_0000115>Features of dementia associated with Parkinson’s disease:

I. Core features

1. Diagnosis of Parkinson’s disease according to Queen Square Brain Bank criteria 

2. A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson’s disease and diagnosed by history, clinical, and mental examination, defined as: 
• Impairment in more than one cognitive domain 
• Representing a decline from premorbid level 
• Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms

II. Associated clinical features

1. Cognitive features:
• Attention: Impaired. Impairment in spontaneous and focused attention, poor performance in attentional tasks; performance may fluctuate during the day and from day to day
• Executive functions: Impaired. Impairment in tasks requiring initiation, planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)
• Visuo-spatial functions: Impaired. Impairment in tasks requiring visual-spatial orientation, perception, or construction 
• Memory: Impaired. Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall 
• Language: Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences may be present 

2. Behavioral features:
• Apathy: decreased spontaneity; loss of motivation, interest, and effortful behavior 
• Changes in personality and mood including depressive features and anxiety 
• Hallucinations: mostly visual, usually complex, formed visions of people, animals or objects 
• Delusions: usually paranoid, such as infidelity, or phantom boarder (unwelcome guests living in the home) delusions 
• Excessive daytime sleepiness

III. Features which do not exclude PD-D, but make the diagnosis uncertain:

• Co-existence of any other abnormality which may by itself cause cognitive impairment, but judged not to be the cause of dementia, e.g. presence of relevant vascular disease in imaging
• Time interval between the development of motor and cognitive symptoms not known 

IV. Features suggesting other conditions or diseases as cause of mental impairment, which, when present make it impossible to reliably diagnose PD-D:

• Cognitive and behavioral symptoms appearing solely in the context of other conditions such as: Acute confusion due to:
  a. Systemic diseases or abnormalities
  b. Drug intoxication Major Depression according to DSM IV
• Features compatible with “Probable Vascular dementia” criteria according to NINDS-AIREN (dementia in the context of cerebrovascular disease as indicated by focal signs in neurological exam such as hemiparesis, sensory deficits, and evidence of relevant cerebrovascular disease by brain imaging AND a relationship between the two as indicated by the presence of one or more of the following: onset of dementia within 3 months after a recognized stroke, abrupt deterioration in cognitive functions, and fluctuating, stepwise progression of cognitive deficits)


Criteria for the diagnosis of possible PD-D:

A. Core features: Both must be present 

B. Associated clinical features:
• Atypical profile of cognitive impairment in one or more domains, such as prominent or receptive-type (fluent) aphasia, or pure storage-failure type amnesia (memory does not improve with cueing or in recognition tasks) with preserved attention
• Behavioral symptoms may or may not be present OR

C. One or more of the group III features present 

D. None of the group IV features present

From the article &quot;Clinical Diagnostic Criteria for Dementia Associated with Parkinson’s Disease&quot;.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001123 -->

    <Class rdf:about="&obo;ND_0001123">
        <rdfs:label>diagnostic guideline for possible corticobasal degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000115>Insidious onset and progression of assymetric cortical and basal ganglionic features. Akinetic, rigid syndrome; hyperkinetic movement disorder; alien limb. Cortical dysfunction: dementia, apraxia, cortical sensory, dysphasia, speech apraxia</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001124 -->

    <Class rdf:about="&obo;ND_0001124">
        <rdfs:label>diagnostic guideline for possible frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001125 -->

    <Class rdf:about="&obo;ND_0001125">
        <rdfs:label>diagnostic guideline for possible multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001126 -->

    <Class rdf:about="&obo;ND_0001126">
        <rdfs:label>diagnostic guideline for possible progressive supranuclear palsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001127 -->

    <Class rdf:about="&obo;ND_0001127">
        <rdfs:label>diagnostic guideline for probable Parkinson dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001122"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>From the article &quot;Clinical Diagnostic Criteria for Dementia Associated with Parkinson’s Disease&quot;.
Movement Disorders
Vol. 22, No. 12, 2007, pp. 1689-1707 © 2007 Movement Disorder Society</obo:IAO_0000119>
        <obo:IAO_0000115>Features of dementia associated with Parkinson’s disease:

I. Core features

1. Diagnosis of Parkinson’s disease according to Queen Square Brain Bank criteria 

2. A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson’s disease and diagnosed by history, clinical, and mental examination, defined as: 
• Impairment in more than one cognitive domain 
• Representing a decline from premorbid level 
• Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms

II. Associated clinical features

1. Cognitive features:
• Attention: Impaired. Impairment in spontaneous and focused attention, poor performance in attentional tasks; performance may fluctuate during the day and from day to day
• Executive functions: Impaired. Impairment in tasks requiring initiation, planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)
• Visuo-spatial functions: Impaired. Impairment in tasks requiring visual-spatial orientation, perception, or construction 
• Memory: Impaired. Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall 
• Language: Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences may be present 

2. Behavioral features:
• Apathy: decreased spontaneity; loss of motivation, interest, and effortful behavior 
• Changes in personality and mood including depressive features and anxiety 
• Hallucinations: mostly visual, usually complex, formed visions of people, animals or objects 
• Delusions: usually paranoid, such as infidelity, or phantom boarder (unwelcome guests living in the home) delusions 
• Excessive daytime sleepiness

III. Features which do not exclude PD-D, but make the diagnosis uncertain:

• Co-existence of any other abnormality which may by itself cause cognitive impairment, but judged not to be the cause of dementia, e.g. presence of relevant vascular disease in imaging
• Time interval between the development of motor and cognitive symptoms not known 

IV. Features suggesting other conditions or diseases as cause of mental impairment, which, when present make it impossible to reliably diagnose PD-D:

• Cognitive and behavioral symptoms appearing solely in the context of other conditions such as: Acute confusion due to:
  a. Systemic diseases or abnormalities
  b. Drug intoxication Major Depression according to DSM IV
• Features compatible with “Probable Vascular dementia” criteria according to NINDS-AIREN (dementia in the context of cerebrovascular disease as indicated by focal signs in neurological exam such as hemiparesis, sensory deficits, and evidence of relevant cerebrovascular disease by brain imaging AND a relationship between the two as indicated by the presence of one or more of the following: onset of dementia within 3 months after a recognized stroke, abrupt deterioration in cognitive functions, and fluctuating, stepwise progression of cognitive deficits)


Criteria for the diagnosis of probable PD-D:

A. Core features: Both must be present 

B. Associated clinical features:
• Typical profile of cognitive deficits including impairment in at least two of the four core cognitive domains (impaired attention which may fluctuate, impaired executive functions, impairment in visuo-spatial functions, and impaired free recall memory which usually improves with cueing)
• The presence of at least one behavioral symptom (apathy, depressed or anxious mood, hallucinations, delusions, excessive daytime sleepiness) supports the diagnosis of Probable PD-D, lack of behavioral symptoms, however, does not exclude the diagnosis

C. None of the group III features present

D. None of the group IV features present



From the article &quot;Clinical Diagnostic Criteria for Dementia Associated with Parkinson’s Disease&quot;.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001128 -->

    <Class rdf:about="&obo;ND_0001128">
        <rdfs:label>diagnostic guideline for probable corticobasal degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001123"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001129 -->

    <Class rdf:about="&obo;ND_0001129">
        <rdfs:label>diagnostic guideline for probable frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001124"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001130 -->

    <Class rdf:about="&obo;ND_0001130">
        <rdfs:label>diagnostic guideline for probable multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001125"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001131 -->

    <Class rdf:about="&obo;ND_0001131">
        <rdfs:label>diagnostic guideline for probable progressive supranuclear palsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001126"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001132 -->

    <Class rdf:about="&obo;ND_0001132">
        <rdfs:label>diagnostic guideline for definite Parkinson dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001127"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001133 -->

    <Class rdf:about="&obo;ND_0001133">
        <rdfs:label>diagnostic guideline for definite corticobasal degeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001128"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001134 -->

    <Class rdf:about="&obo;ND_0001134">
        <rdfs:label>diagnostic guideline for definite frontotemporal dementia with Parkinsonism linked to chromosome 17</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001129"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Frontotemporal_dementia_and_parkinsonism_linked_to_chromosome_17</obo:IAO_0000119>
        <obo:IAO_0000115>*** REVISE ***

Definite diagnosis of FTDP-17 requires a combination of characteristic clinical and pathological features and molecular genetic analysis.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001135 -->

    <Class rdf:about="&obo;ND_0001135">
        <rdfs:label>diagnostic guideline for definite multiple system atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001130"/>
        <obo:IAO_0000115>*** REVISE ***

A definite diagnosis of multiple system atrophy can only be made post-mortem based on pathology in which abundant glial cytoplasmic inclusions are found in the central nervous system.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Multiple_system_atrophy#Diagnosis</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001136 -->

    <Class rdf:about="&obo;ND_0001136">
        <rdfs:label>diagnostic guideline for definite progressive supranuclear palsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001131"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001137 -->

    <Class rdf:about="&obo;ND_0001137">
        <rdfs:label>diagnostic guideline for possible Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0001105"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND#ND_major_diagnostic_criterion"/>
                        <someValuesFrom>
                            <Class>
                                <unionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND#possible_AD1"/>
                                    <rdf:Description rdf:about="&obo;ND#possible_AD2"/>
                                </unionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND#warrants"/>
                        <allValuesFrom rdf:resource="&obo;ND_0001036"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000115>*** REVISE ***

There is a dementia syndrome with an atypical onset, presentation or progression; and without a known etiology; but no co-morbid diseases capable of producing dementia are believed to be in the origin of it.

Similar to the NINCDS-ADRDA Alzheimer&apos;s Criteria are the DSM-IV-TR criteria published by the American Psychiatric Association. At the same time the advances in functional neuroimaging techniques such as PET or SPECT that have already proven their utility to differentiate Alzheimer&apos;s disease from other possible causes, have led to proposals of revision of the NINCDS-ADRDA criteria that take into account these techniques.</obo:IAO_0000115>
        <obo:IAO_0000115>A. The development of multiple cognitive deficits manifested by both 

(1) memory impairment (impaired ability to learn new information or to recall previously learned information) 

(2) one (or more) of the following cognitive disturbances: 

(a) aphasia (language disturbance) 
(b) apraxia (impaired ability to carry out motor activities despite intact motor function) 
(c) agnosia (failure to recognize or identify objects despite intact sensory function) 
(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting)

B. The cognitive deficits in Criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning. 

C. The course is characterized by gradual onset and continuing cognitive decline. 

D. The cognitive deficits in Criteria A1 and A2 are not due to any of the following: 

(1) other central nervous system conditions that cause progressive deficits in memory and cognition (e.g., cerebrovascular disease, Parkinson&apos;s disease, Huntington&apos;s disease, subdural hematoma, normal-pressure hydrocephalus, brain tumor) 
(2) systemic conditions that are known to cause dementia (e.g., hypothyroidism, vitamin B or folic acid deficiency, niacin deficiency, hypercalcemia, neurosyphilis, HIV infection) 
(3) substance-induced conditions 

E. The deficits do not occur exclusively during the course of a delirium. 

F. The disturbance is not better accounted for by another Axis I disorder (e.g., Major Depressive Episode, Schizophrenia). 


DSM IV</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>NINCDS-ADRDA Criteria for the Diagnosis of Alzheimer&apos;s Disease</obo:IAO_0000119>
        <obo:IAO_0000115>I. Probable AD: Core Diagnostic Features
A. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)
B. Deficit in at least two areas of cognition 
i. Memory (required)
ii. Other area besides memory
C. Deficits characterized by gradual onset and progression, onset after age 40
D. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves

II. Possible AD: Core Diagnostic Features 

A. Dementia syndrome in the absence of other neurologic, psychiatric, or systemic disorder, OR
B. Presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be the primary cause of the dementia

III. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain
A. Sudden apoplectic onset
B. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness
C. Seizures or gait disturbances at the onset or very early in the course of the illness</obo:IAO_0000115>
        <obo:IAO_0000119>http://behavenet.com/dementia-alzheimers-type</obo:IAO_0000119>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/NINCDS-ADRDA_Alzheimer%27s_Criteria</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001138 -->

    <Class rdf:about="&obo;ND_0001138">
        <rdfs:label>diagnostic guideline for possible atypical Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001139 -->

    <Class rdf:about="&obo;ND_0001139">
        <rdfs:label>diagnostic guideline for probable Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0001137"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND#ND_major_diagnostic_criterion"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND#probable_AD1"/>
                                    <Class>
                                        <unionOf rdf:parseType="Collection">
                                            <rdf:Description rdf:about="&obo;ND#probable_AD2"/>
                                            <rdf:Description rdf:about="&obo;ND#probable_AD3"/>
                                            <rdf:Description rdf:about="&obo;ND#probable_AD4"/>
                                            <rdf:Description rdf:about="&obo;ND#probable_AD5"/>
                                        </unionOf>
                                    </Class>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND#lacks"/>
                        <someValuesFrom rdf:resource="&obo;ND#probable_AD6"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND#warrants"/>
                        <allValuesFrom rdf:resource="&obo;ND_0001038"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001137"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A. Presence of an early and significant episodic memory impairment that includes the following features:

1. Gradual and progressive change in memory function reported by patients or
informants over more than 6 months

2. Objective evidence of significantly impaired episodic memory on testing: this
generally consists of recall deficit that does not improve significantly or does not
normalize with cueing or recognition testing and after effective encoding of
information has been previously controlled

3. The episodic memory impairment can be isolated or associated with other cognitive
changes at the onset of AD or as AD advances

Plus one or more of the following supportive features B, C, D, and E:

B. Presence of medial temporal lobe atrophy
• Volume loss of hippocampi, entorhinal cortex, amygdala evidenced on MRI with
qualitative ratings using visual scoring (referenced to well characterised population
with age norms) or quantitative volumetry of regions of interest (referenced to well
characterised population with age norms)

C. Abnormal cerebrospinal fluid biomarker
• Low amyloid β1–42 concentrations, increased total tau concentrations, or increased
phospho-tau concentrations, or combinations of the three
• Other well validated markers to be discovered in the future

D. Specific pattern on functional neuroimaging with PET
• Reduced glucose metabolism in bilateral temporal parietal regions
• Other well validated ligands, including those that foreseeably will emerge such as
Pittsburg compound B or FDDNP

E. Proven AD autosomal dominant mutation within the immediate family

And LACKS the following:

History
• Sudden onset
• Early occurrence of the following symptoms: gait disturbances, seizures, behavioural changes

Clinical features
• Focal neurological features including hemiparesis, sensory loss, visual field deficits
• Early extrapyramidal signs 
• Other medical disorders severe enough to account for memory and related symptoms
• Non-AD dementia
• Major depression
• Cerebrovascular disease
• Toxic and metabolic abnormalities, all of which may require specific investigations
• MRI FLAIR or T2 signal abnormalities in the medial temporal lobe that are consistent with infectious or vascular insults
</obo:IAO_0000115>
        <obo:IAO_0000119>NINCDS-ADRDA Criteria for the Diagnosis of Alzheimer&apos;s Disease</obo:IAO_0000119>
        <obo:IAO_0000115>I. Probable AD: Core Diagnostic Features
A. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)
B. Deficit in at least two areas of cognition 
i. Memory (required)
ii. Other area besides memory
C. Deficits characterized by gradual onset and progression, onset after age 40
D. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves

II. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain
A. Sudden apoplectic onset
B. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness
C. Seizures or gait disturbances at the onset or very early in the course of the illness</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001140 -->

    <Class rdf:about="&obo;ND_0001140">
        <rdfs:label>diagnostic guideline for possible frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <rdfs:comment>Only biopsy can determine difference between FTD and frontal variant alzhiemers</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Possible bvFTD
Three of the following behavioral/cognitive symptoms must be present to meet criteria. These symptoms should occur repeatedly, not just as a single instance.
Early behavioral disinhibition (one of the following must be present)
Socially inappropriate behavior: touching or kissing strangers, inappropriate sexual acts, public urination, criminal behavior, etc.
Loss of manners or decorum: examples include
crude or sexually explicit remarks, jokes or opinions which may be offensive to others;
lack of response to social cues (e.g., will continue talking despite other’s attempts to end a conversation);
physical behaviors such as flatulence, touching private body parts, belching or spitting;
poor hygiene or grooming (malodorous, stained, torn or inappropriate clothing),
loss of respect for interpersonal space
Impulsive, rash or careless actions: impulsive behaviors which may or may not be performed in a social context (e.g., new- onset gambling, taking things, stealing (usually food or visually stimulating objects), buying or selling property without regard for consequences)
Early apathy or inertia (one of the following must be present)
Apathy: loss of interest, drive or motivation (e.g., passivity, lack of spontaneity, does not engage in previously rewarding activities)
Inertia: decreased initiation of behavior (e.g., needs prompting to initiate or continue routine activities, less likely to initiate or sustain conversations)
Early loss of sympathy or empathy (one of the following must be present)
Diminished response to other people’s needs and feelings: positive rating of this feature should be based on specific examples that reflect a lack of understanding or indifference to other people’s feelings – e.g., hurtful comments, disregard for other’s pain or distress, making inappropriate jokes
Diminished social interest, interrelatedness or personal warmth: general decrease in social engagement (coldness, lack of eye contact, etc.)
Early perseverative, stereotyped or compulsive/ritualistic behavior (one of the following must be present)
Simple repetitive movements: tapping, clapping, rubbing, scratching, picking at skin or clothing, pursing lips, lip smacking, etc.
Complex, compulsive or ritualistic behaviors: counting and cleaning rituals, collecting, checking, repetitive trips to the bathroom, ordering objects, walking fixed routes, etc.
Stereotypy of speech: repeating words or phrases that have no communicative value
Hyperorality and dietary changes (one of the following must be present)
Altered food preferences: carbohydrate craving (particularly sweets) or food fads
Binge eating, increased consumption of alcohol or cigarettes: patient continues to eat despite satiety (weight gain ____ lb); compulsive smoking, chewing tobacco or gum; or alcohol ingestion
Oral exploration or consumption of inedible objects
Neuropsychological profile: executive/generation deficits with relative sparing of memory and visuospatial functions (all of the following must be present)
Deficits in executive tasks: Trails-B, generation tasks (letter fluency/design fluency) or presence of errors (e.g., perseverations or rule violations)
Relative sparing of episodic memory
Relative sparing of visuospatial skills e.g., ability to copy simple line drawings
Exclusion Criteria for bvFTD
Criteria 1 and 2 must both be answered negatively for any bvFTD diagnosis. Criterion 3 can be positive for possible bvFTD but must be negative for probable bvFTD.
Pattern of deficits is better accounted for by other non-degenerative nervous system or medical disorders (excludes all bvFTD diagnoses) e.g., delirium, cerebrovascular disease, cerebellar disorder, systemic disorders (e.g., hypothyroidism) or substance-induced conditions
Behavioral disturbance is better accounted for by a psychiatric diagnosis (excludes all bvFTD diagnoses) e.g., depression, bipolar disorder, schizophrenia, pre-existing personality disorder
Biomarkers strongly indicative of Alzheimer’s disease or other neurodegenerative process (excludes diagnosis of probable bvFTD) e.g., genetic mutations, extensive PIB binding, CSF markers</obo:IAO_0000115>
        <obo:IAO_0000119>http://memory.ucsf.edu/ftd/medical/diagnosis/criteria/single</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001141 -->

    <Class rdf:about="&obo;ND_0001141">
        <rdfs:label>diagnostic guideline for possible logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001142 -->

    <Class rdf:about="&obo;ND_0001142">
        <rdfs:label>diagnostic guideline for possible posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001143 -->

    <Class rdf:about="&obo;ND_0001143">
        <rdfs:label>diagnostic guideline for possible primary progressive non-fluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001105"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001144 -->

    <Class rdf:about="&obo;ND_0001144">
        <rdfs:label>diagnostic guideline for probable atypical Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001138"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001145 -->

    <Class rdf:about="&obo;ND_0001145">
        <rdfs:label>diagnostic guideline for probable frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001140"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001146 -->

    <Class rdf:about="&obo;ND_0001146">
        <rdfs:label>diagnostic guideline for probable logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001141"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001147 -->

    <Class rdf:about="&obo;ND_0001147">
        <rdfs:label>diagnostic guideline for probable posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001142"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001148 -->

    <Class rdf:about="&obo;ND_0001148">
        <rdfs:label>diagnostic guideline for probable primary progressive non-fluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001143"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001149 -->

    <Class rdf:about="&obo;ND_0001149">
        <rdfs:label>diagnostic guideline for definite Alzheimers disease</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0001139"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;ND#ND_major_diagnostic_criterion"/>
                        <someValuesFrom>
                            <Class>
                                <unionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND#definite_AD1"/>
                                    <rdf:Description rdf:about="&obo;ND#definite_AD2"/>
                                </unionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001139"/>
        <obo:IAO_0000115>I. Probable AD: Core Diagnostic Features
A. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)
B. Deficit in at least two areas of cognition 
i. Memory (required)
ii. Other area besides memory
C. Deficits characterized by gradual onset and progression, onset after age 40
D. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves

II. Possible AD: Core Diagnostic Features 

A. Dementia syndrome in the absence of other neurologic, psychiatric, or systemic disorder, OR
B. Presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be the primary cause of the dementia

III. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain
A. Sudden apoplectic onset
B. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness
C. Seizures or gait disturbances at the onset or very early in the course of the illness

IV. Criteria for diagnosis of Definite Alzheimer&apos;s disease: 
A. Clinical criteria for probable Alzheimer&apos;s disease
B. Histopathologic evidence obtained from a biopsy or autopsy

As AD progresses, patients frequently suffer from neuropsychiatric complications such as agitation, apathy, delusions, hallucinations or depression. In many cases, these constitute a greater burden for caregivers than the cognitive deficits and may require treatment with psychoactive medications.</obo:IAO_0000115>
        <obo:IAO_0000119>NINCDS-ADRDA Criteria for the Diagnosis of Alzheimer&apos;s Disease</obo:IAO_0000119>
        <obo:IAO_0000119>Adapted from: http://en.wikipedia.org/wiki/NINCDS-ADRDA_Alzheimer%27s_Criteria</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>*** REVISE ***

The patient meets the criteria for probable Alzheimer&apos;s disease and has either:
1. Both clinical and histopathological (brain biopsy or autopsy) evidence of the disease, as required by the NIA-Reagan criteria for the post-mortem diagnosis of alzheimers disease 
or
2. Both clinical and genetic evidence (mutation on chromosome 1, 14, or 21) of alzheimers disease </obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001150 -->

    <Class rdf:about="&obo;ND_0001150">
        <rdfs:label>diagnostic guideline for definite atypical Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001144"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001151 -->

    <Class rdf:about="&obo;ND_0001151">
        <rdfs:label>diagnostic guideline for definite frontal variant of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001145"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001152 -->

    <Class rdf:about="&obo;ND_0001152">
        <rdfs:label>diagnostic guideline for definite logopenic aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001146"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001153 -->

    <Class rdf:about="&obo;ND_0001153">
        <rdfs:label>diagnostic guideline for definite posterior cortical atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001147"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001154 -->

    <Class rdf:about="&obo;ND_0001154">
        <rdfs:label>diagnostic guideline for definite primary progressive non-fluent aphasia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001148"/>
        <obo:IAO_0000119>http://memory.ucsf.edu/ftd/medical/diagnosis/criteria/single</obo:IAO_0000119>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>At least one of the core features (1 and 2) must be present, and at least two of the following other features (3-5) must be present.
Agrammatism in language production
Effortful, halting speech with inconsistent distortions, deletions, substitutions, insertions, or transpositions of speech sounds, particularly in polysyllabic words (often considered to reflect &quot;apraxia of speech&quot;)
Impaired comprehension of syntactically complex sentences
Spared single word comprehension
Spared object knowledge
Imaging-Supported NFAV-PPA Diagnosis
Both of the following criteria must be present.
Clinical diagnosis of NFAV-PPA
Imaging must show one or more of the following results:
Predominant left posterior fronto-insular atrophy on MRI
Predominant left posterior fronto-insular hypoperfusion or hypometabolism on SPECT or PET</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0001155 -->

    <Class rdf:about="&obo;ND_0001155">
        <rdfs:label>diagnostic guideline for diagnosing multiple sclerosis according to McDonald criteria</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0001100"/>
        <obo:IAO_0000119>http://www.msdiagnosed.org/McDonald.pdf</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0002022 -->

    <Class rdf:about="&obo;ND_0002022">
        <rdfs:label>leukodystrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0000001"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000054"/>
                <someValuesFrom rdf:resource="&obo;ND_0006016"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000118>dysmyelinating disease</obo:IAO_0000118>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Leukodystrophy</obo:IAO_0000119>
        <obo:IAO_0000119>http://ulf.org/what-is-leukodystrophy</obo:IAO_0000119>
        <obo:IAO_0000115>A neurological disease which is realized by some dysmyelinating disease course.</obo:IAO_0000115>
        <obo:IAO_0000116>Discussion is required to determine the status of the leukodystrophies as asserted types of neurological diseases or whether they are best left as inferred types.</obo:IAO_0000116>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://purl.obolibrary.org/obo/HP_0002415</oboInOwl:hasDbXref>
        <obo:IAO_0000116>The distinguishing features of the leukodystrohies, aka dysmyelinating diseases, that separate them from demyelinating disease are that (1) the pathological processes invloved prevent the normal formation and maintence of myelin and (2) the eitology of the disease is hypothesized to be exclusively genetic. </obo:IAO_0000116>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000428"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0002023 -->

    <Class rdf:about="&obo;ND_0002023">
        <rdfs:label>central nervous system</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000232>NOTE: This term did not exist in FMA at the time of the term&apos;s creation.  Petition FMA to add this term then MIREOT it from FMA.</obo:IAO_0000232>
        <obo:IAO_0000116>For testing reasoning.

Mouse Anatomy: http://purl.obolibrary.org/obo/MA_0000167

NCI Thesarus: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#Central_Nervous_System

FMA: central part of somatic nervous system
http://sig.uw.edu/fma#Central_part_of_somatic_nervous_system</obo:IAO_0000116>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000423"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003000 -->

    <Class rdf:about="&obo;ND_0003000">
        <rdfs:label>dementia</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0003004"/>
        <obo:IAO_0000115>Dementia is the co-occurence of cognitive deficits in at least two domains [memory, visual spatial, attention, orientation, executive function, functional] resulting in a decline of previous functioning.  It typically results from the realization of a dementia disease.

*** TEMPLATE FOR SYNDROME DEFINITIONS??? ***</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003001 -->

    <Class rdf:about="&obo;ND_0003001">
        <rdfs:label>Parkinsonism</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000086"/>
        <obo:IAO_0000118>Parkinsonian syndrome</obo:IAO_0000118>
        <obo:IAO_0000115>Parkinsonism is the co-occurence of any combination of the classical features of Parkinson&apos;s disease [tremor, rigidity, akinesia/bradykinesia, postural instability].  It typically results from the realization of either Parkinsons disease, progressive supranuclear palsy, or multiple system atrophy.</obo:IAO_0000115>
        <obo:IAO_0000118>idiopathic parkinsonism</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003002 -->

    <Class rdf:about="&obo;ND_0003002">
        <rdfs:label>typical Alzheimers syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0003000"/>
        <obo:IAO_0000115>Typical Alzheimers syndrome is the insidious onset of dementia syndrome that is characterized by episodic memory loss.  It typically results from the realization of Alzheimers disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003003 -->

    <Class rdf:about="&obo;ND_0003003">
        <rdfs:label>Parkinson plus syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0003001"/>
        <obo:IAO_0000118>atypical parkinsonian</obo:IAO_0000118>
        <obo:IAO_0000115>Parkinson plus syndrome is the co-occurence of any combination of the classical features of Parkinsons disease [tremor, rigidity, akinesia/bradykinesia, postural instability] with additional features [supranuclear palsy, paralysis of downward gaze, autonomic dysfunction, additional cortical signs, etc] that distinguishes it from simple idiopathic Parkinsons disease.  It typically results from the realization of either multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, or Lewy body dementia.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>disorder of multiple system degeneration</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003004 -->

    <Class rdf:about="&obo;ND_0003004">
        <rdfs:label>mild cognitive impairment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000086"/>
        <obo:IAO_0000115>Mild cognitive impairment is the occurence of one or more cognitive deficits [visual spatial, attention, orientation, executive function, functional] that are beyond those expected based on the age and education of the individual, but which are not significant enough to interfere with their daily activities.  It is typically the result of _________ .</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>MCI</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003005 -->

    <Class rdf:about="&obo;ND_0003005">
        <rdfs:label>atypical Alzheimers syndrome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0003000"/>
        <obo:IAO_0000115>Atypical Alzheimers syndrome is the insidious onset of dementia syndrome that is typically characterized by the absence of episodic memory loss.  It typically results from the realization of either frontal variant of Alzheimers disease, logopenic aphasia, posterior cortical atrophy, or primary progressive nonfluent aphasia.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003006 -->

    <Class rdf:about="&obo;ND_0003006">
        <rdfs:label>epilepsy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000086"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Epilepsy is the occurence of multiple seizures over the course of an individual&apos;s life.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003007 -->

    <Class rdf:about="&obo;ND_0003007">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003008 -->

    <Class rdf:about="&obo;ND_0003008">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003009 -->

    <Class rdf:about="&obo;ND_0003009">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003010 -->

    <Class rdf:about="&obo;ND_0003010">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003011 -->

    <Class rdf:about="&obo;ND_0003011">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003012 -->

    <Class rdf:about="&obo;ND_0003012">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003013 -->

    <Class rdf:about="&obo;ND_0003013">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003014 -->

    <Class rdf:about="&obo;ND_0003014">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003015 -->

    <Class rdf:about="&obo;ND_0003015">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003016 -->

    <Class rdf:about="&obo;ND_0003016">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003017 -->

    <Class rdf:about="&obo;ND_0003017">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003018 -->

    <Class rdf:about="&obo;ND_0003018">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003019 -->

    <Class rdf:about="&obo;ND_0003019">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003020 -->

    <Class rdf:about="&obo;ND_0003020">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003021 -->

    <Class rdf:about="&obo;ND_0003021">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003022 -->

    <Class rdf:about="&obo;ND_0003022">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003023 -->

    <Class rdf:about="&obo;ND_0003023">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003024 -->

    <Class rdf:about="&obo;ND_0003024">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003025 -->

    <Class rdf:about="&obo;ND_0003025">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003026 -->

    <Class rdf:about="&obo;ND_0003026">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003027 -->

    <Class rdf:about="&obo;ND_0003027">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003028 -->

    <Class rdf:about="&obo;ND_0003028">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003029 -->

    <Class rdf:about="&obo;ND_0003029">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003030 -->

    <Class rdf:about="&obo;ND_0003030">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003031 -->

    <Class rdf:about="&obo;ND_0003031">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003032 -->

    <Class rdf:about="&obo;ND_0003032">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003033 -->

    <Class rdf:about="&obo;ND_0003033">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003034 -->

    <Class rdf:about="&obo;ND_0003034">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003035 -->

    <Class rdf:about="&obo;ND_0003035">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003036 -->

    <Class rdf:about="&obo;ND_0003036">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003037 -->

    <Class rdf:about="&obo;ND_0003037">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003038 -->

    <Class rdf:about="&obo;ND_0003038">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0003039 -->

    <Class rdf:about="&obo;ND_0003039">
        <rdfs:subClassOf rdf:resource="&obo;ND_0003006"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005001 -->

    <Class rdf:about="&obo;ND_0005001">
        <rdfs:label>human being</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;NCBITaxon_9606"/>
        <rdfs:comment>Is human an object or is it better represented as a role that an organism plays?

MIREOT this class from:
http://purl.obolibrary.org/obo/NCBITaxon_9606
NCBITaxon labels this class &apos;Homo sapiens&apos; with &apos;human being&apos; as an alternative term and asserts it as a child of &apos;organism&apos;.  &apos;Homo sapiens&apos; should be made singular and &apos;Homo&apos; probably shouldn&apos;t be capitalized.

Is a human being an organism or an extended organism???</rdfs:comment>
        <obo:IAO_0000118>human</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>Should this class be kept?  One major problem with the NCBITaxon terms is that they are all plural.  How should we resolve this issue for our purposes in ND?</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005005 -->

    <Class rdf:about="&obo;ND_0005005">
        <rdfs:label>basal ganglion</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <oboInOwl:hasDbXref>http://bioontology.org/projects/ontologies/fma/fmaOwlDlComponent_2_0#Basal_ganglion_of_telencephalon</oboInOwl:hasDbXref>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>NOTE: This term did not exist in FMA at the time of the term&apos;s creation.  Petition FMA to add this term then MIREOT it from FMA.

It is unclear to me whether this is the same thing as the &apos;Basal ganglion of telencephalon&apos;.</obo:IAO_0000232>
        <obo:IAO_0000115>a group of nuclei of varied origin in the brains of vertebrates that act as a cohesive functional unit. They are situated at the base of the forebrain and are strongly connected with the cerebral cortex, thalamus and other brain areas. The basal ganglia are associated with a variety of functions, including voluntary motor control, procedural learning relating to routine behaviors or &quot;habits&quot; such as bruxism, eye movements, and cognitive, emotional functions.

The main components of the basal ganglia are the striatum, the globus pallidus, the substantia nigra, and the subthalamic nucleus.

The basal ganglia play a central role in a number of neurological conditions, including several movement disorders. The most notable are Parkinson&apos;s disease, which involves degeneration of the dopamine-producing cells in the substantia nigra pars compacta, and Huntington&apos;s disease, which primarily involves damage to the striatum. Basal ganglia dysfunction is also implicated in some other disorders of behavior control such as Tourette syndrome, hemiballismus, obsessive–compulsive disorder, and Wilson&apos;s disease.</obo:IAO_0000115>
        <obo:IAO_0000116>Should this be singular (i.e. ganglion) or plural (i.e. ganglia)?</obo:IAO_0000116>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Basal_ganglia</obo:IAO_0000119>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000423"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005011 -->

    <Class rdf:about="&obo;ND_0005011">
        <rdfs:label>medial temporal lobe</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000115>Medial temporal lobe is a fiat object part consisting of the middle region of a temporal lobe.

The medial temporal lobes (near the Sagittal plane that divides left and right cerebral hemispheres) are thought to be involved in episodic/declarative memory. Deep inside the medial temporal lobes lie the hippocampi, which are essential for memory function – particularly the transference from short to long term memory and control of spatial memory and behavior. Damage to this area typically results in anterograde amnesia.

The medial temporal lobe consists of structures that are vital for explicit memory. The link between the medial temporal lobe and memory was first hypothesized a century ago. Explicit or declarative memory is the conscious memory of facts and events. Explicit memory is further sub-divided into semantic memory and episodic memory. The structures contained within the medial temporal lobe include the hippocampal regions and the parahippocampal gyrus, which consists of the perirhinal, parahippocampal and entorhinal cortices. Though the hippocampus is critical for memory formation, the surrounding medial temporal cortex is also cited as playing a part in establishing memories. Research has shown that lesions in the hippocampus of monkeys results in limited impairment of function, whereas extensive lesions that include the hippocampus and the medial temporal cortex result in severe impairment.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Temporal_lobe</obo:IAO_0000119>
        <obo:IAO_0000232>NOTE: This term did not exist in FMA at the time of the term&apos;s creation.  Petition FMA to add this term then MIREOT it from FMA.</obo:IAO_0000232>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000423"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005013 -->

    <Class rdf:about="&obo;ND_0005013">
        <rdfs:label>tau protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_00055012"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005020"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_00055012"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>tau</obo:IAO_0000118>
        <obo:IAO_0000115>Tau proteins are proteins that stabilize microtubules. They are abundant in neurons of the central nervous system and are less common elsewhere, but are also expressed at very low levels in CNS astrocytes and oligodendrocytes. When tau proteins are defective, and no longer stabilize microtubules properly, they can result in dementias such as Alzheimer&apos;s disease.

The tau proteins are the product of alternative splicing from a single gene that in humans is designated MAPT (microtubule-associated protein tau).

Tau protein is a highly soluble microtubule-associated protein (MAP). In humans, these proteins are mostly found in neurons compared to non-neuronal cells. One of tau&apos;s main functions is to modulate the stability of axonal microtubules.

Six tau isoforms exist in human brain tissue, and they are distinguished by their number of binding domains. Three isoforms have three binding domains and the other three have four binding domains.

Hyperphosphorylation of the tau protein (tau inclusions, pTau) can result in the self-assembly of tangles of paired helical filaments and straight filaments, which are involved in the pathogenesis of Alzheimer&apos;s disease and other tauopathies.

All of the six tau isoforms are present in an often hyperphosphorylated state in paired helical filaments from Alzheimer&apos;s disease brain. In other neurodegenerative diseases, the deposition of aggregates enriched in certain tau isoforms has been reported. When misfolded, this otherwise very soluble protein can form extremely insoluble aggregates that contribute to a number of neurodegenerative diseases.

Recent research suggests that tau may be released extracellularly by an exosome based mechanism in Alzheimer&apos;s disease.

Some aspects of how the disease functions also suggests that it has some similarities to prion proteins.</obo:IAO_0000115>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Tau_protein</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005015 -->

    <Class rdf:about="&obo;ND_0005015">
        <rdfs:label>amyloid beta protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_00055012"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005017"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_00055012"/>
        <rdfs:comment>*** possibly CHANGE LABEL TO  &apos;amyloid beta (A4) precursor protein&apos; ***</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Beta_amyloid</obo:IAO_0000119>
        <obo:IAO_0000118>beta-amyloid</obo:IAO_0000118>
        <oboInOwl:hasDbXref>http://pir.georgetown.edu/cgi-bin/pro/entry_pro?id=PR:000004168</oboInOwl:hasDbXref>
        <obo:IAO_0000118>Abeta</obo:IAO_0000118>
        <obo:IAO_0000118>Aβ</obo:IAO_0000118>
        <obo:IAO_0000118>beta amyloid</obo:IAO_0000118>
        <obo:IAO_0000115>Amyloid beta (Aβ or Abeta) is a peptide of 36–43 amino acids that is processed from the Amyloid precursor protein. While best known as a component of amyloid plaques in association with Alzheimer&apos;s disease, evidence has been found that Aβ is a highly multifunctional peptide with significant non-pathological activity. Aβ is the main component of deposits found in the brains of patients with Alzheimer&apos;s disease.

Several potential activities have been discovered for Aβ that are not associated with disease, including activation of kinase enzymes, protection against oxidative stress, regulation of cholesterol transport, functioning as a transcription factor, and anti-microbial activity (potentially associated with Aβ&apos;s pro-inflammatory activity).

Aβ is the main component of amyloid plaques (deposits found in the brains of patients with Alzheimer&apos;s disease). Similar plaques appear in some variants of Lewy body dementia and in inclusion body myositis (a muscle disease), while Aβ can also form the aggregates that coat cerebral blood vessels in cerebral amyloid angiopathy. The plaques are composed of a tangle of regularly ordered fibrillar aggregates called amyloid fibers, a protein fold shared by other peptides such as the prions associated with protein misfolding diseases. Recent research suggests that soluble oligomeric forms of the peptide may be causative agents in the development of Alzheimer&apos;s disease. A number of genetic, cell biology, biochemical and animal studies support the concept that Aβ plays a central role in the development of Alzheimer’s disease pathology.

Brain Aβ is elevated in patients with sporadic Alzheimer’s disease. Aβ is the main constituent of brain parenchymal and vascular amyloid, it contributes to cerebrovascular lesions and is neurotoxic. It is unresolved how Aβ accumulates in the central nervous system and subsequently initiates the disease of cells. Significant efforts have been focused on the mechanisms responsible for Aβ production, including the proteolytic enzymes alpha- and ß-secretases which generate Aβ from its precursor protein, APP (amyloid precursor protein). Aβ circulates in plasma, cerebrospinal fluid (CSF) and brain interstitial fluid (ISF) mainly as soluble Aβ40 Senile plaques contain both Aβ40 and Aβ42, while vascular amyloid is predominantly the shorter Aβ40. Several sequences of Aβ were found in both lesions. Generation of Aβ in the CNS may take place in the neuronal axonal membranes after APP-mediated axonal transport of ß-secretase and presenilin-1.

Aβ is formed after sequential cleavage of the amyloid precursor protein (APP), a transmembrane glycoprotein of undetermined function. APP can be processed by α-, β- and γ-secretases; Aβ protein is generated by successive action of the β and γ secretases. The γ secretase, which produces the C-terminal end of the Aβ peptide, cleaves within the transmembrane region of APP and can generate a number of isoforms of 36-43 amino acid residues in length. The most common isoforms are Aβ40 and Aβ42; the shorter form is typically produced by cleavage that occurs in the endoplasmic reticulum, while the longer form is produced by cleavage in the trans-Golgi network. The Aβ40 form is the more common of the two, but Aβ42 is the more fibrillogenic and is thus associated with disease states.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>amyloid-beta</obo:IAO_0000118>
        <obo:IAO_0000118>amyloid beta</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005016 -->

    <Class rdf:about="&obo;ND_0005016">
        <rdfs:label>amyloid beta protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005018"/>
        <obo:IAO_0000115>An amyloid beta protein fragment is a protein fragment that has been proteolytically derived from an amyloid beta protein.  Amyloid beta protein fragments often aggregate and become parts of protein aggregates, such as amyloid beta plaques, which are thought to frequently form the material basis of many neurological diseases.</obo:IAO_0000115>
        <obo:IAO_0000118>amyloid beta fragment</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005017 -->

    <Class rdf:about="&obo;ND_0005017">
        <rdfs:label>amyloid beta protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005033"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005015"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005033"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>amyloid beta part</obo:IAO_0000118>
        <obo:IAO_0000115>An amyloid beta protein part is a peptide or polypeptide that is a fiat object part of a larger amyloid beta protein.  When an amyloid beta protein part is proteolytically derived from an amyloid beta protein, it becomes an amyloid beta protein fragment.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005018 -->

    <Class rdf:about="&obo;ND_0005018">
        <rdfs:label>protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000115>A protein fragment is a protein part that has been proteolytically derived from a protein and is now a detached independent continuant.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005019 -->

    <Class rdf:about="&obo;ND_0005019">
        <rdfs:label>tau protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005018"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A tau protein fragment is a protein fragment that has been proteolytically derived from a tau protein.  Tau protein fragments often aggregate and become parts of protein aggregates, such as neurofibrillary tangles, Lewy bodies, and Lewy neurites, which are thought to frequently form the material basis of many neurological diseases.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005020 -->

    <Class rdf:about="&obo;ND_0005020">
        <rdfs:label>tau protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005033"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005013"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005033"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A tau protein part is a peptide or polypeptide that is a fiat object part of a larger tau protein.  When a tau protein part is proteolytically derived from a tau protein, it becomes a tau protein fragment.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005021 -->

    <Class rdf:about="&obo;ND_0005021">
        <rdfs:label>alpha synuclein protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_00055012"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005022"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_00055012"/>
        <obo:IAO_0000118>alpha-synuclein protein</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005022 -->

    <Class rdf:about="&obo;ND_0005022">
        <rdfs:label>alpha synuclein protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005033"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005021"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005033"/>
        <obo:IAO_0000118>alpha-synuclein protein part</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005023 -->

    <Class rdf:about="&obo;ND_0005023">
        <rdfs:label>alpha synuclein protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005018"/>
        <obo:IAO_0000118>alpha-synuclein protein fragment</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005024 -->

    <Class rdf:about="&obo;ND_0005024">
        <rdfs:label>ubiquitin protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_00055012"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005025"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_00055012"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005025 -->

    <Class rdf:about="&obo;ND_0005025">
        <rdfs:label>ubiquitin protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005033"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005024"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005033"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005026 -->

    <Class rdf:about="&obo;ND_0005026">
        <rdfs:label>ubiquitin protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005018"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005027 -->

    <Class rdf:about="&obo;ND_0005027">
        <rdfs:label>neurofilament protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_00055012"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005028"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_00055012"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005028 -->

    <Class rdf:about="&obo;ND_0005028">
        <rdfs:label>neurofilament protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005033"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005027"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005033"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005029 -->

    <Class rdf:about="&obo;ND_0005029">
        <rdfs:label>neurofilament protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005018"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005030 -->

    <Class rdf:about="&obo;ND_0005030">
        <rdfs:label>alpha B crystallin protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_00055012"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005031"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_00055012"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005031 -->

    <Class rdf:about="&obo;ND_0005031">
        <rdfs:label>alpha B crystallin protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005033"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005030"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005033"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005032 -->

    <Class rdf:about="&obo;ND_0005032">
        <rdfs:label>alpha B crystallin protein fragment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005018"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005033 -->

    <Class rdf:about="&obo;ND_0005033">
        <rdfs:label>protein part</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;BFO_0000040"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000186"/>
                        <someValuesFrom rdf:resource="&obo;ND_00055012"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000232>I don&apos;t think this class and its subclasses add anything to the ontology.  I think that everything that I originally wanted &apos;protein part&apos; to do can be accommodated by using &apos;protein fragment&apos;, but this will require further review.

The original intention in creating this class was to identify fiat parts of longer amino acid chains in order to identify protein fragments as having originated in a larger amino acid chain which was later subjected to a &quot;snipping&quot; process that separated the fiat protein part and generated an independent continuant that is equivalent to the appropriate protein fragment.

Alexander P. Cox</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005037 -->

    <Class rdf:about="&obo;ND_0005037">
        <rdfs:label>prion</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005511"/>
        <obo:IAO_0000117>Alexander D. Diehl</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005038 -->

    <Class rdf:about="&obo;ND_0005038">
        <rdfs:label>human immunodeficiency virus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;NCBITaxon_10239"/>
        <obo:IAO_0000118>HIV</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander D. Diehl</obo:IAO_0000117>
        <rdfs:comment>HIV dementia only assocated with HIV1</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005039 -->

    <Class rdf:about="&obo;ND_0005039">
        <rdfs:label>Treponema pallidum</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;NCBITaxon_2"/>
        <obo:IAO_0000117>Alexander D. Diehl</obo:IAO_0000117>
        <obo:IAO_0000116>See: http://en.wikipedia.org/wiki/Treponema_pallidum for 4 known subspecies.

Alexander P. Cox</obo:IAO_0000116>
        <obo:IAO_0000232>Is &apos;syphilis bacterium&apos; an alternative term for this class?

Alexander P. Cox</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005040 -->

    <Class rdf:about="&obo;ND_0005040">
        <rdfs:label>herpes simplex virus</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;NCBITaxon_10239"/>
        <obo:IAO_0000117>Alexander D. Diehl</obo:IAO_0000117>
        <obo:IAO_0000118>HSV</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005500 -->

    <Class rdf:about="&obo;ND_0005500">
        <rdfs:label>amyloid beta plaque</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005511"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005016"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005504"/>
        <obo:IAO_0000115>An amyloid plaque is an extracellular aggregation of amyloid beta protein fragments that develops in the brain.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>amyloid plaque</obo:IAO_0000118>
        <obo:IAO_0000118>beta-amyloid plaque</obo:IAO_0000118>
        <rdfs:comment>*** Should this term exist or is it synonymous with &apos;amyloid plaque&apos;? ***</rdfs:comment>
        <obo:IAO_0000118>senile plaque</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005501 -->

    <Class rdf:about="&obo;ND_0005501">
        <rdfs:label>neurological disorder</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000045"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000127"/>
                <someValuesFrom rdf:resource="&obo;ND_0000001"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000115>A disorder which is the material basis of a neurologcal disease. </obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_00055012 -->

    <Class rdf:about="&obo;ND_00055012">
        <rdfs:label>protein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;BFO_0000040"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005033"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>We may or may not want to add more terms related to proteins such as:

A polypeptide is a single linear polymer chain of amino acids bonded together by peptide bonds between the carboxyl and amino groups of adjacent amino acid residues. The sequence of amino acids in a protein is defined by the sequence of a gene, which is encoded in the genetic code.

From: http://en.wikipedia.org/wiki/Protein</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Protein</obo:IAO_0000119>
        <obo:IAO_0000115>A protein is a biochemical compound consisting of one or more polypeptides typically folded into a globular or fibrous form, that facilitates a biological function.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005502 -->

    <Class rdf:about="&obo;ND_0005502">
        <rdfs:label>neurofibrillary tangle</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005511"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005019"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005511"/>
        <obo:IAO_0000118>tau tangle</obo:IAO_0000118>
        <obo:IAO_0000119>Alexander P. Cox</obo:IAO_0000119>
        <obo:IAO_0000115>Neurofibrillary tangle is an intracellular aggregation of tau proteins that develop in neurons in the brain.  The development of neurofibrillary tangles typically results in the disruption of the transportation of nutrients and other important substances within the neuron, which typically results in the destruction and death of the cell.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>NFT</obo:IAO_0000118>
        <rdfs:comment>Neurofibrillary Tangles (NFTs) are aggregates of hyperphosphorylated tau protein that are most commonly known as a primary marker of Alzheimer&apos;s Disease. Their presence is also found in numerous other diseases known as Tauopathies. Little is known about their exact relationship to the different pathologies.

Neurofibrillary tangles are formed by hyperphosphorylation of a microtubule-associated protein known as tau, causing it to aggregate, or group, in an insoluble form. (These aggregations of hyperphosphorylated tau protein are also referred to as PHF, or &quot;paired helical filaments&quot;). The precise mechanism of tangle formation is not completely understood, and it is still controversial whether tangles are a primary causative factor in disease or play a more peripheral role.

From:
http://en.wikipedia.org/wiki/Neurofibrillary_tangles</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005503 -->

    <Class rdf:about="&obo;ND_0005503">
        <rdfs:label>autoimmune demyelinating disorder</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005501"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000127"/>
                <someValuesFrom rdf:resource="&obo;ND_0000026"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000116>This may not be correct. It is possible that once we have the material bases for these diseases worked out, there may be no unifying property and the fact they are all neurolgical disorders will be inferred. But, for now, this class provides readability, organization and reasoning, etc.</obo:IAO_0000116>
        <obo:IAO_0000115>A disorder that bears the disposition for an autoimmune demyelinating disease.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005504 -->

    <Class rdf:about="&obo;ND_0005504">
        <rdfs:label>amyloid plaque</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005511"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>An amyloid plaque is an extracellular aggregation of amyloid protein fragments that develops in the brain.</obo:IAO_0000115>
        <rdfs:comment>Pathogenesis of amyloidosis:

When a native cell creates a protein, it could either make the actual protein or protein fragments. These fragments could come and join together to form the actual protein. Such a protein can sometimes regress into the protein fragments. This process of &quot;flip flopping&quot; happens frequently in certain proteins, especially the ones that cause this disease.

The fragments or actual proteins are at risk of mis-folding as they are synthesized, to make a bad protein. This causes proteolysis, which is the directed degradation of proteins by cellular enzymes called proteases or by intramolecular digestion; proteases come and digest the mis-folded fragments and proteins. The problem occurs when the proteins do not dissolve in proteolysis. This happens because the mis-folded proteins sometimes become robust enough that they are not dissolved by normal proteolysis. When the fragments do not dissolve, they get spit out of proteolysis and they aggregate to form oligomers. The reason they aggregate is that the parts of the protein that do not dissolve in proteolysis are the β-pleated sheets, which are extremely hydrophobic. They are usually sequestered in the middle of the protein, while parts of the protein that are more soluble are found near the outside. When they are exposed to water, these hydrophobic pieces tend to aggregate with other hydrophobic pieces. This ball of fragments gets stabilized by GAG&apos;s (glycosaminoglycans) and SAP (serum amyloid P), a component found in amyloid aggregations that is thought to stabilize them and prevent proteolytic cleavage). The stabilized balls of protein fragments are called oligomers. The oligomers can aggregate together and further stabilize to make amyloid fibrils.

Both the oligomers and amyloid fibrils can cause cell toxicity and organ dysfunction.

From:
http://en.wikipedia.org/wiki/Amyloidosis

Also see:
http://en.wikipedia.org/wiki/Amyloid</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005505 -->

    <Class rdf:about="&obo;ND_0005505">
        <rdfs:label>Lewy body</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005509"/>
                    <Class>
                        <unionOf rdf:parseType="Collection">
                            <Restriction>
                                <onProperty rdf:resource="&ro;has_part"/>
                                <someValuesFrom rdf:resource="&obo;ND_0005019"/>
                            </Restriction>
                            <Restriction>
                                <onProperty rdf:resource="&ro;has_part"/>
                                <someValuesFrom rdf:resource="&obo;ND_0005026"/>
                            </Restriction>
                            <Restriction>
                                <onProperty rdf:resource="&ro;has_part"/>
                                <someValuesFrom rdf:resource="&obo;ND_0005029"/>
                            </Restriction>
                            <Restriction>
                                <onProperty rdf:resource="&ro;has_part"/>
                                <someValuesFrom rdf:resource="&obo;ND_0005032"/>
                            </Restriction>
                        </unionOf>
                    </Class>
                    <Restriction>
                        <onProperty rdf:resource="&ro;has_part"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005023"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005509"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Lewy body is an abnormal aggregate of protein that develops inside nerve cells in Parkinson&apos;s disease (PD), Lewy Body Dementia and some other disorders. They are identified under the microscope when histology is performed on the brain.  Lewy bodies appear as spherical masses that displace other cell components.  There are two morphological types: classical (brain stem) Lewy bodies and cortical Lewy bodies.

A Lewy body is composed of the protein alpha-synuclein associated with other proteins such as ubiquitin, neurofilament protein, and alpha B crystallin.  Tau proteins may also be present, and Lewy bodies may occasionally be surrounded by neurofibrillary tangles.

It is believed that Lewy bodies represent an aggresome response in the cell.</obo:IAO_0000115>
        <obo:IAO_0000119>WEB:http://en.wikipedia.org/wiki/Lewy_body@2012-08-15</obo:IAO_0000119>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005506 -->

    <Class rdf:about="&obo;ND_0005506">
        <rdfs:label>classical Lewy body</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005505"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Lewy_body</obo:IAO_0000119>
        <obo:IAO_0000115>A classical Lewy body is an eosinophilic cytoplasmic inclusion that consists of a dense core surrounded by a halo of 10-nm wide radiating fibrils, the primary structural component of which is alpha-synuclein.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:synonym>brain stem Lewy body</obo:synonym>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005507 -->

    <Class rdf:about="&obo;ND_0005507">
        <rdfs:label>cortical Lewy body</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005505"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Lewy_body</obo:IAO_0000119>
        <obo:IAO_0000115>A cortical Lewy body is an eosinophilic cytoplasmic inclusion that is composed of alpha-synuclein fibrils, but is less well defined than a classical Lewy body and lacks the halo.  Cortical Lewy bodies are a distinguishing feature of Dementia with Lewy bodies (DLB) and may occasionally be seen in ballooned neurons characteristic of Pick&apos;s disease and corticobasal degeneration, as well as in patients with other tauopathies.  They are also seen in cases of multiple system atrophy, particularly the Parkinsonian variant.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005508 -->

    <Class rdf:about="&obo;ND_0005508">
        <rdfs:label>Lewy neurite</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005509"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Lewy_body</obo:IAO_0000119>
        <obo:IAO_0000115>Similar to Lewy bodies, Lewy neurites are proteinaceous formations found in neurons of the disease brain, comprising abnormal α-synuclein filaments and granular material.  They are a feature of α-synucleinopathies such as Dementia with Lewy bodies, Parkinson&apos;s disease and multiple system atrophy (MSA), and are found in the CA2-3 region of the hippocampus in Alzheimer&apos;s disease.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005509 -->

    <Class rdf:about="&obo;ND_0005509">
        <rdfs:label>filamentous inclusion made of the protein alpha synuclein</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0005511"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000110"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005023"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0005511"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>filamentous inclusion made of the protein alpha-synuclein</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005510 -->

    <Class rdf:about="&obo;ND_0005510">
        <rdfs:label>aggresome</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000040"/>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Aggresome

*** REVIEW THIS SOURCE FOR ACCURACY ***</obo:IAO_0000119>
        <obo:IAO_0000116>This is a place holder until PR takes over this term.</obo:IAO_0000116>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <oboInOwl:hasDbXref>http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016235</oboInOwl:hasDbXref>
        <obo:IAO_0000115>An aggresome is a proteinaceous inclusion body that forms when cellular degradation machinery is impaired or overwhelmed, leading to an accumulation of protein for disposal. An aggresome is formed as the result of an aggresomal response.

Typically, an aggresome forms in response to a cellular stress which generates a large amount of misfolded or partially denatured protein: hyperthermia, overexpression of an insoluble or mutant protein, etc. The formation of the aggresome is largely believed to be a protective response, sequestering potentially cytotoxic aggregates and also acting as a staging center for eventual autophagic clearance from the cell.

An aggresome forms around the microtubule organizing center in eukaryotic cells, adjacent to or enveloping the cell&apos;s centrosomes. Lysine linked (63) polyubitiuntation tags the protein for retrograde transport via HDAC6 binding and microtubule-based motor protein, dynein. The protein aggregate is transported through the microtubule and unloaded via p97 forming the aggresome. Mediators such as p62 are believed to be involved in aggrosome formation in sequestering omega-somes, which bind and increase the size of the aggreseome. The aggreseome is eventually targeted for autophagic clearance for the cell. Some pathological proteins, such as a-synuclein, cannot be degraded and cause the aggresomes to form inclusion bodies or, in Parkinsons, Lewy bodies, which contribute to neuronal dysfunction and death.

Certain cellular inclusions seen in human disease are thought to represent an aggresomal response, such as the Lewy body seen in neurons in the brain in Parkinson&apos;s disease and Mallory&apos;s Hyaline seen in liver cells in conditions such as alcoholic liver disease.</obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000423"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0005511 -->

    <Class rdf:about="&obo;ND_0005511">
        <rdfs:label>protein aggregate</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000045"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000127"/>
                <someValuesFrom rdf:resource="&obo;ND_0000152"/>
            </Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&ro;has_part"/>
                <someValuesFrom rdf:resource="&obo;ND_0005018"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>This is a place holder until PR takes over this term.</obo:IAO_0000116>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000116>I don&apos;t think it is correct to have this typed as a disorder. Are ALL protein aggregates the material basis of some disease?
-MJ</obo:IAO_0000116>
        <obo:IAO_0000116>This term label assumes that all protein aggregates are pathological in nature.  A review of the literature supports this interpretation; however, it is still an open question wether there are some nonpathological protein aggregates.  If this is the case, then this lable should be changed to &apos;pathological protein aggregate&apos; and another class should be created labled &apos;protein aggregate&apos; that is not a subclass of &apos;disorder&apos;.</obo:IAO_0000116>
        <obo:IAO_0000119>http://groups.molbiosci.northwestern.edu/holmgren/Glossary/Definitions/Def-P/protein_aggregate.html</obo:IAO_0000119>
        <obo:IAO_0000115>A protein aggregate is a misfolded, rigid protein grouping.</obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000423"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006000 -->

    <Class rdf:about="&obo;ND_0006000">
        <rdfs:label>neurodegeneration</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000061"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Neurodegeneration is a pathological bodily process that produces the loss of structure or function of neurons and can also produce the death of neurons.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006001 -->

    <Class rdf:about="&obo;ND_0006001">
        <rdfs:label>demyelination</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000061"/>
        <obo:IAO_0000115>Demyelination is a pathological bodily process that produces damage to the myelin sheath of neurons.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000111>demyelination</obo:IAO_0000111>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006002 -->

    <Class rdf:about="&obo;ND_0006002">
        <rdfs:label>aggresomal response</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000060"/>
        <rdfs:comment>aggresome assembly

From: http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0070842

*** MAKE THIS ANOTHER BODILY PROCESS AND THEN ADD &apos;aggresomal response&apos; has_part &apos;aggresome assembly&apos; ***</rdfs:comment>
        <obo:IAO_0000232>Is it correct to give this a logical definition that includes:

&apos;has specified output&apos; some aggresome ???

In other words, does every aggresomal response generate an aggresome?

See also: &apos;protein aggregation&apos;

Alexander P. Cox</obo:IAO_0000232>
        <rdfs:comment>Intracellular deposition of misfolded protein aggregates into ubiquitin-rich cytoplasmic inclusions is linked to the pathogenesis of many diseases. Why these aggregates form despite the existence of cellular machinery to recognize and degrade misfolded protein and how they are delivered to cytoplasmic inclusions are not known. We have investigated the intracellular fate of cystic fibrosis transmembrane conductance regulator (CFTR), an inefficiently folded integral membrane protein which is degraded by the cytoplasmic ubiquitin-proteasome pathway. Overexpression or inhibition of proteasome activity in transfected human embryonic kidney or Chinese hamster ovary cells led to the accumulation of stable, high molecular weight, detergent-insoluble, multiubiquitinated forms of CFTR. Using immunofluorescence and transmission electron microscopy with immunogold labeling, we demonstrate that undegraded CFTR molecules accumulate at a distinct pericentriolar structure which we have termed the aggresome.  Aggresome formation is accompanied by redistribution of the intermediate filament protein vimentin to form a cage surrounding a pericentriolar core of aggregated, ubiquitinated protein. Disruption of microtubules blocks the formation of aggresomes. Similarly, inhibition of proteasome function also prevented the degradation of unassembled presenilin-1 molecules leading to their aggregation and deposition in aggresomes. These data lead us to propose that aggresome formation is a general response of cells which occurs when the capacity of the proteasome is exceeded by the production of aggregation-prone misfolded proteins.

Source: http://jcb.rupress.org/content/143/7/1883.abstract</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>WARNING: Not all aggresomal responses are pathological!  This term should be labled &apos;pathological aggresomal response&apos; instead and a new class labled &apos;aggresomal response&apos; should be created as a bodily process.</rdfs:comment>
        <obo:IAO_0000119>http://en.wikipedia.org/wiki/Aggresome

*** REVIEW THIS SOURCE FOR ACCURACY ***</obo:IAO_0000119>
        <obo:IAO_0000115>An aggresomal response is believed to be a generalised-protective cell biological response to the presence of a high load of abnormal or damaged protein within the cytosol of a cell which fails to be eliminated by the usual ubiquitin proteasome system for protein degradation.

Typically, an aggresome forms in response to a cellular stress which generates a large amount of misfolded or partially denatured protein: hyperthermia, overexpression of an insoluble or mutant protein, etc. The formation of the aggresome is largely believed to be a protective response, sequestering potentially cytotoxic aggregates and also acting as a staging center for eventual autophagic clearance from the cell.

An aggresome forms around the microtubule organizing center in eukaryotic cells, adjacent to or enveloping the cell&apos;s centrosomes. Lysine linked (63) polyubitiuntation tags the protein for retrograde transport via HDAC6 binding and microtubule-based motor protein, dynein. The protein aggregate is transported through the microtubule and unloaded via p97 forming the aggresome. Mediators such as p62 are believed to be involved in aggrosome formation in sequestering omega-somes, which bind and increase the size of the aggreseome. The aggreseome is eventually targeted for autophagic clearance for the cell. Some pathological proteins, such as a-synuclein, cannot be degraded and cause the aggresomes to form inclusion bodies or, in Parkinsons, Lewy bodies, which contribute to neuronal dysfunction and death.

Certain cellular inclusions seen in human disease are thought to represent an aggresomal response, such as the Lewy body seen in neurons in the brain in Parkinson&apos;s disease and Mallory&apos;s Hyaline seen in liver cells in conditions such as alcoholic liver disease.</obo:IAO_0000115>
        <obo:IAO_0000118>aggresome response</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006003 -->

    <Class rdf:about="&obo;ND_0006003">
        <rdfs:label>protein aggregation</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006006"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005018"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;OBI_0000299"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005510"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006006"/>
        <obo:IAO_0000232>Are &apos;pathological aggresomal response&apos; and &apos;protein aggregation&apos; the same process?  If not, what differentiates them?  Is &apos;protein aggregation&apos; a subclass of &apos;pathological aggresomal response&apos; as I have currently asserted?  If so, what other types of &apos;pathological aggresomal response&apos; are there?  If not, why not?


Is it correct to give this a logical definition that includes:
&apos;has specified output&apos; some aggresome ???
In other words, does every aggresomal response generate an aggresome?

See also: &apos;aggresomal response&apos;

Alexander P. Cox</obo:IAO_0000232>
        <obo:IAO_0000115>Protein aggregation is the process through which misfolded protein fragments group together to form a protein aggregate.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>Consider adding subclasses of &apos;protein aggregate&apos; to represent the following properties that they can have:

Aggregates of proteins may arise from several mechanisms and may be classified in numerous ways, including soluble/insoluble, covalent/noncovalent, reversible/irreversible, and native/denatured.

Source: http://www.aapsj.org/view.asp?art=aapsj080366</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006004 -->

    <Class rdf:about="&obo;ND_0006004">
        <rdfs:label>tau protein aggregation</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006003"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005019"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;OBI_0000299"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005502"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006003"/>
        <obo:IAO_0000115>Tau protein aggregation is the pathological bodily process through which a neurofibrillary tangle is formed from tau protein fragments.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>tau aggregation</obo:IAO_0000118>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006005 -->

    <Class rdf:about="&obo;ND_0006005">
        <rdfs:label>amyloid beta protein aggregation</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006003"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005016"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;OBI_0000299"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005500"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006003"/>
        <obo:IAO_0000115>Amyloid beta protein aggregation is the pathological bodily process through which an amyloid beta plaque is formed from amyloid beta protein fragments.</obo:IAO_0000115>
        <obo:IAO_0000118>amyloid beta aggregation</obo:IAO_0000118>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006006 -->

    <Class rdf:about="&obo;ND_0006006">
        <rdfs:label>pathological aggresomal response</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000061"/>
        <obo:IAO_0000115>Pathological aggresomal response is the process that occurs when an aggresomal response becomes a pathological bodily process.  A pathological aggresomal response typically (always???) produces (results in???) too many aggresomes, which then typically become the material basis of one or more diseases.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006007 -->

    <Class rdf:about="&obo;ND_0006007">
        <rdfs:label>typical Alzheimers disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006031"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000004"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006031"/>
        <disjointWith rdf:resource="&obo;ND_0006008"/>
        <rdfs:comment>*** TO DO ***

Revise definition and add disease courses for each of the subclasses of Alzheimers disease.</rdfs:comment>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes typical Alzheimers disease.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006008 -->

    <Class rdf:about="&obo;ND_0006008">
        <rdfs:label>atypical Alzheimers disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006031"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000161"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006031"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes atypical Alzheimers disease.</obo:IAO_0000115>
        <rdfs:comment>*** TO DO ***

Revise definition and add disease courses for each of the subclasses of Alzheimers disease.</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006009 -->

    <Class rdf:about="&obo;ND_0006009">
        <rdfs:label>multiple sclerosis disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006019"/>
        <rdfs:subClassOf>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000033"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <allValuesFrom rdf:resource="&obo;ND_0000033"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <Class>
                <unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0000201"/>
                    <rdf:Description rdf:about="&obo;ND_0000202"/>
                </unionOf>
            </Class>
        </rdfs:subClassOf>
        <obo:IAO_0000116>This may belong under OGMS &apos;progressive disease course&apos;. It is unlcear at this time how to make sense of the distinctions between OGMS disease courses. All realizations of MS, even the replapsing variant, are considerd progressive at some level of granularity (REF).</obo:IAO_0000116>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000115>A disease course which realizes multiple sclerosis.</obo:IAO_0000115>
        <obo:IAO_0000116>All instances of a mutliple sclerosis disease course contain a process profile (relapsing remitting, secondary progressive or primary progressive) which characterizes the degree of neurological functioning of the organism that bears the disease.</obo:IAO_0000116>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006010 -->

    <Class rdf:about="&obo;ND_0006010">
        <rdfs:label>acute disseminated encephalomyelitis transient disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000066"/>
        <disjointWith rdf:resource="&obo;ND_0006013"/>
        <obo:IAO_0000115>Acute encephalomyelitis is a transient dymelinating disease course in which the patient has a single brief but intense attack of inflammation in the brain, or spinal cord, or optic nerve that causes damage to the myelin.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006011 -->

    <Class rdf:about="&obo;ND_0006011">
        <rdfs:label>clinically isolated syndrome transient disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000066"/>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000115>A transient disease course that realizes clinically isolated syndrome disease.

***Expand on this!

Alexander P. Cox</obo:IAO_0000115>
        <rdfs:comment>This is not correct. A CIS is mono- or multifocal epsiode lasting 24 hours or more. A CIS can be ADEM or ON, or any of a variety of other neurologic episode. Not sure where to put CIS in ontology. It could be that CIS is merely a supercalss of types of diagnosis, charaterizing cases of possible MS. MJ</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006013 -->

    <Class rdf:about="&obo;ND_0006013">
        <rdfs:label>optic neuritis transient disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000066"/>
        <obo:IAO_0000115>A transient disease course that realizes optic neuritis transient disease.

***Expand on this!

Alexander P. Cox</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006016 -->

    <Class rdf:about="&obo;ND_0006016">
        <rdfs:label>dysmyelination</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000061"/>
        <rdfs:comment>The leukodystrophies are caused by imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers. Myelin, from which the white matter of the brain takes its colour, is a complex substance made up of at least ten different chemicals. Each of the leukodystrophies is the result of a defect in the gene that controls the production or metabolism of one (and only one) of the component molecules of myelin. [Wikipedia]

Note:
I do not know yet if dysmelination is a universal process kind or just a defined class to capture a set of processes that marks a distinction between abnormal development of myelin vs. normal development and subsequent decay (demyelination). </rdfs:comment>
        <rdfs:comment>A generic term that will probably be replaced by the more correct term leukodystrophy, that is used for a variety of congenital white matter diseases in which myelin is never formed correctly or is not maintained due to some sort of enzymatic defect.

From:
http://www.medcyclopaedia.com/library/topics/volume_vi_1/d/dysmyelinating_diseases.aspx</rdfs:comment>
        <obo:IAO_0000115>A patholigical process that results in imperfect growth or maintence of white matter in an organism&apos;s brain. </obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006017 -->

    <Class rdf:about="&obo;ND_0006017">
        <rdfs:label>autoimmune process</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000061"/>
        <obo:IAO_0000119>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#Autoimmune_Process</obo:IAO_0000119>
        <obo:IAO_0000115>A specific humoral or cell-mediated immune response against autologous (self) antigens. An autoimmune process may produce or be caused by autoimmune disease and may be developmentally complex, not necessarily pathological, and possibly pervasive.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <rdfs:comment>Not sure about this.</rdfs:comment>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006019 -->

    <Class rdf:about="&obo;ND_0006019">
        <rdfs:label>neurological disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000063"/>
        <rdfs:subClassOf>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000001"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <allValuesFrom rdf:resource="&obo;ND_0000001"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </rdfs:subClassOf>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000115>A disease course that realizes a neurological disease.</obo:IAO_0000115>
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006020 -->

    <Class rdf:about="&obo;ND_0006020">
        <rdfs:label>frontotemporal dementia disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006023"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000167"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006023"/>
        <obo:IAO_0000115>A progressive disease course that realizes frontotemporal dementia disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006021 -->

    <Class rdf:about="&obo;ND_0006021">
        <rdfs:label>Parkinsons disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006037"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000139"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0006000"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000066"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_62907"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006037"/>
        <obo:IAO_0000115>A progressive disease course that realizes Parkinsons disease and involves degeneration of pigmented neurons in the substantia nigra pars compacta.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006022 -->

    <Class rdf:about="&obo;ND_0006022">
        <rdfs:label>vascular disease resulting in dementia disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;OGMS_0000094"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <allValuesFrom rdf:resource="&obo;ND_0000173"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000094"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>An acute disease course that realizes vascular disease and results in dementia.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006023 -->

    <Class rdf:about="&obo;ND_0006023">
        <rdfs:label>tauopathy disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006042"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000151"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006004"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006042"/>
        <obo:IAO_0000115>A progressive disease course that realizes tauopathy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006024 -->

    <Class rdf:about="&obo;ND_0006024">
        <rdfs:label>corticobasal degeneration disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006023"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000169"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom>
                            <Class>
                                <intersectionOf rdf:parseType="Collection">
                                    <rdf:Description rdf:about="&obo;ND_0006000"/>
                                    <Restriction>
                                        <onProperty rdf:resource="&obo;BFO_0000066"/>
                                        <someValuesFrom rdf:resource="&obo;FMA_242199"/>
                                    </Restriction>
                                </intersectionOf>
                            </Class>
                        </someValuesFrom>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006023"/>
        <obo:IAO_0000115>A progressive disease course that realizes coticobasal degeneration disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006025 -->

    <Class rdf:about="&obo;ND_0006025">
        <rdfs:label>normal pressure hydrocephalus disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000064"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A chronic disease course that realizes normal pressure hydrocephalus disease and involves elevated cerebral spinal fluid pressure in the brain and spinal cord.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006026 -->

    <Class rdf:about="&obo;ND_0006026">
        <rdfs:label>frontotemporal dementia with motor neuron disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006020"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes frontotemporal dementia with motor neuron disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006027 -->

    <Class rdf:about="&obo;ND_0006027">
        <rdfs:label>Picks disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006020"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes Picks disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006028 -->

    <Class rdf:about="&obo;ND_0006028">
        <rdfs:label>primary progressive aphasia disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006020"/>
        <obo:IAO_0000115>A progressive disease course that realizes primary progressive aphasia disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006029 -->

    <Class rdf:about="&obo;ND_0006029">
        <rdfs:label>semantic aphasia disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006020"/>
        <obo:IAO_0000115>A progressive disease course that realizes semantic aphasia disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006030 -->

    <Class rdf:about="&obo;ND_0006030">
        <rdfs:label>progressive supranuclear palsy disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006023"/>
        <obo:IAO_0000115>A progressive disease course that realizes progressive supranuclear palsy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006031 -->

    <Class rdf:about="&obo;ND_0006031">
        <rdfs:label>amyloidopathy disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006042"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000186"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006005"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006042"/>
        <obo:IAO_0000115>A progressive disease course that realizes amyloidopathy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006032 -->

    <Class rdf:about="&obo;ND_0006032">
        <rdfs:label>motor neuron disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006042"/>
        <obo:IAO_0000115>A progressive disease course that realizes motor neuron disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006033 -->

    <Class rdf:about="&obo;ND_0006033">
        <rdfs:label>amyotrophic lateral sclerosis disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006032"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes amyotrophic lateral sclerosis disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006034 -->

    <Class rdf:about="&obo;ND_0006034">
        <rdfs:label>progressive bulbar palsy disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006032"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes progressive bulbar palsy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006035 -->

    <Class rdf:about="&obo;ND_0006035">
        <rdfs:label>spinal muscular atrophy disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006032"/>
        <obo:IAO_0000115>A progressive disease course that realizes spinal muscular atrophy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006036 -->

    <Class rdf:about="&obo;ND_0006036">
        <rdfs:label>cerebral amyloid angiopathy disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006031"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes cerebral amyloid angiopathy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006037 -->

    <Class rdf:about="&obo;ND_0006037">
        <rdfs:label>alpha synucleinopathy disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006042"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000068"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006000"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006043"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006042"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A progressive disease course that realizes alpha synucleinopathy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006038 -->

    <Class rdf:about="&obo;ND_0006038">
        <rdfs:label>Lewy body disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006037"/>
        <obo:IAO_0000115>A progressive disease course that realizes Lewy body disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006039 -->

    <Class rdf:about="&obo;ND_0006039">
        <rdfs:label>Parkinson dementia disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006021"/>
        <obo:IAO_0000115>A progressive disease course that realizes Parkinsons dementia disease, results in dementia, and involves degeneration of pigmented neurons in the substantia nigra pars compacta.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006040 -->

    <Class rdf:about="&obo;ND_0006040">
        <rdfs:label>multiple system atrophy disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006037"/>
        <obo:IAO_0000115>A progressive disease course that realizes multiple system atrophy disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006041 -->

    <Class rdf:about="&obo;ND_0006041">
        <rdfs:label>Huntingtons disease course</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006042"/>
        <obo:IAO_0000115>A progressive disease course that realizes Huntingtons disease and involves degeneration of neurons in the brain.

***Expand on this!</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006042 -->

    <Class rdf:about="&obo;ND_0006042">
        <rdfs:label>neurodegenerative disease course</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;OGMS_0000065"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000113"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000117"/>
                        <someValuesFrom rdf:resource="&obo;ND_0006000"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000065"/>
        <obo:IAO_0000115>A progressive disease course that realizes a neurological disease that involves degeneration of neurons in the brain.</obo:IAO_0000115>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006043 -->

    <Class rdf:about="&obo;ND_0006043">
        <rdfs:label>alpha synuclein protein aggregation</rdfs:label>
        <equivalentClass>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="&obo;ND_0006003"/>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000057"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005023"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;OBI_0000299"/>
                        <someValuesFrom rdf:resource="&obo;ND_0005509"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006003"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000118>alpha synuclein aggregation</obo:IAO_0000118>
        <obo:IAO_0000115>Alpha synuclein protein aggregation is the pathological bodily process through which a filamentous inclusion is formed from alpha synuclein protein fragments.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006051 -->

    <Class rdf:about="&obo;ND_0006051">
        <rdfs:label>secondary progressive disease course part</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006055"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000132"/>
                <someValuesFrom rdf:resource="&obo;ND_0000201"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A disease course part of a relapsing multiple sclerosis disease course that is charaterized by a pattern of: (1) relpases in neurological functioning followed by periods of remission during which functioning decreases but is at a lower level of disabilty than that of the relapse, or (2) a steady decline in neurological functioning is measured with no relapses.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006052 -->

    <Class rdf:about="&obo;ND_0006052">
        <rdfs:label>primary progressive multiple sclerosis process profile</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006055"/>
        <rdfs:subClassOf>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000133"/>
                        <someValuesFrom rdf:resource="&obo;ND_0000202"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000133"/>
                        <allValuesFrom rdf:resource="&obo;ND_0000202"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </rdfs:subClassOf>
        <obo:IAO_0000115>A multiple sclerosis process profile which illustrates a steady decline in neurological functioning without relapse or remission.</obo:IAO_0000115>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000116>Part of a solution when process profiles were considered. Most likely this class will be deleted. </obo:IAO_0000116>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006054 -->

    <Class rdf:about="&obo;ND_0006054">
        <rdfs:label>relapsing remitting disease course part</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;ND_0006055"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000132"/>
                <someValuesFrom rdf:resource="&obo;ND_0000201"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000116>characterizes the degree of deficit and overall worsening in neurological function (eg- muscle weakness or paralysis, optical disturbances, ambulation, etc.), inlcuding frequency of relapse and remisison, in a multiple sclerosis disease course measured according to a standardized scale such as the Kurtze Expanded Disability Status Scale (EDSS).</obo:IAO_0000116>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000115>A disease course part of a relapsing multiple sclerosis disease course that is charaterized by a pattern of relpases in neurological functioning followed by periods of remission during which functioning does not decrease and is at a lower level of disabilty than that of the relapse.</obo:IAO_0000115>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND_0006055 -->

    <Class rdf:about="&obo;ND_0006055">
        <rdfs:label>disease course part</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000063"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000132"/>
                <someValuesFrom rdf:resource="&obo;OGMS_0000063"/>
            </Restriction>
        </rdfs:subClassOf>
        <obo:IAO_0000119>TO DO</obo:IAO_0000119>
        <obo:IAO_0000117>Mark Jensen</obo:IAO_0000117>
        <obo:IAO_0000116>TO DO</obo:IAO_0000116>
        <obo:IAO_0000115></obo:IAO_0000115>
        <obo:IAO_0000232 rdf:resource="&obo;IAO_0000123"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0000093 -->

    <rdf:Description rdf:about="&obo;OBI_0000093">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OBI_0100026 -->

    <rdf:Description rdf:about="&obo;OBI_0100026">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000121"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OGMS_0000031 -->

    <rdf:Description rdf:about="&obo;OGMS_0000031">
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000052"/>
                <someValuesFrom rdf:resource="&obo;OBI_0100026"/>
            </Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000113"/>
                <someValuesFrom rdf:resource="&obo;OGMS_0000045"/>
            </Restriction>
        </rdfs:subClassOf>
        <disjointWith rdf:resource="&obo;ND#normal"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OGMS_0000045 -->

    <rdf:Description rdf:about="&obo;OGMS_0000045">
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000127"/>
                <someValuesFrom rdf:resource="&obo;OGMS_0000031"/>
            </Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000171"/>
                <someValuesFrom rdf:resource="&obo;OGMS_0000087"/>
            </Restriction>
        </rdfs:subClassOf>
        <disjointWith rdf:resource="&obo;ND#normal"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <rdfs:comment>**** NOTE ****

To assert that something is clinically abnormal is then to state:

(1) that it is not part of the life plan for an organism of the relevant type (thus aging or pregnancy are not clinically abnormal),
(2) that it is causally linked to an elevated risk of pain or suffering or other feelings of illness or of death or dysfunction on the part of the organism, and
(3) that it is such that this elevated risk exceeds a certain threshold level.

From pages 8-9 of Ceusters and Smith &quot;Foundations for a realist ontology of mental disease&quot;, Journal of Biomedical Semantics 2010, 1:10 http://www.jbiomedsem.com/content/1/1/10

Alexander P. Cox</rdfs:comment>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OGMS_0000063 -->

    <rdf:Description rdf:about="&obo;OGMS_0000063">
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;BFO_0000057"/>
                <someValuesFrom rdf:resource="&obo;OGMS_0000087"/>
            </Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <Class>
                <intersectionOf rdf:parseType="Collection">
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <someValuesFrom rdf:resource="&obo;OGMS_0000031"/>
                    </Restriction>
                    <Restriction>
                        <onProperty rdf:resource="&obo;BFO_0000055"/>
                        <allValuesFrom rdf:resource="&obo;OGMS_0000031"/>
                    </Restriction>
                </intersectionOf>
            </Class>
        </rdfs:subClassOf>
        <obo:IAO_0000116>Why isn&apos;t &apos;disease course&apos; a subclass of &apos;bodily process&apos;?  There is currently no definition for &apos;bodily process&apos;, but perhaps it is intended to capture only those processes that occur in the body that are &quot;normal&quot; or &quot;non-diseased&quot;.  If this is the intended distinction, it will undoubtedly be very difficult to construct an acceptable definition that will even hold up in most cases.

APC</obo:IAO_0000116>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OGMS_0000073 -->

    <rdf:Description rdf:about="&obo;OGMS_0000073">
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;ND#is_about"/>
                <someValuesFrom>
                    <Class>
                        <intersectionOf rdf:parseType="Collection">
                            <rdf:Description rdf:about="&obo;OBI_0100026"/>
                            <Restriction>
                                <onProperty rdf:resource="&obo;BFO_0000087"/>
                                <someValuesFrom rdf:resource="&obo;OBI_0000093"/>
                            </Restriction>
                            <Restriction>
                                <onProperty rdf:resource="&obo;BFO_0000158"/>
                                <someValuesFrom>
                                    <Class>
                                        <intersectionOf rdf:parseType="Collection">
                                            <rdf:Description rdf:about="&obo;OGMS_0000031"/>
                                            <Restriction>
                                                <onProperty rdf:resource="&obo;BFO_0000055"/>
                                                <someValuesFrom>
                                                    <Class>
                                                        <intersectionOf rdf:parseType="Collection">
                                                            <rdf:Description rdf:about="&obo;OGMS_0000063"/>
                                                            <Restriction>
                                                                <onProperty rdf:resource="&obo;BFO_0000167"/>
                                                                <someValuesFrom rdf:resource="&obo;OBI_0100026"/>
                                                            </Restriction>
                                                        </intersectionOf>
                                                    </Class>
                                                </someValuesFrom>
                                            </Restriction>
                                        </intersectionOf>
                                    </Class>
                                </someValuesFrom>
                            </Restriction>
                        </intersectionOf>
                    </Class>
                </someValuesFrom>
            </Restriction>
        </rdfs:subClassOf>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OGMS_0000086 -->

    <rdf:Description rdf:about="&obo;OGMS_0000086">
        <disjointWith rdf:resource="&obo;ND#normal"/>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/OGMS_0000087 -->

    <rdf:Description rdf:about="&obo;OGMS_0000087">
        <rdfs:comment>Move &apos;extended organism&apos; a subclass of OBI:organism.

Alexander P. Cox</rdfs:comment>
    </rdf:Description>
    


    <!-- http://purl.obolibrary.org/obo/PR_000000001 -->

    <Class rdf:about="&obo;PR_000000001">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/PR_000021937 -->

    <Class rdf:about="&obo;PR_000021937">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/elevated_cerebral_spinal_fluid_pressure -->

    <Class rdf:about="&obo;elevated_cerebral_spinal_fluid_pressure">
        <rdfs:label>elevated cerebral spinal fluid pressure</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000045"/>
        <obo:IAO_0000232>Change entity URI

I had to move this term here in order to keep the reasoner (FaCT++) from telling me that &apos;normal pressure hydrocephalus&apos; is equivalent to NOTHING.  This was due to the use of &apos;has material basis at all times&apos;, which has a domain/range restriction that limits it to material entities.

Alexander P. Cox</obo:IAO_0000232>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#ND_0002000 -->

    <Class rdf:about="&obo;ND#ND_0002000">
        <rdfs:label>memory deficit clinical finding</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#definite_AD1 -->

    <Class rdf:about="&obo;ND#definite_AD1">
        <rdfs:label>histopathological (brain biopsy or autopsy) evidence of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#definite_AD2 -->

    <Class rdf:about="&obo;ND#definite_AD2">
        <rdfs:label>genetic evidence (mutation on chromosome 1, 14, or 21) of Alzheimers disease</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#diagnostic_action -->

    <Class rdf:about="&obo;ND#diagnostic_action">
        <rdfs:label>diagnostic guideline action specification</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;IAO_0000007"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>Instructions for the clinician to diagnose the patient with the relevant disease, disorder, syndrome, or normal health when the diagnostic criteria provided by the diagnostic guideline are satisfied.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#diagnostic_objective -->

    <Class rdf:about="&obo;ND#diagnostic_objective">
        <rdfs:label>diagnostic guideline objective specification</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;IAO_0000005"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>The objective of a diagnostic guideline is for a clinician to determine whether or not the patient should be diagnosed with the relevant disease, disorder, or syndrome.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#normal -->

    <Class rdf:about="&obo;ND#normal">
        <rdfs:label>normal physiological feature</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;BFO_0000019"/>
        <obo:IAO_0000117>Alexander P. Cox</obo:IAO_0000117>
        <obo:IAO_0000115>A physiological feature that has the quality of being normal in virtue of not being diseased, disordered, or presenting with a syndrome.</obo:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#possible_AD1 -->

    <Class rdf:about="&obo;ND#possible_AD1">
        <rdfs:label>dementia in the absence of other neurologic, psychiatric, or systemic disorders</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;ND#is_about"/>
                <someValuesFrom rdf:resource="&obo;ND_0003000"/>
            </Restriction>
        </rdfs:subClassOf>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#possible_AD2 -->

    <Class rdf:about="&obo;ND#possible_AD2">
        <rdfs:label>dementia in the presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be its primary cause</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="&obo;ND#is_about"/>
                <someValuesFrom rdf:resource="&obo;ND_0003000"/>
            </Restriction>
        </rdfs:subClassOf>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#probable_AD1 -->

    <Class rdf:about="&obo;ND#probable_AD1">
        <rdfs:label>presence of an early and significant episodic memory impairment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#probable_AD2 -->

    <Class rdf:about="&obo;ND#probable_AD2">
        <rdfs:label>presence of medial temporal lobe atrophy</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000017"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#probable_AD3 -->

    <Class rdf:about="&obo;ND#probable_AD3">
        <rdfs:label>abnormal cerebrospinal fluid biomarker</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000018"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#probable_AD4 -->

    <Class rdf:about="&obo;ND#probable_AD4">
        <rdfs:label>reduced glucose metabolism in bilateral temporal parietal regions measured by functional neuroimaging with PET</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000018"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#probable_AD5 -->

    <Class rdf:about="&obo;ND#probable_AD5">
        <rdfs:label>proven AD autosomal dominant mutation within the immediate family</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000015"/>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/ND#probable_AD6 -->

    <Class rdf:about="&obo;ND#probable_AD6">
        <rdfs:label>sudden onset of episodic memory impairment</rdfs:label>
        <rdfs:subClassOf rdf:resource="&obo;OGMS_0000014"/>
    </Class>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotations
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <rdf:Description rdf:about="&obo;FMA_62209">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000038">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62200">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62201">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_226239">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62202">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62205">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_84355">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72820">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62402">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72821">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62401">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62404">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62403">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72824">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62406">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72825">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000035">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000034">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72822">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62407">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72823">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83881">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000031">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000030">
        <obo:IAO_0000412 rdf:resource="&obo;bfo.owl"/>
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62218">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55652">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_223151">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62212">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77464">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62210">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62211">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77466">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62216">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62217">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_40674">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62215">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77458">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_13889">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62419">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62418">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83873">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000293">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83874">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000017">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000018">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68614">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000015">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000016">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_7149">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70714">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70710">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70711">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70712">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70713">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000011">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000026">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_7157">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000471">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000027">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000029">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_226223">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_226221">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70709">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71011">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70708">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70707">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70705">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70706">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70703">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70704">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70701">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70702">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70700">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000272">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000021935">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000078">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000020">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000023">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_7153">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_7154">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000024">
        <obo:IAO_0000412 rdf:resource="&obo;bfo.owl"/>
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000079">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83840">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62441">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62443">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000070">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0500000">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_42603">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000084">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;subject">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000085">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000086">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_49443">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000080">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000081">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000083">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77220">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242675">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_229583">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_229585">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000059">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000053">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000051">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#surrounded_by">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83860">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000058">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62429">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62424">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000245">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62440">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_9526">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0100001">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000067">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62438">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62436">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62434">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62435">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;relation">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83859">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000011">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242609">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74510">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83687">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83686">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71235">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74519">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242611">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74628">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268481">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258762">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258760">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258766">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258764">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258768">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74636">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78590">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71248">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74509">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242625">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258772">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242627">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74882">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_45688">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77700">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67498">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83699">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_86103">
        <obo:IAO_0000232>If this class and all of its subclasses are intended to be regions and not parts of material entities, then its placement in the hierarchy here is inconsistent with the BFO hierarchy.  If this is the case, then this class properly belongs under &apos;immaterial entity&apos; despite being currently located under &apos;material entity&apos; due to the FMA hierarchy.  I believe that I have resolved most of the more glaring inconsistencies between BFO and FMA with this import as a temporary solution.  In the case of this class, I have left it here because there is a lot of room for confusion between referring to the regions that fiat parts of the brain occupy and the physical brain matter that occupies those regions.  Ultimately, this issue needs to be resolved by the curators of the FMA.  Hopefully they will make FMA compliant with BFO soon!

Alexander P. Cox</obo:IAO_0000232>
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;date">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55676">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74866">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_117570">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_117571">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78563">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#bounded_by">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000002">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000018263">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000003">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000001">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000833">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;identifier">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000018264">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000066">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000009">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000008">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000006">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000004">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_84770">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67325">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67329">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;pr#lacks_part">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_20394">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78540">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55662">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55661">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71259">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000225">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77011">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258749">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000030">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <obo:IAO_0000412 rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_86596">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_86595">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_86594">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55675">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77006">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55672">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71267">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55671">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_55670">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74520">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_24137">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256377">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67812">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67811">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#constitutional_part_of">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256381">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54501">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_236869">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_236867">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_89593">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61899">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256198">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256196">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72438">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61894">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61893">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61898">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61897">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000016778">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000016777">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61896">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67687">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256194">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77868">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72429">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_64990">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74046">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://www.w3.org/2002/07/owl#Thing">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74047">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_64989">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77871">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;language">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256133">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256135">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72698">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72697">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72699">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72694">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72693">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_33213">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72696">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72695">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83465">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72691">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72692">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72690">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72484">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72689">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72688">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54545">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72687">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72686">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72685">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_79876">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72684">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72683">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72682">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_73730">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67440">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72473">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72477">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72478">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72680">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72479">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72681">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72672">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256150">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72671">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72674">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72673">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77096">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72676">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72481">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72480">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72675">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72678">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72483">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72677">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72679">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;pr#derives_from">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62189">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;pr#part_of">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72465">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72468">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72670">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72469">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72466">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77628">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67135">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72662">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72661">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72660">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72472">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72667">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72666">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72471">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72665">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62190">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_33208">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62193">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72669">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72668">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62194">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62195">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_85592">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62198">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62184">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62187">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62186">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72659">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242388">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72657">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72658">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72655">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242384">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72656">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72653">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242386">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72654">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242380">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242382">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61839">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61834">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61833">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61835">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61830">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72248">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72247">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72246">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61831">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62177">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72245">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62178">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000207">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72243">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62179">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_5897">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72242">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72260">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62176">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62175">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62174">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62172">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000417">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62170">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242378">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242376">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54588">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242374">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242372">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256301">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242370">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61849">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61845">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0010000">
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61842">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62374">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61841">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61840">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62372">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72253">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62166">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62165">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62164">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61819">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67890">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;publisher">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005911">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54585">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005910">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61815">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61817">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005919">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62156">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005913">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005912">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62150">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000202">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62154">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005909">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62153">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72240">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62347">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62152">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72241">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62151">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242392">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67883">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54565">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61825">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54573">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72239">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61695">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61823">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61822">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242390">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61826">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000016963">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62146">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62147">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005908">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62145">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000005907">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61821">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61820">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62148">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62350">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_314295">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62141">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62142">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000600">
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74038">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000601">
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_314293">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62138">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74042">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74044">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74045">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74041">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72413">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72411">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72412">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61878">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_266054">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72607">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72603">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_9347">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_84081">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61887">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61884">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000019502">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61885">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000602">
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000019505">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72405">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_76928">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61889">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72814">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72813">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72812">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72811">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72818">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72817">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72816">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72815">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62398">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62399">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72810">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_84053">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_84054">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_49187">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_270201">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61856">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61857">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72819">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61859">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72801">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72800">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72803">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_81150">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72802">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72805">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72804">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72807">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72806">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61860">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_84059">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_224858">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;coverage">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_224854">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61862">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62394">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62393">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72808">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_224850">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72809">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_224852">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68462">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68463">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000170">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000174">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000175">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268537">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000172">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000173">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61908">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000178">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61907">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000176">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61909">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268539">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000177">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61903">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;rights">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61904">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72969">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61905">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61906">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61900">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61901">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_45728">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61902">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62502">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_261141">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62313">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62314">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62311">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000589">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62312">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000181">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62310">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000182">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000184">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000185">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000187">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72976">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72977">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72978">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72972">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62514">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72973">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72974">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72975">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72970">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72971">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62320">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_7776">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_234941">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62323">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000572">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62326">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_75007">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61921">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61922">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242982">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61924">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_58817">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_6072">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_14065">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242980">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62331">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62332">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62337">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62335">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62336">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62339">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61918">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_261139">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61913">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61910">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61911">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61916">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78438">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61914">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61915">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62532">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268180">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000130">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78450">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78451">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78452">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78453">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78454">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268185">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268183">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;source">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_8287">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78447">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000138">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000139">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000136">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78449">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000137">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78448">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000140">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000142">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000144">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78467">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000146">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000145">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242368">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242366">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000147">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242364">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268175">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78459">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000148">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242362">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_268177">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242360">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000157">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_82478">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000156">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000155">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000154">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000153">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78471">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000152">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000151">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_82472">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72981">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_32525">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72980">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78469">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_32523">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_32524">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_2759">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000159">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000166">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000165">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000168">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000162">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000161">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000164">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000163">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000160">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_12247">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_12237">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258682">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258685">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000169">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_2157">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000116">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000104">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000112">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <rdfs:isDefinedBy rdf:resource="&obo;iao.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000124">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000108">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000107">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242166">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_9647">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71108">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_71106">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_75260">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_9604">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_9605">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000020724">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000101">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256726">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000119">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_235320">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000115">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83956">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_235322">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_46448">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83952">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83951">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_269079">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000011119">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000011118">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242787">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000111">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000112">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000129">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000126">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000125">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_9668">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000123">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000124">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;BFO_0000121">
        <rdfs:isDefinedBy rdf:resource="&obo;bfo.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77108">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;format">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000144">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_74414">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_207598">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242197">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242193">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_33154">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000011120">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_85700">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62908">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242176">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77537">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77538">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242180">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77536">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77534">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000136">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000125"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242182">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61775">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256271">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_50705">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67242">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000310">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242207">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256279">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54614">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242003">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256277">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83904">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258704">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256275">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83902">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256273">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54611">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258708">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;bfo.owl">
        <rdfs:isDefinedBy rdf:resource="http://bfo.googlecode.com/svn/trunk/src/ontology/owl-group/specification/"/>
        <rdfs:seeAlso rdf:resource="http://bfo.googlecode.com/svn/trunk/src/tools/"/>
        <foaf:homepage rdf:resource="http://code.google.com/p/bfo/"/>
        <dc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/"/>
        <rdfs:seeAlso rdf:resource="http://goo.gl/bIlrEE"/>
        <rdfs:seeAlso rdf:resource="http://groups.google.com/group/bfo-devel"/>
        <rdfs:seeAlso rdf:resource="http://groups.google.com/group/bfo-discuss"/>
        <rdfs:seeAlso rdf:resource="http://groups.google.com/group/bfo-owl-devel"/>
        <foaf:homepage rdf:resource="http://ifomis.org/bfo"/>
        <rdfs:isDefinedBy rdf:resource="&obo;bfo/2012-07-20/Reference"/>
        <rdfs:isDefinedBy rdf:resource="&obo;bfo/2012-07-20/ReleaseNotes"/>
        <rdfs:isDefinedBy rdf:resource="&obo;bfo/dev/bfo.clif"/>
        <foaf:mbox rdf:resource="mailto:bfo-owl-devel@googlegroups.com"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54617">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242000">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_258700">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256281">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256283">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;IAO_0000300">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256289">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54602">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54603">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256285">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62000">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256287">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54608">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67949">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62009">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62007">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72577">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67944">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62008">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67943">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72576">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62005">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67942">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72573">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62003">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62004">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67947">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72572">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72575">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62001">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72574">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62010">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72580">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72581">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256255">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256259">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_73423">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;creator">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67552">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67555">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_73422">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62019">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62013">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62014">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256261">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62020">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256263">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72571">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62022">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256265">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62021">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54621">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256267">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_54624">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256269">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62024">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62023">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72598">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62029">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72599">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67966">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62028">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62027">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_73435">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_75741">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_73434">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83115">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62032">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62030">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72799">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72798">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62035">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72585">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72586">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67957">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72584">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72790">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72791">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62038">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67292">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#part_of">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_75735">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_75730">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_75732">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72789">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72784">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72783">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72782">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67962">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72781">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62041">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72788">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72787">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72786">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62043">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72785">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83929">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256293">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256291">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83142">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_77719">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_314146">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;type">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256297">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256295">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83926">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256299">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256691">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256693">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83153">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83143">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_242209">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72750">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72751">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61979">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72754">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72755">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70663">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72752">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72753">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72758">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000312">
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72759">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72756">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62477">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62476">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72757">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62478">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61973">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_80183">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62482">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62483">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62484">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70671">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70672">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83700">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256200">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70675">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70676">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70673">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70674">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72744">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68862">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72745">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61981">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61982">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72746">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68861">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70677">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72747">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256208">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70678">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61980">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72748">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72749">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83703">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_33316">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_9443">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83704">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83701">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256204">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_83702">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68855">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_33511">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78498">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_78497">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_76828">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72776">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72777">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68596">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72774">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72775">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72772">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61998">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72773">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72770">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72771">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000338">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000120"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61996">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61997">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#systemic_part_of">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68875">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68874">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61992">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72778">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72779">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61993">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72780">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_58895">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&dc;title">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/elements/1.1/"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72763">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72764">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72765">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72766">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72760">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72761">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72762">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_80187">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_80186">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_80185">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_80184">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72767">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72768">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72769">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62486">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_80188">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_68876">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62493">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;OBI_0000339">
        <obo:IAO_0000114 rdf:resource="&obo;IAO_0000122"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72715">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72712">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72719">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72718">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_376913">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72717">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72716">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256235">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256230">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72711">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61939">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_81257">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_81255">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_81256">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_81254">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000015322">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61731">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61732">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61733">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72702">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72701">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72704">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#regional_part_of">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72703">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72706">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72705">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_61940">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256245">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72700">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_62223">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_7711">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;fma#receives_input_from">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256216">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256218">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72739">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72738">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_7647">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72737">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70689">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72736">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70688">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70685">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70684">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70687">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256210">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70686">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72730">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70681">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;PR_000004168">
        <obo:IAO_0000412 rdf:resource="&obo;pr.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256212">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70683">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256214">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70682">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_24208">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70690">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72538">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72536">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72537">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67504">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72728">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256228">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;NCBITaxon_7742">
        <obo:IAO_0000412 rdf:resource="&obo;ncbitaxon.owl"/>
        <obo:IAO_0000412 rdf:resource="&obo;obi.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72729">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256226">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72724">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72723">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72726">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72725">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72720">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256220">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70696">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72722">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70695">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_72721">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70694">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70693">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256224">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70692">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_70691">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_256222">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_24218">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67705">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
    <rdf:Description rdf:about="&obo;FMA_67706">
        <obo:IAO_0000412 rdf:resource="&obo;fma.owl"/>
    </rdf:Description>
</rdf:RDF>



<!-- Generated by the OWL API (version 3.4.2) http://owlapi.sourceforge.net -->

